Publikationen

... aus dem Institut für Biochemie der Deutschen Sporthochschule Köln

Die Publikationen sind nach Erscheinungsjahr ab 1990 aufgeführt. Innerhalb des Jahrgangs sind sie alphabetisch nach Autoren geordnet.   

2024

Breuer J, Garzinsky AM, Thomas A, Nieschlag E, Kliesch S, Fedoruk M, Geyer H, Thevis M. Complementary information concerning the suspected interindividual transmission of GW1516, a substance prohibited in sport, through intimate contact: a case report. Forensic Toxicol. 2024 Jul;42(2):248-254. doi: 10.1007/s11419-024-00689-x.

F. Eichler, A. Ehrle, M. Machnik, K.C. Jensen, S. Wagner, N. Baudisch, J. Bolk, M. Pötzsch, M. Thevis, W. Bäumer, C. Lischer and M. Wiegard (2024) Behavioral observations, heart rate and cortisol monitoring in horses following multiple ral administrations of a cannabidiol containing paste (part 2/2). Frontiers in Veterinary Science 10, 1 – 13. DOI 10.3389/fvets.2023.1305873

F. Eichler, B. Poźniak, M. Machnik, I. Schenk, A. Wingender, N. Baudisch, M. Thevis, W. Bäumer, C. Lischer and A. Ehrle (2023) Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses. Frontiers in Veterinary Science 10, 1 – 14. DOI 10.3389/fvets.2023.1234551. 

Görgens C, Möller T, Guddat S, Svambayev E, Geyer H, Thomas A, Thevis M. Urinary metabolites indicative of the administration of hypoxen monitored by liquid chromatography-high resolution/accurate mass tandem mass spectrometry. Drug Test Anal. 2024 Apr 23. doi: 10.1002/dta.3701. Epub ahead of print. PMID: 38654556.

Oliver Krug, Mario Thevis, Chiral analysis of ostarine in commercially available products and doping control urine samples, Journal of Chromatography Open, Volume 5,2024,10013,ISSN 2772 3917, doi.org/10.1016/j.jcoa.2024.100137. 

M. Machnik, S. Wagner, I. Schenk and M. Thevis (2023) Doping-Gefahr für Sportpferde durch kontaminierte Futtermittel. Der Praktische Tierarzt 104 (12), 1184–1191. doi 10.2376/0032-681X-2930

Paßreiter A, Naumann N, Thomas A, Grogna N, Delahaut P, Thevis M. Detection of sgRNA via SHERLOCK as Potential CRISPR Related Gene Doping Control Strategy. Anal Chem. 2024 May 14;96(19):7452-7459. doi: 10.1021/acs.analchem.3c05776

Piper T, Krombholz S, Thevis M. Carbon isotope ratios of phenethylamine and its urinary metabolite phenylacetylglutamine. Drug Test Anal. 2023 Dec 4. doi: 10.1002/dta.3616. Epub ahead of print. PMID: 38048815.

Piper T, Fußhöller G, Thevis M. Employing 11-Ketotestosterone as a Target Analyte for Adrenosterone (11OXO) Administration in Doping Controls. Metabolites. 2024 Feb 26;14(3):141. doi: 10.3390/metabo14030141. PMID: 38535301; PMCID: PMC10972305.

Thomas A, Walpurgis K, Thevis M. Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples. J Mass Spectrom. 2024 Jan;59(1):e4996. doi: 10.1002/jms.4996. PMID: 38197510.

Thomas A, Walpurgis K, Thevis M. Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples. J Mass Spectrom. 2024 Jan;59(1):e4996. doi: 10.1002/jms.4996. PMID: 38197510.

Tuma C, Thomas A, Trede L, Braun H, Thevis M. Pharmacokinetic Profile of Caffeine and Its Two Main Metabolites in Dried Blood Spots After Five Different Oral Caffeine Administration Forms-A Randomized Crossover Study. Int J Sport Nutr Exerc Metab. 2024 Jan 12:1-10. doi: 10.1123/ijsnem.2023-0141. Epub ahead of print. PMID: 38215733.

Tuma C, Thomas A, Braun H, Thevis M. Development of an LC-HRMS/MS Method for Quantifying Steroids and Thyroid Hormones in Capillary Blood: A Potential Tool for Assessing Relative Energy Deficiency in Sport (RED-S). Metabolites. 2024 Jun 12;14(6):328. doi: 10.3390/metabo14060328. PMID: 38921463; PMCID: PMC11205421.

Vierbaum L, Weiss N, Kaiser P, Kremser M, Wenzel F, Thevis M, Schellenberg I, Luppa PB. Longitudinal analysis of external quality assessment of immunoassay-based steroid hormone measurement indicates potential for improvement in standardization. Front Mol Biosci. 2024 Jan 31;11:1345356. doi: 10.3389/fmolb.2024.1345356. PMID: 38357630; PMCID: PMC10865096.

Walpurgis K, Thomas A, Sato M, Okano M, Geyer H, Thevis M. Detection of the GH analog somatrogon in sports drug testing: Immunological approaches and LC-HRMS/MS. Drug Test Anal. 2024 Jul 11. doi: 10.1002/dta.3766. Epub ahead of print. PMID: 38992930.

2023

Andersson A, Piper T, Ekström L, Hirschberg AL, Thevis M. Usefulness of serum androgen isotope ratio mass spectrometry (IRMS) to detect testosterone supplementation in women. Drug Test Anal. 2023 Apr;15(4):465-469. doi: 10.1002/dta.3428. Epub 2022 Dec 30. PMID: 36564145.

Bauhaus H, Jensen PM, Braun H, Thevis M. Evaluation of Validity and Reliability of a German General and Sports Nutrition Knowledge Questionnaire for Athletes and Coaches (GSNKQ-AC). Nutrients. 2023 Nov 20;15(22):4844. doi: 10.3390/nu15224844. PMID: 38004238; PMCID: PMC10674910.

Bauhaus, H.; Erdogan, P.; Braun, H.; Thevis, M. Continuous Glucose Monitoring (CGM) in Sports—A Comparison between a CGM Device and Lab-Based Glucose Analyser under Resting and Exercising Conditions in Athletes. Int. J. Environ. Res. Public Health 2023, 20, 6440. doi.org/10.3390/

Brockbals L, Thomas A, Schneider TD, Kraemer T, Steuer AE, Thevis M. Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 3: LC-MS/MS-based peptide analysis for dried blood spot sampling time point estimation. Drug Test Anal. 2023 Feb 24. doi: 10.1002/dta.3463. Epub ahead of print. PMID: 36829300.

Eichler F, Poźniak B, Machnik M, Schenk I, Wingender A, Baudisch N, Thevis M, Bäumer W, Lischer C, Ehrle A. Pharmacokinetic modelling of orally administered cannabidiol and implications for medication control in horses. Front Vet Sci. 2023 Aug 9;10:1234551. doi: 10.3389/fvets.2023.1234551. PMID: 37621871; PMCID: PMC10445762.

Euler L, Mürdter T, Heinkele G, Schwab M, Miller GD, Eichner D, Thomas A, Thevis M. Identification and synthesis of (Z)-3'-hydroxy clomiphene as a new potential doping-relevant metabolite of clomiphene. Rapid Commun Mass Spectrom. 2023 Sep 15;37(17):e9599. doi: 10.1002/rcm.9599. PMID: 37580503.

Garzinsky AM, Thomas A, Guddat S, Görgens C, Dib J, Thevis M. Dried Blood Spots for Doping Controls - Development of a comprehensive Initial Testing Procedure with fully automated sample preparation. Biomed Chromatogr. 2023 Mar 27:e5633. doi: 10.1002/bmc.5633. Epub ahead of print. PMID: 36974028.

Krombholz S, Thomas A, Delahaut P, Bidlingmaier M, Schilbach K, Miller G, Thevis M. A combined top-down and bottom-up LC-HRMS/MS method for the quantification of human growth hormone in plasma and serum. Growth Horm IGF Res. 2023 Nov 21;72-73:101560. doi: 10.1016/j.ghir.2023.101560. Epub ahead of print. PMID: 37995539.

Krug O, Guddat S, Görgens C, Piper T, Möller T, Thevis M. Determination of urinary deanol-N-oxide excretion profiles after ingestion of nutritional supplements containing deanol. Drug Test Anal. 2023 Sep 21. doi: 10.1002/dta.3580. Epub ahead of print. PMID: 37735938

Möller T, Wen HC, Naumann N, Krug O, Thevis M. Identification and Synthesis of Selected In Vitro Generated Metabolites of the Novel Selective Androgen Receptor Modulator (SARM) 2f. Molecules. 2023 Jul 20;28(14):5541. doi: 10.3390/molecules28145541. PMID: 37513414; PMCID: PMC10385812.

Naumann N, Walpurgis K, Rubio A, Thomas A, Paßreiter A, Thevis M. Detection of doping control sample substitutions via single nucleotide polymorphism-based ID typing. Drug Test Anal. 2023 Nov 9. doi: 10.1002/dta.3597. Epub ahead of print. PMID: 37946680.

Naumann N, Paßreiter A, Thomas A, Krug O, Walpurgis K, Thevis M. Analysis of Potential Gene Doping Preparations for Transgenic DNA in the Context of Sports Drug Testing Programs. Int J Mol Sci. 2023 Oct 31;24(21):15835. doi: 10.3390/ijms242115835. PMID: 37958821; PMCID: PMC10648417.

Piper T, Thevis M. Investigations into the human metabolism of ecdysterone. Drug Test Anal. 2023 Oct 1. doi: 10.1002/dta.3582. Epub ahead of print. PMID: 37778393.

Rubio A, Thomas A, Euler L, Geyer H, Krug O, Reis G, Padilha MC, Pereira HMG, Muniz-Santos R, Cameron LC, Stojanovic B, Kuehne D, Lagojda A, McLeod MD, Thevis M. Investigations into Annona fruit consumption as a potential source of dietary higenamine intake in the context of sports drug testing. Drug Test Anal. 2023 Nov-Dec;15(11-12):1488-1502. doi: 10.1002/dta.3558. Epub 2023 Jul 31. PMID: 37525530.

Schenk I, Broussou D, Roques B, Lagershausen H, Machnik M, Röttgen H, Toutain PL, Thevis M. Control of a sulfadoxine/trimethoprim combination in the competition horse: Elimination, metabolism and detection following an intravenous administration. Drug Test Anal. 2023 Feb 20. doi: 10.1002/dta.3461. Epub ahead of print. PMID: 36806946.

Sobolevsky T, Walpurgis K, Goergens C, Fedoruk M, Lewis L, Ahrens B, Thevis M. Detection of capromorelin in urine following oral and dermal routes of administration. Drug Test Anal. 2023 Sep 8. doi: 10.1002/dta.3573. Epub ahead of print. PMID: 37688359.

Thevis M, Kuuranne T, Geyer H. Annual banned-substance review 16th edition-Analytical approaches in human sports drug testing 2022/2023. Drug Test Anal. 2023 Nov 20. doi: 10.1002/dta.3602. Epub ahead of print. PMID: 37985429.

Thevis M, Görgens C, Guddat S, Thomas A, Geyer H. Mass spectrometry in sports drug testing – Analytical approaches and the athletes' exposome. Scand J Med Sci Sports. 2022 Dec 20. doi:10.1111/sms.14228

Thomas A, Krombholz S, Breuer J, Walpurgis K, Thevis M. Insulin-mimetic peptides in sports drug testing. Drug Test Anal. 2023 Sep 11. doi: 10.1002/dta.3572. Epub ahead of print. PMID: 37691519.

Thomas A, Thevis M. Recent advances in mass spectrometry for the detection of doping. Recent advances in mass spectrometry for the detection of doping. Expert Rev Proteomics. 2024 Jan-Mar;21(1-3):27-39. doi: 10.1080/14789450.2024.2305432. 

Tuma C, Schick A, Pommerening N, Braun H, Thevis M. Effects of an Individualized vs. Standardized Vitamin D Supplementation on the 25(OH)D Level in Athletes. Nutrients. 2023 Nov 10;15(22):4747. doi: 10.3390/nu15224747. PMID: 38004144; PMCID: PMC10675819.

Tuma C, Thomas A, Braun H, Thevis M. Quantification of 25-hydroxyvitamin D2 and D3 in Mitra® devices with volumetric absorptive microsampling technology (VAMS®) by UHPLC-HRMS for regular vitamin D status monitoring. J Pharm Biomed Anal. 2023 May 10;228:115314. doi: 10.1016/j.jpba.2023.115314. Epub 2023 Mar 1. PMID: 36870118.

Wagener F, Naumann N, Göldner V, Görgens C, Guddat S, Karst U, Thevis M. Comparison of in vitro approaches for predicting the metabolism of the selective androgen receptor modulator RAD140. Anal Bioanal Chem. 2023 Sep;415(23):5657-5669. doi: 10.1007/s00216-023-04835-z. Epub 2023 Jul 8. PMID: 37421437; PMCID: PMC10473985.

Walpurgis K, Gäde A, Thomas A, Gochard S, Delahaut P, Thevis M. Detection of extracellular hemoglobin from Arenicola marina in doping control serum samples by means of liquid chromatography and high-resolution tandem mass spectrometry. Drug Test Anal. 2023 Nov 2. doi: 10.1002/dta.3591. Epub ahead of print. PMID: 37918029.

Walpurgis, K., Piper, T., Reihlen, P., Thomas, A., Görgens, C., Guddat, S., Dib, J., Krug, O., Thevis, M. "Sports Drug Testing" - Chapter 4. In Karch's Drug Abuse Handbook (3rd Edition). Edited By Steven B. Karch, Bruce A. Goldberger, published November 29, 2022 by CRC Press, pages 367-436, ISBN 9781420094992

Walpurgis K, Agricola J, Thomas A, Thevis M. Myostatin inhibitory peptides in sports drug testing. Drug Test Anal. 2023 Nov-Dec;15(11-12):1477-1487. doi: 10.1002/dta.3473. Epub 2023 Mar 29. PMID: 36946003.

Breuer J, Thomas A, Geyer H, Thevis M. Probing for the presence of semenogelin in human urine by immunological and chromatographic-mass spectrometric methods in the context of sports drug testing. Anal Sci Adv. 2022;3:21–28. doi.org/10.1002/ansa.202100058

Carthaus A, Görgens C, Knoop A, Geyer H, Thevis M. Dried blood spots as option to monitor the Anti-SARS-CoV-2 antibody response after infection or vaccination. Dtsch Z Sportmed. 2022; 73: 53-60. doi:10.5960/dzsm.2021.519

Euler, L., Wagener. F., Thomas, A. & Thevis, M. Determination and enantioselective separation of zilpaterol in human urine after mimicking consumption of contaminated meat by HPLC-MS/MS techniques. Rapid Commun Mass Spectrom. 2022 Oct 15;36(19):e9357. doi: 10.1002/rcm.9357. PMID: 35851724.

Euler L, Gillard N, Delahaut P, Pierret G, Mürdter T, Schwab M, Döhmen G, Thomas A, Thevis M. Assessing human urinary clomiphene metabolites after consumption of eggs from clomiphene-treated laying hens using chromatographic-mass spectrometric approaches. Anal Chim Acta. 2022 Apr 15;1202:339661. doi: 10.1016/j.aca.2022.339661. Epub 2022 Mar 1. PMID: 35341524.

Fußhöller G, Geyer H, Haenelt N, Hülsemann F, Gougoulidis V, Blatt C, Thevis M: Additional investigations in connection with atypical findings for 19-norandrosterone - a case study. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 38-40

Garzinsky AM, Thomas A, Thevis M. Probing for factors influencing exhaled breath drug testing in sports- Pilot studies focusing on the tested individual's tobacco smoking habit and sex. Rapid Commun Mass Spectrom. 2022 Apr 30;36(8):e9262. doi: 10.1002/rcm.9262. PMID: 35094434.

Gessner L, Thevis M, Rothschild MA, Juebner M. Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application. Drug Test Anal. 2022;14(10): 1744‐1761. doi:10.1002/dta.3355

Haenelt N, Lourens L, Fußhöller G, Geyer H, Goldmann L, Schult C, Schwenke A, Hülsemann F, Gougoulidis V, Blatt C, Thevis M:  Follow-up investigations of atypical passport findings for the ratio 5a-Androstane-3a,17b-diol/5b-Androstane-3a,17b-diol. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021). 34 37

Krombholz S, Thomas A, Thevis M. Investigations into the In Vitro Metabolism of hGH and IGF-I Employing Stable-Isotope-Labelled Drugs and Monitoring Diagnostic Immonium Ions by High-Resolution/High-Accuracy Mass Spectrometry. Metabolites. 2022 Feb 4;12(2):146. doi: 10.3390/metabo12020146. PMID: 35208220; PMCID: PMC8877552.

Krug O, Geyer H, Thomas A, Walpurgis K, Piper T, Thevis M: Black market products suspected to contain doping relevant ingredients - report for 2019^_2020. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 122-127

Mareck U, Fusshöller G, Schertel T, Petring S, Huestis MA, Thevis M. Risk of unintentional antidoping rule violations by consumption of hemp products. Drug Test Anal. 2022 May 28. doi: 10.1002/dta.3327. Epub ahead of print. PMID: 35633098.

Mareck U, Geyer H, Fußhöller G, Haenelt N, Thevis M:  Results of confirmation procedures in the scope of the steroidal athlete biological passport in the Cologne laboratory from 2017^_2019. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 41-44

Mareck U, Fußhöller G, Haenelt N, Thevis M: Risk of unintentional antidoping rule violations by consumption of hemp products. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 128-132

Mareck U, Fußhöller G, Geyer H, Thevis M: Simplified confirmation analysis for Carboxy-THC. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 163-166

Paßreiter A, Naumann N, Thomas A, Grogna N, Delahaut P, Thevis M. How to detect CRISPR with CRISPR - employing SHERLOCK for doping control purposes. Analyst. 2022 Nov 21;147(23):5528-5536. doi: 10.1039/d2an01318e.

Piper T, Thevis M. Addressing recent challenges in isotope ratio mass spectrometry: Development of a method applicable to 1-androstene-steroids, 6α-hydroxyandrostenedione, and androstatrienedione. Drug Test Anal. 2022;1‐13. doi:10.1002/dta.3361

Piper T, Fusshöller G, Schänzer W, Thevis M. Investigations on the in vivo metabolism of 5α-androst-2-en-17-one. Rapid Commun Mass Spectrom. 2022 Jun 23:e9343. doi: 10.1002/rcm.9343. Epub ahead of print. PMID: 35737649.

Piper T, Geyer H, Toboc A, Ahrens B, Pohanka A, Thevis M: Recent findings on 7-oxo-DHEA and its improved detection based on reference population-derived thresholds for 7β-OH-DHEA and 5α-androstane-3β,7β-diol-17-one. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 45-49

Piper T, Panto S, Thevis M: Highly sensitive low resolution GCxGC-TOF as a complement in doping control analysis of anabolic androgenic steroids. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 50-54

Rubio A, Geyer H, Costa Padilha M, Pereira H, Cameron L, Thevis M: Higenamine quantification and investigation into structural characteristics of its metabolites in urine samples. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 73-77

Rubio A, Sigmund G, Piper T, Geyer H, Thevis M: Evaluation of doping control samples to determine the prevalence of nicotine use by German elite athletes. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 167-170

Solheim SA, Thomas A, Ringsted TK, Thevis M, Breenfeldt Andersen A, Holm-Sørensen H, Nordsborg NB, Mørkeberg J. Analysis of dried blood spots is a feasible alternative for detecting ephedrine in doping control. Drug Test Anal. 2022 Jun 23. doi: 10.1002/dta.3338. Epub ahead of print. PMID: 35738840.

Thevis M, Kuuranne T, Geyer H. Annual banned-substance review - Analytical approaches in human sports drug testing 2021/2022 . Drug Test Anal. 2022;1‐22. doi:10.1002/dta.3408

M. Thevis, Katja Walpurgis & A. Thomas (2022): DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing, Critical Reviews in Clinical Laboratory Sciences, DOI:10.1080/10408363.2022.2103085

Thomas A, Thilmany S, Hofmann A, Thevis M. Probing for peptidic drugs (2–10 kDa) in doping control blood samples. Anal Sci Adv. 2022;3:235–243. doi.org/10.1002/ansa.202200027

Thomas A, Thevis M. Stereoisomers in sports drug testing: Analytical strategies and applications. J Chromatogr A. 2022 Jul 5;1674:463154. doi: 10.1016/j.chroma.2022.463154. Epub 2022 May 17. PMID: 35613502.

Thomas A, Fox J, Slade S, Kislyuk S, Gastall H, Thevis M: Preliminary data for ion mobility separation of recombinant and synthetic insulin ariants on a cyclic IMS mass spectrometer. In: Thevis M, Geyer H, Mareck U eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 96-100

Wagener, F., Euler, L., Görgens, C., Guddat, S. & Thevis, M. Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for Doping Control Purposes: Metabolites; 2022 Jul 20;12(7):666. doi: 10.3390/metabo12070666.

Walpurgis, K., Thomas, A. & Thevis, M. Blood in Sports Drug Testing: Biological Matrix and Doping Agents. In: The Blood Project. 2022 Sep 27.

Walpurgis K, Piper T, Thevis M. Androgens, sports, and detection strategies for anabolic drug use. Best Pract Res Clin Endocrinol Metab. 2021 Dec 27:101609. doi: 10.1016/j.beem.2021.101609. Epub ahead of print. PMID: 35120801.

2021

Equey T, Pastor A, de la Torre Fornell R, Thomas A, Giraud S, Thevis M, Kuuranne T, Baume N, Barroso O, Aikin R. Application of the Athlete Biological Passport approach to the detection of growth hormone doping. J Clin Endocrinol Metab. 2022 Feb 17;107(3):649-659. doi: 10.1210/clinem/dgab799. PMID: 34726230.

Garzinsky AM, Thomas A, Krug O, Thevis M. Probing for the presence of doping agents in exhaled breath using chromatographic/mass spectrometric approaches. Rapid Commun Mass Spectrom. 2021 Jan 15;35(1):e8939. doi: 10.1002/rcm.8939. PMID: 32881194.
download article

Geyer H, Fusshöller G, Haenelt N, Mareck U, Blatt C, Gougoulidis V, Hülsemann F, Piper T, Thevis M: The ratio 5aAdiol/E as indicator for the detection of testosterone doping in athletes with naturally low T/E – a case study. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (28). Sportverlag Strauß, Köln (2020), 90-93.

Görgens C, Walker K, Boeser C, Wijeratne N, Martins C, Guddat S, Thevis M. Paper spray mass spectrometry - A potential complementary technique for the detection of polar compounds in sports drug testing. Drug Test Anal. 2020 Nov;12(11-12):1658-1665. doi: 10.1002/dta.2909. Epub 2020 Sep 9. PMID: 32776416

Görgens C, Ramme AP, Guddat S, Schrader Y, Winter A, Dehne EM, Horland R, Thevis M. Organ-on-a-chip: Determine feasibility of a human liver microphysiological model to assess long-term steroid metabolites in sports drug testing. Drug Test Anal. 2021 Nov;13(11-12):1921-1928. doi: 10.1002/dta.3161. Epub 2021 Sep 22. PMID: 34505743.

Lorenz Göschl, Günter Gmeiner, Peter Gärtner, Georg Stadler, Valentin Enev, Mario Thevis, Wilhelm Schänzer, Sven Guddat, Guro Forsdahl. Stanozolol-N-glucuronide metabolites in human urine samples as suitable targets in terms of routine anti-doping analysis. Drug Test Anal. 2021 Sep;13(9):1668-1677. doi: 10.1002/dta.3109. Epub 2021 Jun 9. PMID: 34089570.

Guddat S, Görgens C, Sobolevsky T, Thevis M. Meldonium residues in milk: A possible scenario for inadvertent doping in sports? Drug Test Anal. 2021 Nov;13(11-12):1906-1910. doi: 10.1002/dta.3145. Epub 2021 Aug 26. PMID: 34448364.

Knoop A, Fußhöller G, Haenelt N, Goergens G, Guddat S, Geyer H, Thevis M. Mass spectrometric characterization of urinary hydrafinil metabolites for routine doping control purposes. Drug Test Anal. 2021;13(11-12):1915-1920. doi:10.1002/dta.3137

Knoop A, Geyer H, Lerch O, Rubio A,  Schrader Y, Thevis M. Detection of anti-SARS-CoV-2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA). Anal Sci Adv. 2021;1-7.

Knoop A, Geyer H, Lerch O, Rubio A, Schrader Y, Thevis M. Detection of anti-SARS-CoV-2 antibodies in dried blood spots utilizing manual or automated spot extraction and electrochemiluminescence immunoassay (ECLIA). Anal Sci Adv. 2021;1-7

Knoop A, Planitz P, Wüst B, Thevis M. Analysis of cobalt for human sports drug testing purposes using ICP- and LC-ICP-MS. Drug Test Anal. 2020 Nov;12(11-12):1666-1672. doi: 10.1002/dta.2962. Epub 2020 Nov 16. PMID: 33142033.

Krug O, Thomas A, Thevis M: Identification and characterization of urinary isopropylnorsynephrine metabolites. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (29). Sportverlag Strauß, Köln (2021), 55-59

Krug O, Thomas A, Thevis M. Mass spectrometric identification and characterization of urinary metabolites of isopropylnorsynephrine for doping control purposes. Anal Sci Adv. 2021;1-8. 

Krombholz S, Thomas A, Piper T, Lagojda A, Kühne D, Thevis M. Urinary phenylethylamine metabolites as potential markers for sports drug testing purposes. Biomed Chromatogr. 2022 Feb;36(2):e5274. doi: 10.1002/bmc.5274. Epub 2021 Nov 17. PMID: 34729800.

Kühne L, Völker LA, Hagmann H, Hägele H, Osterholt T, Eichenauer DA, Thomas A, Breuer J, Grüttner B, Gottschalk I, Kann M, Benzing T, Thevis M, Müller AM, Brinkkoetter PT. First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy. Br J Haematol. 2022 Feb;196(3):e30-e33. doi: 10.1111/bjh.17833. Epub 2021 Sep 29. PMID: 34585743.

Lange T, Thomas A, Görgens C, Bidlingmaier M, Schilbach K, Fichant E, Delahaut P, Thevis M. Comprehensive insights into the formation of metabolites of the ghrelin mimetics capromorelin, macimorelin and tabimorelin as potential markers for doping control purposes. Biomed Chromatogr. 2021 Jun;35(6):e5075. doi: 10.1002/bmc.5075. Epub 2021 Feb 2. PMID: 33458843.

Mareck U, Geyer H, Schertel T, Petring S, Krug O, Thevis M. Detection of undeclared doping substances in nutritional supplements in the context of followup investigations concerning adverse analytical findings. Drug Test Anal. 2021 Nov;13(11-12):1911-1914. doi: 10.1002/dta.3158. Epub 2021 Sep 2. PMID: 34476910.

Piper T, Geyer H, Haenelt N, Huelsemann F, Schaenzer W, Thevis M. Current Insights into the Steroidal Module of the Athlete Biological Passport.  Int J Sports Med. 2021 Sep;42(10):863-878. doi: 10.1055/a-1481-8683. Epub 2021 May 28. PMID: 34049412; PMCID: PMC8445669.

Piper T, Geyer H, Nieschlag E, Bally L, Thevis M. Carbon isotope ratios of endogenous steroids found in human serum-method development, validation, and reference population-derived thresholds. Anal Bioanal Chem. 2021 Jun 18. doi: 10.1007/s00216-021-03439-9. Epub ahead of print. PMID: 34142201.

Piper T, Thevis M. Investigations in carbon isotope ratios of seized testosterone and boldenone preparations.  Drug Test Anal. 2022 Mar;14(3):514-518. doi: 10.1002/dta.3120. Epub 2021 Jul 3. PMID: 34192821.

Thevis M, Piper T, Thomas A. Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing. J Pharm Biomed Anal. 2021 Oct 25;205:114312. doi: 10.1016/j.jpba.2021.114312. Epub 2021 Aug 8. PMID: 34391136.

Piper T, Haenelt N, Fusshöller G, Geyer H, Thevis M. Sensitive detection of testosterone and testosterone prohormone administrations based on urinary concentrations and carbon isotope ratios of androsterone and etiocholanolone. Drug Test Anal. 2021 Oct 14.  doi: 10.1002/dta.3168. Online ahead of print.

Putkaradze N, Hartz P, Hutter MC, Zapp J, Thevis M, Bernhardt R. Metabolism of oral turinabol by human brain cholesterol 24-hydroxylase CYP46A1.  J Steroid Biochem Mol Biol. 2021 Sep;212:105927. doi: 10.1016/j.jsbmb.2021.105927. Epub 2021 Jun 2. PMID: 34089835.

Reichel C, Erceg D, Lorenc B, Scheiblhofer V, Farmer L, Zanitzer K, Geisendorfer T, Gmeiner G, Thevis M. Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol. Drug Test Anal. 2021 Jan 15. doi: 10.1002/dta.2989. Epub ahead of print. PMID: 33450134

Reihlen P, Blobel M, Weiß P, Harth J, Wittmann J, Leenders F, Thevis M. Introduction of a PEGylated EPO conjugate as internal standard for EPO analysis in doping controls. Drug Test Anal. 2021 Dec 14. doi: 10.1002/dta.3211. Epub ahead of print. PMID: 34905300.

Reihlen P, Blobel M, Machnik M, Schenk I, Loup B, Joré C, Popot MA, Bailly-Chouriberry, Thevis M. Screening and Confirmation of rHuEPOs in Equine Blood by MAIIA-SARCOSYL-PAGE. Proc. of the 22nd Int. Conf. of Rac. Anal. and Vets. 2018. Dubai (2020): 594-600.

Ana Rubio, Christian Görgens, Sven Guddat, Thomas Piper, Ann-Marie Garzinsky, Oliver Krug, Mario Thevis. Chiral analysis of selected enantiomeric drugs relevant in doping controls. . Journal of Chromatography Open, Volume 1, 2021, 100017, ISSN 2772-391, doi.org/10.1016/j.jcoa.2021.100017.

Rubio A, Görgens C, Krug O, Okano M, Fedoruk M, Ahrens B, Geyer H, Thevis M. Chromatographic-mass spectrometric analysis of the urinary metabolite profile of chlorphenesin observed after dermal application of chlorphenesin-containing sunscreen. Rapid Commun Mass Spectrom. 2021 Aug 25:e9183. doi: 10.1002/rcm.9183. Epub ahead of print. PMID: 34431558.

Schenk I, Broussou D, Meuly A, Düe M, Guddat S, Lagershausen H, Machnik M, Röttgen H, Toutain PL, Thevis M. Plasma and urinary elimination of Diazepam and its metabolites in the horse following intravenous Diazepam administration. Proc. of the 22nd Int. Conf. of Rac. Anal. and Vets. 2018. Dubai (2020): 581-592.

Schenk I, Machnik M, Broussou D, Meuly A, Roques BB, Lallemand E, Düe M, Röttgen H, Lagershausen H, Toutain PL, Thevis M. Kinetic disposition of diazepam and its metabolites after intravenous administration of diazepam in the horse: Relevance for doping control.  J Vet Pharmacol Ther. 2021 Sep;44(5):733-744. doi: 10.1111/jvp.12991. Epub 2021 Jun 11. PMID: 34115414.

Seyerlein L, Gillard N, Delahaut P, Pierret G, Thomas A, Thevis M. Depletion of clomiphene residues in eggs and muscle after oral administration to laying hens. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2021 Nov;38(11):1875-1882. doi: 10.1080/19440049.2021.1949497. Epub 2021 Jul 15. PMID: 34266369.

Sigmund G, Geyer H, Goergens C, Thevis M: Prevalence of the imidazole derivatives naphazoline, oxymetazoline and xylometa-zoline in doping control samples. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (28). Sportverlag Strauß, Köln (2020), 28-31.

Thevis M, Kuuranne T, Geyer H. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021. Drug Test Anal. 2021 Nov 17. doi: 10.1002/dta.3199. Epub ahead of print. PMID: 34788500.

Thevis M, Kuuranne T, Thomas A, Geyer H. Do dried blood spots have the potential to support result management processes in routine sports drug testing? - Part 2: Proactive sampling for follow-up investigations concerning atypical or adverse analytical findings. Drug Test Anal. 2021;1–5.

Thevis M. Broadening the Horizon of Antidoping Analytical Approaches Using Dried Blood Spots. Clin Chem. 2021 Aug 5;67(8):1041-1043. doi: 10.1093/clinchem/hvab074. PMID: 34060612.

Thevis M, Piper T, Thomas A. Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing. J Pharm Biomed Anal. 2021 Aug 8;205:114312. doi: 10.1016/j.jpba.2021.114312. Epub ahead of print. PMID: 34391136

Thevis M, Kuuranne T, Fedoruk M, Geyer H. Sports Drug Testing and the Athletes' Exposome. Drug Test Anal. 2021 Nov;13(11-12):1814-1821. doi: 10.1002/dta.3187. Epub 2021 Nov 1. PMID: 34694748.

Thomas A, Benzenberg L, Bally L, Thevis M. Facilitated Qualitative Determination of Insulin, Its Synthetic Analogs, and C-Peptide in Human Urine by Means of LC-HRMS. Metabolites. 2021 May 12;11(5):309. doi: 10.3390/metabo11050309. PMID: 34065812.

Thomas A, Krombholz S, Wolf C, Thevis M. Determination of ghrelin and desacyl ghrelin in human plasma and urine by means of LC-MS/MS for doping controls. Drug Test Anal. 2021 Nov;13(11-12):1862-1870. doi: 10.1002/dta.3176. Epub 2021 Oct 26. PMID: 34633773.

Wagener F, Guddat S, Görgens C, Angelis YS, Petrou M, Lagojda A, Kühne D, Thevis M. Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes. Anal Bioanal Chem. 2022 Jan;414(2):1151-1162. doi: 10.1007/s00216-021-03740-7. Epub 2021 Nov 4. PMID: 34734312; PMCID: PMC8724150.

Walpurgis K, Weigand T, Knoop A, Thomas A, Reichel C, Dellanna F, Thevis M. Detection of follistatin-based inhibitors of the TGF-β signaling pathways in serum/plasma by means of LC-HRMS/MS and Western blotting. Drug Test Anal. 2020 Nov;12(11-12):1636-1648. doi: 10.1002/dta.2925. Epub 2020 Oct 12. PMID: 32959984.

Zwingmann L, Below T, Braun H, Wahl P, Goldmann JP. Consequences of police-related personal protective equipment and physical training status on thermoregulation and exercise energy expenditure. J Sports Med Phys Fitness 2021 Feb 23. DOI: 10.23736/S0022- 4707.21.12196 6 [Epub ahead of print]

2020

H Bauhaus, A Vassiliadis, H Braun, HG Predel, M Thevis. Comparison of Selected Spirometric Systems for Measuring the Resting Metabolic Rate. International Journal of Sport Nutrition and Exercise Metabolism, 2020, 30, S1-3 - S1-4.

Braun H, Carlsohn A, Großhauser M, König D, Lampen A, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Ziegenhagen R, Heseker H. Position of the working group sports nutrition of the German Nutrition Society (DGE): energy needs in sports. Dtsch Z Sportmed. 2020; 71: 171-177. doi:10.5960/dzsm.2020.451

Carlsohn A, Braun H, Großhauser M, König D, Lampen A, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Ziegenhagen R, Heseker H. Position of the working group sports nutrition of the German Nutrition Society (DGE): minerals and vitamins in sports nutrition. Dtsch Z Sportmed. 2020; 71: 208-215.doi:10.5960/dzsm.2020.454

Collins J, Maughan RJ, Gleeson M, Bilsborough J, Jeukendrup A, Morton JP, Phillips SM, Armstrong LE, Burke LM, Close GL, Duffield R, Larson-Meyer E, Louis J, Medina D, Meyer F, Rollo I, Sundgot-Borgen JK, Wall B, Boullosa B, Dupont G, Lizarraga A, Res P, Bizzini M, Castagna C, Cowie CM, D'Hooghe M, Geyer H, Meyer T, Papadimitiou N, Vouillamoz M, McCall A. Infographic. UEFA expert group 2020 statement on nutrition in elite football. Br J Sports Med. 2020 Oct 23:bjsports-2020-103410. doi: 10.1136/bjsports-2020-103410. Epub ahead of print. PMID: 33097526

Collins J, Maughan RJ, Gleeson M, Bilsborough J, Jeukendrup A, Morton JP, Phillips SM, Armstrong L, Burke LM, Close GL, Duffield R, Larson-Meyer E, Louis J, Medina D, Meyer F, Rollo I, Sundgot-Borgen J, Wall BT, Boullosa B, Dupont G, Lizarraga A, Res P, Bizzini M, Castagna C, Cowie CM, D'Hooghe M, Geyer H, Meyer T, Papadimitriou N, Vouillamoz M, McCall A. UEFA expert group statement on nutrition in elite football. Current evidence to inform practical recommendations and guide future research. Br J Sports Med. 2020 Oct 23:bjsports-2019-101961. doi: 10.1136/bjsports-2019-101961. Epub ahead of print. PMID: 33097528.

Dib J, Bosse C, Tsivou M, et al. Isheptaminol a (major) metabolite of octodrine? Drug Test Anal. 2019; 11:1761–1763.

Fußhöller G, Geyer H, Schänzer W, Thevis M: Bacterial activities in urine samples: Formation of metandienone and 6β-hydroxy-metandienone from the internal standard methyltestosterone – a case study. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (27). Sportverlag Strauß, Köln (2019) 35 38.

Fußhöller G, Guddat S, Schänzer W, Geyer H, Thevis M: Testolactone – Derivatisation Artifact due to the Incorporation of an Ethylmercapto Group. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (27). Sportverlag Strauß, Köln (2019) 62 65.

Gavanda S, Geisler S, Quitmann OJ, Bauhaus H, Schiffer T. Three Weeks of Detraining Does Not Decrease Muscle Thickness, Strength or Sport Performance in Adolescent Athletes. Int J Exerc Sci 13(6): 633-644, 2020.

Görgens C, Guddat S, Bosse C, Knoop A, Geyer H, Thevis M. Implementation of the HIF activator IOX-2 in routine doping controls – Pilot study data. Drug Test Anal. 2020;1–6.

Hülsemann F, Fußhöller G, Lehn C, Thevis M. Excretion of 19-norandrosterone after consumption of boar meat. Drug Test Anal. 2020;1–6. doi.org/10.1002/dta.2958

Knoop, A., Görgens, C., Geyer, H., & Thevis, M.  Elevated urinary cobalt concentrations identified in routine doping controls can originate from vitamin B 12. Rapid Communications in Mass Spectrometry 2020 Apr 15;34 (7)

König D, Braun H, Carlsohn A, Großhauser M, Lampen A, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Ziegenhagen R, Heseker H. Position of the working group sports nutrition of the German Nutrition Society (DGE): carbohydrates in sports nutrition. Dtsch Z Sportmed. 2020; 71: 185-191. doi:10.5960/dzsm.2020.456

König D, Carlsohn A, Braun H, Großhauser M, Lampen A, Mosler S, Nieß A, Schäbethal K, Schek A, Virmani K, Ziegenhagen R, Heseker H: Proteins in sports nutrition. Position of the working group sports nutrition of the German Nutrition Society (DGE). Ernahrungs Umschau 2020; 67(7): 132–9.

König D, Carlsohn A, Braun H, Großhauser M, Lampen A, Mosler S, Nieß A, Schäbethal K, Schek A, Stehle P, Virmani K, Ziegenhagen R, Heseker H. Position of the working group sports nutrition of the German Nutrition Society (DGE): protein intake in sports. Dtsch Z Sportmed. 2020; 71: 192-198.doi:10.5960/dzsm.2020.450

Krug O , Thomas A , Walpurgis K , Piper T , Geyer H , Thevis M: Black market products suspected to contain doping relevant ingredients - annual report for 2018. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (27). Sportverlag Strauß, Köln (2019) 98 102.

Lange T, Thomas A, Walpurgis K, Thevis M. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS. Anal Bioanal Chem. 2020; 412(15): 3765–3777.

Mareck U, Fusshöller G, Geyer H, Huestis MA, Scheiff AB, Thevis M. Preliminary data on the potential for unintentional antidoping rule violations by permitted cannabidiol (CBD) use.  Drug Test Anal. 2021 Mar;13(3):539-549. doi: 10.1002/dta.2959. Epub 2020 Dec 14. PMID: 33125823.

Mosler S, Braun H, Carlsohn A, Großhauser M, König D, Lampen A, Nieß A, Oberritter H, Schäbethal K, Schek A,Stehle P, Virmani K, Ziegenhagen R, Heseker H. Position of the working group sports nutrition of the German Nutrition Society (DGE): fluid replacement in sports. Dtsch Z Sportmed. 2020; 71: 178-184. 

C. Osterkamp-Baerens, A. Stensitzky-Thielemans, H. Braun, K. Brüning, A. Carlsohn (AG Sporternährung des DOSB). Interne Kühlmethoden im Überblick. Leistungssport, 50 (2), 28 f

S.W. Paine, J. Bright, J.P. Scarth, P.R. Hincks, C.M. Pearce, C. Hannan, M. Machnik, and L. Hillyer. The intravenous pharmacokinetics of butorphanol and detomidine dosed in combination compared with individual dose administrations to exercised horses. J. vet. Pharmacol. Therap. 2020; 43, 162-170.

Paßreiter A, Thomas A, Grogna N, Delahaut P, Thevis M. First Steps toward Uncovering Gene Doping with CRISPR/Cas by Identifying SpCas9 in Plasma via HPLC-HRMS/MS. Anal Chem. 2020 Dec 15;92(24):16322-16328.

Piper T, Heimbach S, Adamczewski M, Thevis M. An in vitro assay approach to investigate the potential impact of different doping agents on the steroid profile.Drug Test Anal. 2021 May;13(5):916-928. doi: 10.1002/dta.2991. Epub 2020 Dec 14.

Piper T, Fusshöller G, Schänzer W,Lagojda A, Kuehne D, Thevis M. Studies on the in vivometabolism of methylstenbolone and detection of novel longterm metabolites for doping control analysis.Drug Test Anal.2019; 11:1644–1655.

Piper T, Thevis M: Do urinary concentrations of dimethyl sulfoxide and its metabolite dimethyl sulfone indicate topical administrations of doping agents? In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (27). Sportverlag Strauß, Köln (2019) 17 20.

Piper T, Fusshöller G, Geyer H, Toboc A, Dănilă MG, Thevis M. Detecting the misuse of 7-oxo-DHEA by means of carbon isotope ratio mass spectrometry in doping control analysis. Rapid Commun Mass Spectrom. 2020;34(12):e8776. doi:10.1002/rcm.8776print]

Putz M, Piper T, Thevis M: Identification of trenbolone metabolites using hydrogen isotope ratio mass spectrometry and liquid chromatography/high accuracy/high resolution mass spectrometry for doping control analysis. Frontiers in Chemistry. (2020) 8:435.

Reichel C, Gmeiner G, Thevis M. Detection of black market follistatin 344. Drug Test Anal. 2019; 11:1675–1697. doi.org/10.1002/dta.2741

Romberg S, Kempkes R, Thevis M: Athlete Biological Passport in Practice: Computer Assisted Evaluation of Sysmex Measurements at the Analysis Site. In: Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (27). Sportverlag Strauß, Köln (2019) 30 34

Schek A, Braun H, Carlsohn A, Großhauser M, König D, Lampen A, Mosler S,Nieß A, Oberritter H, Schäbethal K, Stehle P, Virmani K, Ziegenhagen R, Heseker H. Position of the working group sports nutrition of the German Nutrition Society (DGE): fats, fat loading, and sports performance. Dtsch Z Sportmed. 2020; 71: 199-207. doi:10.5960/dzsm.2020.448

Schänzer W, Geyer H, Thevis M. Tainted toothpaste- Analytical investigation into an unusual adverse finding. Drug Test Anal. 2020 May;12(5):570-572.

Stoffel W, Schmidt-Soltau I, Binczek E, Thomas A, Thevis M, Wegner I. Dietary ω3-and ω6-Polyunsaturated fatty acids reconstitute fertility of Juvenile and adult Fads2-Deficient mice. Mol Metab. 2020 Mar 17;36:100974. doi: 10.1016/j.molmet.2020.100974. [Epub ahead of print]

Thevis M, Kuuranne T, Geyer H. Annual banned-substance review-analytical approaches in human sports drug testing 2019/2020. Drug Test Anal. 2021 Jan;13(1):8-35. doi: 10.1002/dta.2969. Epub 2020 Dec 2. PMID: 33185038.

Thevis M, Knoop A, Schaefer MS, Dufaux B, Schrader Y, Thomas A, Geyer H. Can Dried Blood Spots (DBS) Contribute to Conducting Comprehensive SARS-CoV-2 Antibody Tests? Drug Test Anal. 2020;12(7):994-997.

Thevis M, Kuuranne T, Geyer H. Annual banned-substance review - Analytical approaches in human sports drug testing. Drug Test Anal. 2020 Jan;12(1):7-26. doi: 10.1002/dta.2735. Epub 2020 Jan 15.

Mario Thevis. The 37th Manfred Donike workshop on doping analysis - Editorial.  Drug Test Anal.2019;11:1587–1588.

Thevis M, Kuuranne T, Dib J, Thomas A, Geyer H. Do dried blood spots (DBS) have the potential to support result management processes in ro  utine sports drug testing?  Drug Test Anal. 2020;12:704–710.

Thomas A, Thevis M.  Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy. Clin Chem Lab Med. 2020;58(5):690‐700. 

Thomas A, Thevis M. Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy. Clin Chem Lab Med. 2020, 58, 690.

Thomas A, Yang R, Petring S, Bally,L Thevis M. Simplified quantification of insulin, its synthetic analogs and C-peptide in human plasma by means of LC-HRMS. Drug Test Anal. 2020, 12, 382-390.

Walpurgis K, Rubio A, Wagener F, Krug O, Knoop A, Görgens C, Guddat S, Thevis M. Elimination profiles of microdosed ostarine mimicking contaminated products ingestion. Drug Test Anal. 2020 Nov;12(11-12):1570-1580. doi: 10.1002/dta.2933. Epub 2020 Oct 12. PMID: 32959982.

Walpurgis K, Scheiff AB, Welz M,et al. Pilot study on the effects of intravesical oxybutyninhydrochloride instillations on the validity of doping controlurine samples. Drug Test Anal. 2019; 11:1755–1760. https://doi.org/10.1002/dta.2705

Walpurgis K, Thomas A, Thevis M. Detection of the myostatin-neutralizing antibody Domagrozumab in serum by means of Western blotting and LC-HRMS. Drug Test Anal. 2019; 11:1714–1723. doi. org/10.1002/dta.2729

Ziegenhagen R, Braun H, Carlsohn A, Großhauser M, Heseker H, König D, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Lampen A. Position of the working group sports nutrition of the German Nutrition Society (DGE): safety aspects of dietary supplements in sports. Dtsch Z Sportmed. 2020; 71: 216-224. doi:10.5960/dzsm.2020.455

Ziegenhagen R, Braun H, Carlsohn A, Großhauser M, Heseker H, König D, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Lampen A: Safety aspects of dietary supplements in sports. Position of the working group sports nutrition of the German Nutrition Society (DGE). Ernahrungs Umschau 2020; 67(2): 42–50.e1–e2

2019

Bauhaus, H., von Andrian-Werburg, J. U., Braun, H. (2019). Ernährungsstrategien für Langstreckenläufer. Leichtathletiktraining, 30(6), 32-37.

Braun H, Carlsohn A, Großhauser M, König D, Lampen A, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Ziegenhagen R, Heseker H (2019) Energy needs in sports. Position of the working group sports nutrition of the German Nutrition Society (DGE). Ernahrungs Umschau 66(8): 146–153.

Braun H, von Andrian-Werburg J, Malisova O, Athanasatou A, Kapsokefalou M, Ortega JF, Mora-Rodriguez R, Thevis M. Differing Water Intake and Hydration Status in Three European Countries—A Day-to-Day Analysis. Nutrients. 2019; 11(4):773.

Carlsohn A, Braun H, Großhauser M, König D, Lampen A, Mosler S, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Ziegenhagen R, Heseker H. Minerals and vitamins in sports nutrition. Position of the working group sports nutrition of the German Nutrition Society (DGE). Ernahrungs Umschau 2019; 66(12): 250–257.

de Oliveira FA, Casilli A, Piper T, da Silva TR, da Silva CA, da Silva RVS, Dal Sasso MA, Salgueiro GRDSG, Padilha MC, Pereira HMG, Thevis M, Aquino Neto FR. Implementation and performance of the gas chromatography/combustion/isotope ratio mass spectrometry-based method for the confirmatory analysis of endogenous anabolic steroids during the Rio de Janeiro Olympic and Paralympic Games 2016. Anal Chem. 2019 Sep 17;91(18):11747-11756. doi: 10.1021/acs.analchem.9b02341. Epub 2019 Aug 29.

Dias KA, Lawley JS, Gatterer H, Howden EJ, Sarma S, Cornwell WK 3rd, Hearon CM Jr, Samels M, Everding B, Shuo-Wen Liang A, Hendrix M,Piper T, Thevis M, Bruick RK, Levine BD. Effect of Acute and Chronic Xenon Inhalation on Erythropoietin, Hematological Parameters, and Athletic Performance. J Appl Physiol (1985). 2019 Dec 1;127(6):1503-1510. doi: 10.1152/japplphysiol.00289.2019. Epub 2019 Aug 15.

Flenker U, Riemann P, Hülsemann F, Gougoulidis V, Thevis M, Schänzer W: Intracrine androgen metabolism.Fundamentals and a new approach to make use of 13C/12C signals of endogenous Steroids. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent dvances in doping analysis (26). Sportverlag Strauß, Köln (2018) 36–42.

Garzinsky AM, Walpurgis K, Krug O, Thevis M. Does oral fluid contribute to exhaled breath samples collected by means of an electret membrane? Drug Test Anal. 2019 Nov; 11: 1764 1770. https://doi.org/10.1002/dta.2597

Gaunitz F, Thomas A, Fietzke M, Franz F, Auwärter V, Thevis M, Mercer-Chalmers-Bender K. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation. Int J Legal Med. 2019 Jul;133(4):1049-1064.

Gaunitz F, Dahm P, Mogler L, Thomas A, Thevis M, Mercer-Chalmers-Bender K. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples. Anal Bioanal Chem. 2019 Jun;411(16):3561-3579.

Görgens C, Guddat S, Södje D, Geyer H, Thevis M: Detection of myo-inositol trispyrophosphate (ITPP) in human urine following an oral administration of ITPP – a pilot study. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (26). Sportverlag Strauß, Köln (2018) 109–113.

Guddat S, Görgens C, Geyer H, Pfanner T, Thevis M: Clomiphene - targeting of the unchanged drug results in unusual prolonged detection windows in urine. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (26). Sportverlag Strauß, Köln (2018) 118–121.

Hammels I, Binczek E, Schmidt-Soltau I, Jenke B, Thomas A, Vogel M, Thevis M, Filipova D, Papadopoulos S, Stoffel W. Novel CB1-ligands maintain homeostasis of the endocannabinoid system in ω3- and ω6-long-chain-PUFA deficiency. J Lipid Res. 2019 Aug;60(8):1396-1409.

Hansson A, Knych H, Stanley S, Thevis M, Bondesson U, Hedeland M. Equine in vivo-derived metabolites of the SARM LGD-4033 and comparison with human and fungal metabolites. J Chrom B. 2018; 1074 1075: 91–98. 

Hoffmeister T, Schwenke D, Krug O, Wachsmuth N, Geyer H, Thevis M, Byrnes WC, Schmidt WFJ.Effects of 3 Weeks of Oral Low-Dose Cobalt on Hemoglobin Mass and Aerobic Performance.Front Physiol. 2018 Sep 19;9:1289. doi: 10.3389/fphys.2018.01289. eCollection 2018  

Knoop A, Thomas A, Thevis M. Development of a mass spectrometry-based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes. Rapid Commun Mass Spectrom. 2019 Feb 28;33(4):371–380.

Daniel König, Hans Braun, Anja Carlsohn, Mareike Großhauser, Alfonso Lampen, Stephanie Mosler, Andreas Nieß, Helmut Oberritter, Klaus Schäbethal, Alexandra Schek, Peter Stehle, Kiran Virmani, Rainer Ziegenhagen, Helmut Heseker: Kohlenhydrate in der Sporternährung. Position der Arbeitsgruppe Sporternährung der Deutschen Gesellschaft für Ernährung e. V. (DGE). Ernahrungs Umschau, 2019; 66(11): 228–235.

Krug O, Thomas A, Walpurgis K, Piper T, Laußmann T, Röder R, Thevis M: Black market products suspected to contain doping relevant ingredients - annual report for 2017. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (26). Sportverlag Strauß, Köln (2018) 76–81

Krug O, Thomas A, Geyer H, Thevis M: Testing doping agents from exhaled breath – Pilot study data. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (26). Sportverlag Strauß, Köln (2018) 21–28.

Lange T, Walpurgis K, Thomas A, Geyer H, Thevis M. Development of two complementary LC-HRMS methods for analyzing sotatercept in dried blood spots for doping controls. Bioanalysis. 2019 May;11(10):923–940.

Lawley JS, Gatterer H, Dias KA, Howden EJ, Sarma S, Cornwell WK 3rd, Hearon CM Jr, Samels M, Everding B, Hendrix M, Piper T, Thevis M, Levine BD. Safety, hemodynamic effects and detection of acute xenon inhalation: Rationale for banning xenon from sport. J Appl Physiol (1985). 2019 Dec 1;127(6):1511-1518. doi: 10.1152/japplphysiol.00290.2019. Epub 2019 Aug 15.

Lehmann S, Schulze B, Thomas A, Kamphausen T, Thevis M, Rothschild MA, Mercer-Chalmers-Bender K. Organ distribution of 4‑MEC, MDPV, methoxetamine and α‑PVP: comparison of QuEChERS and SPE. Forensic Toxicol (2018) 36:320–333.

Lehmann S, Thomas A, Schiwy-Bochat KH, Geyer H, Thevis M, Glenewinkel F, Rothschild MA, Andresen-Streichert H, Juebner M. Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone). Forensic Sci Int. 2019 Oct;303:109925. doi: 10.1016/j.forsciint.2019.109925. Epub 2019 Aug 8.

Mareck U, Fußhöller G, Geyer H, Görgens C, Guddat S, Haenelt N, Romberg S, Schänzer W,Thevis M: Urinary ethyl glucuronide in doping control samples – evaluation of gender, sport discipline, type of control and concentration. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (26). Sportverlag Strauß, Köln (2018) 167–169.

Mosler S, Braun H, Carlsohn A, Großhauser M, König D, Lampen A, Nieß A, Oberritter H, Schäbethal K, Schek A, Stehle P, Virmani K, Ziegenhagen R, Heseker H (2019) Fluid replacement in sports. Position of the working group sports nutrition of the German Nutrition Society (DGE). Ernahrungs Umschau 66(3): 52–59. 

Mori Y, Ko E, Furrer R, Qu LC, Wiber SC, Fantus GI, Thevis M, Medline A, Giacca A. Effects of insulin and analogues on carcinogen-induced mammary tumours in high fat-fed rats. Endocr. Connect. 2018, 7: 739–748.

Nader E, Grau M, Fort R, Collins B, Cannas G, Gauthier A, Walpurgis K, Martin C, Bloch W, Poutrel S, Hot A, Renoux C, Thevis M, Joly P, Romana M, Guillot N, Connes P. Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway. Nitric Oxide. 2018 Dec 1;81:28-35. doi: 10.1016/j.niox.2018.10.003. Epub 2018 Oct 19 

S.W. Paine, J. Bright, J.P. Scarth, P.R. Hincks, C.M. Pearce, C. Hannan, M. Machnik, and L. Hillyer (2016). Equine Pharmacokinetics of Butorphanol in Combination with an Alpha-2 Agonist Sedative. In: Proceedings of the 20th International Conference of Racing Analysts and Veterinarians, Mauritius 2014. R & W Publications Ltd., Newmarket, 243 – 250. 

Putz M, Piper T, Dubois M, Delahaut P, Thevis M Analysis of endogenous steroids in urine by means of multi-immunoaffinity chromatography and isotope ratio mass spectrometry for sports drug testing. Analytical and Bioanalytical Chemistry (2019) 411:7563–7571

Reichel, C; Gmeiner, G.; Reihlen, P.; Thevis, M.; Schänzer, W., SARCOSYL—PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins. In Electrophoretic Separation of Proteins: Methods and Protocols. Methods Mol Biol. 2019;1855:131-149. doi: 10.1007/978-1-4939-8793-1–14. 

Romberg S , Sauer M , Klose C , Schänzer W , Thevis M: Paperless Communication of Sample Collection Documentation. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (26). Sportverlag Strauß, Köln (2018) 173–178.

Schek A, Braun H, Carlsohn A, Großhauser M, König D, Lampen A, Mosler S, Nieß A, Oberritter H, Schäbethal K, Stehle P, Virmani K, Ziegenhagen R, Heseker H (2019) Fats in sports nutrition. Position of the working group sports nutrition of the German Nutrition Society (DGE). Ernahrungs Umschau 66(9): 181–188 DOI: 10.4455/eu.2019.042

Thevis M, Thomas A. Nachweis synthetischer Insuline in Doping-Analytik und Forensik, Detection of synthetic insulin in doping and forensic analyses,  Rechtsmedizin 31, 1–9 (2021). doi.org/10.1007/s00194-019-00347-2

Thevis M, Kuuranne T, Geyer H. Annual banned-substance review: Analytical approaches in human sports drug testing. Drug Test Anal. 2019 Jan;11(1):8-26. doi: 10.1002/dta.2549. Epub 2019 Jan 6.

Mario Thevis, Katja Walpurgis, Andreas Thomas and Hans Geyer. Peptidic drugs and drug candidates in sports drug testing: agents affecting mitochondrial biogenesis or preventing activing receptor II activation. Current Opinion in Endocrine and Metabolic Research 2019, 9:22–27.

Thevis M, Walpurgis K, Thomas A. Analytical Approaches in Human Sports Drug Testing: Recent Advances, Challenges, and Solutions. Anal Chem. 2020 Jan 7;92(1):506-523. doi: 10.1021/acs.analchem.9b04639. Epub 2019 Oct 31.

Thomas A, Thevis M. Recent advances in the determination of insulins from biological fluids. Adv Clin Chem. 2019;93:115-167. doi: 10.1016/bs.acc.2019.07.003. Epub 2019 Sep 11.

M. Viljanto, M.A. Popot, I. Schenk, M. Machnik, E. Li, P. Zahra, M. Hedeland, L. Brooks and J. Scarth (2017). International population study of free-testosterone concentrations in plasma samples from fillies. In: Proceedings of the 21th International Conference of Racing Analysts and Veterinarians, Montevideo 2016. R & W Publications Ltd., Newmarket, 82 – 87. 

2018

Judith von Andrian-Werburg, Hans Braun; Ernährung jugendlicher Leistungsssportler. Leichtathletiktraining. 2018 (29), 2+3, 32-35 

Arsene CG, Schulze D, Röthke A, Thevis M, Henrion A. Growth Hormone Isoform-Differential Mass Spectrometry for Doping Control Purposes. Drug Test Analysis 2018; 10 (6): 938-946. 

Braun H, von Andrian-Werburg J, Schänzer W, Thevis M. Nutrition Status of Young Elite Female German Football Players. Pediatric Exercise Science. 2018, 30, 157-167. 

Braun, H., von Andrian-Werburg, J. U., Schröder, S. & Czimek, J. V. M.; Kapitel 10: Ernährung, in: Volleyball - Training & Coaching. Vom Jugend- zum Leistungsvolleyballer: Kombinierte Rahmentrainingskonzeption Volleyball und Beach-Volleyball des Deutschen Volleyball-Verbandes. Czimek, J. & DVV (Hrsg.). 1. Aufl. 2017 Aachen: Meyer & Meyer, S. 528-541.

Bauhaus H, von Andrian-Werburg J, Braun H; Periodisierung der Ernährung bei Läufern. Leichtathletiktraining, 2018, (29), 8, 28-33.  

Dib, J. Tretzel, L. Piper, T. Lagojda, A.  Kuehne, D. Schänzer, W. Thevis, M. Screening for adiponectin receptor agonists and their metabolites in urine and dried blood spots. Clim Mass Spec, 2017, 13-20.  

Eichner D, Van Wagoner RM, Brenner M, Chou J, Leigh S, Wright LR, Flippin LA, Martinelli M, Krug O, Schänzer W, Thevis M. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls. Drug Test Anal. 2017 Nov;9(11-12):1768-78. 

Forsdahl G, Geisendorfer T, Göschl L, Pfeffer S, Gärtner P, Thevis M , Gmeiner G. Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone. Drug Test. Analysis 2018 Mar 23. doi: 10.1002/dta.2385. [Epub ahead of print]

Garg N, Hansson A, Knych HK, Stanley SD, Thevis M, Bondesson U, Hedeland M, Globisch D. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control. Org Biomol Chem. 2018; 16: 698-702 

Geyer H, Sigmund G, Krug O, Mareck U, Gougoulidis V, Schänzer W, Thevis M. Contaminated nutritional supplements as possible source for findings of low concentrations of methylhexaneamine in doping control samples - a case study. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (25). Sportverlag Strauß, Köln, 2017, 60-62. 

Görgens C, Guddat S, Thomas A, Thevis M. Recent improvements in sports drug testing concerning the initial testing for peptidic drugs (< 2 kDa) - sample preparation, mass spectrometric detection, and data review. Drug Test Anal. 2018 Nov;10(11-12):1755-1760. doi: 10.1002/dta.2503. Epub 2018 Nov 8. 

Görgens C, Thevis M, Schänzer W, Geyer H, Guddat S, Bosse C: Investigation of urinary detection windows after multiple oral dosages of meldonium - a pilot study. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (25). Sportverlag Strauß, Köln, 2017, 37-40. 

Hansson A, Thevis M, Cox H, Miller G, Eichner D, Bondesson U, Hedeland M. Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry. J Pharm Biomed Anal. 2017 Feb 5;134:228-236.

Hoffmeister T, Schwenke D, Wachsmuth N, Krug O, Thevis M, Byrnes W, Schmidt W. Erythropoietic effects of low-dose cobalt application. Drug Test Anal. 2018 Aug 15. doi: 10.1002/dta.2478. [Epub ahead of print] 

Hülsemann F, Gougoulidis V, Schertel T, Fusshöller G, Flenker U, Piper T, Thevis M. Case Study: Atypical δ13C values of urinary norandrosterone. Drug Test Anal. 2018 Nov;10(11-12):1728-1733. doi: 10.1002/dta.2498. Epub 2018 Oct 25 

Koehler K, Geyer H, Schultze G, Parr MK, Guddat S, Braun H, Mareck U, Thevis M, Schänzer W: Nutritional Supplements: Still a Risk of Inadvertent Doping? An Extended International Follow-up. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (25). Sportverlag Strauß, Köln, 2017, 63-68. 

Krug O, Walpurgis K, Thomas A, Piper T, Sigmund G, Schänzer W, Thevis M: Black market products suspected to contain doping relevant ingredients - annual report for 2016. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (25). Sportverlag Strauß, Köln, 2017, 69-74. 

Machnik M, Wagner S, Schenk I, Broussou D, Toutain PL, Düe Kietzmann M. Schänzer W. Treatment of Competition Horses with Corticosteroids: Elimination and Detection Times of Flumethason in the Horse after I.V. Administration. In: E.Houghton, P.Symons, P.Knight, R.Sams, P.Wynne and C. Gordon Gentil (eds.) Proc. of the 21th Int. Conf. of Rac. Anal. and Vets. 2016. Uruguay (2017): 598-603. 

Mattausch NR, Domnik K, Koehler K, Schaenzer W, Braun H. Case Study: Hydration Intervention Improves Pre-game Hydration Status in Female Collegiate Soccer Players. Int J Sport Nutr Exerc Metab. 2017, 27, 475-481. 

Maughan RJ, Burke LM, Dvorak J, Larson-Meyer DE, Peeling P, Phillips SM, Rawson ES, Walsh NP, Garthe I, Geyer H, Meeusen R, van Loon L, Shirreffs SM, Spriet LL, Stuart M, Vernec A, Currell K, Ali VM, Budgett RGM, Ljungqvist A, Mountjoy M, Pitsiladis Y, Soligard T, Erdener U, Engebretsen L. IOC Consensus Statement: Dietary Supplements and the High-Performance Athlete. Int J Sport Nutr Exerc Metab. 2018 Mar 1;28(2):104-125. 

Maughan RJ, Burke LM, Dvorak J, Larson-Meyer DE, Peeling P, Phillips SM, Rawson ES, Walsh NP, Garthe I, Geyer H, Meeusen R, van Loon LJC, Shirreffs SM, Spriet LL, Stuart M, Vernec A, Currell K, Ali VM, Budgett RGM, Ljungqvist A, Mountjoy M, Pitsiladis YP, Soligard T, Erdener U, Engebretsen L. IOC consensus statement: dietary supplements and the high-performance athlete Br J Sports Med 2018;0:1–17. doi:10.1136/bjsports-2018-099027.

Mori Y, Ko E, Furrer R, Qu LC, Wiber SC, Fantus GI, Thevis M. Medline A, Giacca A. Effects of insulin and analogues on carcinogen-induced mammary tumours in high fat-fed rats. Endocr. Connect. 2018, 7, 739-748 

Piper T, Dib J, Putz M, Fusshöller G, Pop V, Lagojda A, Kuehne D, Geyer H, Schänzer W, Thevis M. Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls. Drug Test Anal. 2018 Nov;10(11-12):1646-1656. doi: 10.1002/dta.2527. Epub 2018 Nov 18 

Pütz M, Piper T, Casilli A, Radler de Aquino Neto F, Pigozzo F, Thevis M. Development and validation of a multidimensional gas chromatography/combustion/isotope ratio mass spectrometry-based test method for analyzing urinary steroids in doping controls, Anal. Chim. Acta 1030, 2018,105-114. 

Pütz M, Piper T, Schänzer W, Thevis M: In vitro metabolism studies of SARM YK-11. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (25). Sportverlag Strauß, Köln (2017) 91 94 

Reichel C, Gmeiner G, Walpurgis K, Thevis M. Updated protocols for the detection of Sotatercept and Luspatercept in human serum. Drug Test Anal. 2018 Nov;10(11-12):1708-1713. doi: 10.1002/dta.2500. Epub 2018 Oct 1 

Reichel C, Gmeiner G, Thevis M. Antibody-based strategies for the detection of Luspatercept (ACE-536) in human serum. Drug Test Anal. 2017 Sep 19. doi: 10.1002/dta.2302 

Reichel C, Farmer L, Gmeiner G, Walpurgis K, Thevis M. Detection of Sotatercept (ACE-011) in human serum by SAR-PAGE and Western Single Blotting. Drug Test Anal. 2017. doi: 10.1002/dta.2346 

Schänzer W, Fusshöller G, Guddat S, Geyer H, Piper T, Thevis M. Long Term Metabolites - Historical Aspects and the Cologne Strategy. Lecture held at the 16th Annual USADA Meeting in Orlando, USA on 1st October 2017.

Schenk I, Broussou D, Düe M, Guddat S, Machnik M, Röttgen H, Schänzer W,  Toutain PL. Plasma and Urinary Elimination and Metabolism of Omeprazole in the Horse during and after a 10-Days Treatment with Gastrogard. In: E.Houghton, P.Symons, P.Knight, R.Sams, P.Wynne and C. Gordon Gentil (eds.) Proc. of the 21th Int. Conf. of Rac. Anal. and Vets. 2016. Uruguay (2017): 526-538. 

Thevis M, Volmer D. Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation. Eur J Mass Spectrom. 2018; 24: 145-156

Thevis M, Schänzer W: Detection of SARMs in doping control analysis. Mol Cell Endocrinol. 2018 Mar 15;464:34-45. doi: 10.1016/j.mce.2017.01.040. Epub 2017 Jan 27.

Thevis M, Krug O, Geyer H, Walpurgis K, Baume N, Thomas A. Analytical challenges in sports drug testing, Anal. Bioanal. Chem. 2018; 410: 2275-81
 
Thevis M, Kuuranne T, Geyer H. Annual banned-substance review: Analytical approaches in human sports drug testing. Drug Test Anal. 2018 Jan;10 (1): 9-27

Thevis M, Piper T, Dib J, Lagojda A, Kühne D, Packschies L, Geyer H, Schänzer W. Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposes. Rapid Commun Mass Spectrom. 2017 Jul 30;31(14):1175-1183.

Thomas A, Thevis M. Analysis of insulin and insulin analogs from dried blood spots by means of liquid chromatography-high resolution mass spectrometry. Drug Test Anal. 2018 Nov;10(11-12):1761-1768. doi: 10.1002/dta.2518. Epub 2018 Nov 8. 

Walpurgis K, Thomas A, Dellanna F, Schänzer W, Thevis M. Detection of the Human Anti-ActRII Antibody Bimagrumab in Serum by Means of Affinity Purification, Tryptic Digestion, and LC-HRMS. Proteomics Clin. Appl. 2017 Dec 11. doi: 10.1002/prca.201700120. [Epub ahead of print]   

2017

Barton AK, Heinemann H, Schenk I, Machnik M, Gehlen H. Influence of respiratory tract disease and mode of inhalation on detectability of budesonide in equine urine and plasma. AJVR, 78 (2017) 244-250.

Buntenkötter K, Osmers M, Schenk I, Schänzer W, Machnik M, Düe M, Kietzmann M. Pharmacokinetics and in vitro efficacy of salicylic acid after oral administration of acetylsalicylic acid in horses. BMC Vet Res. 2017 Jan 19;13(1):28. doi: 10.1186/s12917-017-0955-1

Geesmann B, Gibbs JC, Mester J, Koehler K. Association Between Energy Balance and Metabolic Hormone Suppression During Ultra-Endurance Exercise. International Journal of Sports Physiology and Performance. doi: http://dx.doi.org/10.1123/ijspp.2016-0061

Görgens C, Guddat S, Bosse C, Geyer H, Pop V, Schänzer W, Thevis M. The atypical excretion profile of meldonium: Comparison of urinary detection windows after single- and multiple-dose application in healthy volunteers. J Pharm Biomed Anal 138 (2017) 175–179.

Hengevoss J, Piechotta M, Müller D, Hanft F, Parr MK, Schänzer W, Diel P. Combined effects of androgen anabolic steroids and physical activity on the hypothalamic-pituitary-gonadal axis. J Steroid Biochem Mol Biol. 2015 Jun;150:86-96.

Hülsemann F, Koehler K, Flenker U, Schänzer W. Do we excrete what we eat? Analysis of stable nitrogen isotope ratios of human urinary urea. Rapid Communications in Mass Spectrometry 2017, 31, 1221–1227.

Hülsemann F, Koehler K, Wittsiepe J, Wilhelm M, Hilbig A, Kersting M, Hans Braun, Flenker U, Schänzer W. Prediction of human dietary δ15N intake from standardised food records: validity and precision of single meal and 24-h diet data. Isotopes In Environmental And Health Studies 2017, http://dx.doi.org/10.1080/10256016.2017.1302447

Krug O, Walpurgis K, Thomas A, Piper T, Sigmund G, Schänzer W, Thevis M:Black market products with suspiciously doping relevant ingredients – annual report. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (24). Sportverlag Strauß, Köln  (2016) 135-139.

Knych HK, Stanley SD, McKemie DS, Arthur RM, Bondesson U, Hedeland M, Thevis M, Kass PH. Pharmacokinetics and Pharmacodynamics of Meldonium in Exercised Thoroughbred Horses. Drug Test Anal. 2017 May 16. doi: 10.1002/dta.2214. [Epub ahead of print]

Mehling LM, Piper T, Spottke A, Heidbreder A, Young P, Madea B, Thevis M, Hess C. GHB-O-b-glucuronide in blood and urine is not a suitable tool for the extension of the detection window after GHB intake. Forensic Toxicol. 2017, DOI 10.1007/s11419-016-0352-7

Piper T, Putz M, Delahaut P, Thevis M. Carbon isotope ratios of endogenous steroids in Belgian Blue and Holstein cattle: Method development, reference population studies and application to steroid misuse control. Rapid Commun Mass Spectrom. 2017 Aug 22. doi: 10.1002/rcm.7964. [Epub ahead of print] 

Thomas Piper, Mario Thevis. Applications of Isotope Ratio Mass Spectrometry in Sports Drug Testing Accounting for Isotope Fractionation in Analysis of Biological Samples.  Methods in Enzymology. Available online 24 August  2017, doi.org/10.1016/bs.mie.2017.07.013.

Piper T, Mehling LM, Spottke A, Heidbreder A, Young P, Madea B, Hess C, Schänzer W, Thevis M.  Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection. Forensic Sci Int. 2017 Aug 26;279:157-164. doi: 10.1016/j.forsciint.2017.08.023. [Epub ahead of print] 

Piper T, Geyer H, Blatt C, Schänzer W, Thevis M: Hydrogen isotope ratios of urinary norandrosterone - a case study. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (24). Sportverlag Strauß, Köln  (2016) 112-115.

Roscher KA, Failing K, Schenk I, Moritz A. Suspected aspirin resistance in individual healthy adult warmblood horses. J. vet. Pharmacol. Therap. 2017; Apr 7. doi: 10.1111/jvp.12408. [Epub ahead of print]

Thevis M, Krug O, Geyer H, Schänzer W. Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath. Rapid Commun Mass Spectrom. 2017 Aug 15;31(15):1290-1296.

Thevis M, Kuuranne T, Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal. 2017 Jan;9(1):6-29. doi: 10.1002/dta.2139

Thomas A, Schänzer W, Thevis M. Immunoaffinity techniques coupled to mass spectrometry for the analysis of human peptide hormones: advances and applications.  Expert Rev Proteomics. 2017 Aug 4:1-9. doi: 10.1080/14789450.2017.1362338 

Thomas A, Walpurgis K, Delahaut P, Fichant E, Schänzer W, Thevis M. Determination of LongR3-IGF-I, R3-IGF-I, Des1-3 IGF-I and their metabolites in human plasma samples by means of LC-MS. Growth Horm IGF Res. 2017 Jun 27;35:33-39. doi:10.1016/j.ghir.2017.06.002 

Walpurgis K, Thomas A, Lange T, Reichel C, Geyer H, Thevis M. Combined detection of the ActRII-Fc fusion proteins Sotatercept (ActRIIA-Fc) and Luspatercept (modified ActRIIB-Fc) in serum by means of immunoaffinity purification, tryptic digestion, and LC-MS/MS. Drug Test Anal. 2018 Nov;10(11-12):1714-1721. doi: 10.1002/dta.2513. Epub 2018 Oct 30. 

Walpurgis K, Thomas A, Dellanna F, Geyer H, Schänzer W, Thevis M: Multiplexed detection of ActRII-Fc fusion proteins in serum by means of Western blotting and LC-HRMS. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (25). Sportverlag Strauß, Köln (2017) 98 101 

Walpurgis, K., Krug, O., Thomas, A., Laussmann, T., Schänzer, W., Thevis, M.: Detection of an unknown fusion protein in confiscated black market products.  Drug Test Anal (2014) 6: 1117-24. 

Walpurgis K, Schultze G, Mareck U, Geyer H, Schänzer W, Thevis M: Detection of endogenous and pseudoendogenous steroids in dietary supplements containing Rhodiola rosea. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (24). Sportverlag Strauß, Köln  (2016) 131 134

 2016

Andres S, Ziegenhagen R, Trefflich I, Pevny S, Schultrich K, Braun H, Schänzer W, Hirsch-Ernst KI, Schäfer B, Lampen A. Creatine and creatine forms intended for sports nutrition. Mol Nutr Food Res. 2016 Dec 25. doi: 10.1002/mnfr.201600772. [Epub ahead of print]

Braun H.; Die Besonderheiten der Ernährung im Leistungssport – von Freizeit- bis zu Hochleistungsaktivitäten, Ernahrungsmed 2016; 41, Supplement 1: S10–S14 

Casilli A, Piper T, de Oliveira FA, Padilha MC, Pereira HM, Thevis M, de Aquino Neto FR Optimization of an on-line heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine. Drug Test Anal. 2016 Nov;8(11-12):1204-1211

Dib J, Mongongu C, Buisson C, Molina A, Schänzer W, Thuss U, Thevis M. Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls. Drug Test Anal. 2016 Jun 27 . doi: 10.1002/dta.2011. [Epub ahead of print] 

Josef Dib, Andreas Thomas, Philippe Delahaut, Eric Fichant, Wilhelm Schänzer, Mario Thevis. Identification and characterization of in vitro and in vivo generated metabolites of the adiponectin receptor agonists AdipoRon and 112254. Journal of Pharmaceutical and Biomedical Analysis. Volume 125, 5 June 2016, Pages 68–76

Geyer H. Adulterated nutritional supplements and unapproved pharmaceuticals as new sources of doping substances for fitness and recreational sports. In: Ahmadi N, Ljungqvist A, Svedsäter Göran: Doping and public health. Routledge, London, New York, 2016, 64-70

Görgens C, Guddat S, Thomas A, Wachsmuth P, Orlovius AK, Sigmund G, Thevis M, Schänzer W.Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry. J Pharm Biomed Anal. 2016 Nov 30;131:482-496

Guddat S, Görgens C, Steinhart V, Schänzer W, Thevis M. Mitragynine (Kratom) - monitoring in sports drug testing. Drug Test Anal. 2016 Nov;8(11-12):1114-1118

Hansson A, Thevis M, Cox H, Miller G, Eichner D, Bondesson U, Hedeland M. Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry. J Pharm Biomed Anal. 2016 Nov 27;134:228-236. doi: 10.1016/j.jpba.2016.11.041. [Epub ahead of print]

Joseph A. M. J. L. Janssen, Leo J. Hofland , Christian J. Strasburger , Elisabeth S. R. van den Dungen , Mario Thevis. Potency of Full- Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations. PLoS One. 2016 Mar 18;11(3):e0150453. doi: 10.1371/journal.pone.0150453. eCollection 2016

Hansson A, Knych H, Stanley S, Thevis M, Bondesson U, Hedeland M. Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry. Rapid Commun Mass Spectrom. 2016 Apr 15;30(7):833-42

Helmlin HJ , André Mürner A Steiner S, Kamber M, Weber C, Geyer H, Guddat S, Schänzer W, Thevis M.,Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination. Forensic Science International 267 (2016) 166–172

Hülsemann, F; Praxis der Sporternährung für verschiedene Belastungsbereiche: Extremsport/Ausdauer, Ernährungsmed. 2016, 41, Supplement 1; S27-S28 

Karsten Koehler, Neele R. Hoerner, Jenna C. Gibbs, Christoph Zinner, Hans Braun, Mary Jane De Souza & Wilhelm Schaenze. Low energy availability in exercising men is associated with reduced leptin and insulin but not with changes in other metabolic hormones. J Sports Sci. 2016 Oct;34(20):1921-9. doi: 10.1080/02640414.2016.1142109. Epub 2016 Feb 6.

Knoop A, Thomas A, Fichant E, Delahaut P, Schänzer W, Thevis M. Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Anal Bioanal Chem. 2016 May;408(12):3145-53. doi: 10.1007/s00216-016-9377-3. Epub 2016 Feb 15.

Lagojda A, Kuehne D, Krug O, Thomas A, Wigger T, Karst U, Schänzer W, Thevis M. Identification of selected in vitro-generated phase-I metabolites of the steroidal selective androgen receptor modulator MK-0773 for doping control purposes. Eur. J. Mass Spectrom. 22, 49–59 (2016) 

Olga Malisova, Adelais Athanasatou, Alex Pepa, Marlien Husemann, Kirsten Domnik, Hans Braun, Ricardo Mora-Rodriguez, Juan F. Ortega, Valentin E. Fernandez-Elias and Maria Kapsokefalou. Water Intake and Hydration Indices in Healthy European Adults: The European Hydration Research Study. Nutrients 2016, 8(4), 204; doi:10.3390/nu8040204

Machnik M, Kaiser S, Koppe S, Kietzmann M, Schenk I, Düe M, Thevis M, Schänzer W, Toutain PL. Control of methylxanthines in the competition horse: pharmacokinetic/pharmacodynamic studies on caffeine, theobromine and theophyllinefor the assessment of irrelevant concentrations. Drug Test Anal. 2016 Sep 23. doi: 10.1002/dta.2097. [Epub ahead of print]

Machnik M, Fußhöller G, Schenk I, Wagner S, Wingender A, Thevis M, Schänzer W. Multi-target screening of unconjugated, volatile and alkaline drugs in horse blood and urine using GC-MS/MS in SRM-full SCAN mode. Proc. of the 20th Int. Conf. of Rac. Anal. and Vets. 2014. Mauritius (2015): 361-374.

Mehling LM, Piper T, Dib J, Pedersen DS, Madea B, Hess C, Thevis M. Development and validation of a HPLC–QTOF-MS method for the determination of GHB-?-O-glucuronide and GHB-4-sulfate in plasma and urine. Forensic Toxicol (2016). doi:10.1007/s11419-016-0339-4

Mora-Rodriguez, R.; Ortega, J.F.; Fernandez-Elias, V.E.; Kapsokefalou, M.; Malisova, O.; Athanasatou, A.; Husemann, M.; Domnik, K.; Braun, H. Influence of Physical Activity and Ambient Temperature on Hydration: The European Hydration Research Study (EHRS). Nutrients 2016, 8, 252.

Okano M, Thevis M , Sato M, Kageyama S. Analytical detection of trimetazidine produced by metabolic conversion of lomerizine in doping control analysis. Drug Test Anal. 2016 Aug;8(8):869-74. doi: 10.1002/dta.1893. Epub 2015 Nov 11.

Perdan-Pirkmajer K, Pirkmajer S, Thevis M, Thomas A, Praprotnik S, Ho?evar A, Rotar Ž, Gašperši? N, Sodin-Šemrl S, Žibert J, Omersel J, Chibalin AV, Tomši? M, Ambroži? A. Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis. Scand J Rheumatol . 2016 Jan 4:1-9.

Piper T, Schänzer W, Thevis M. Genotype-dependent metabolism of exogenous testosterone - new biomarkers result in prolonged detectability. Drug Test Anal. 2016 Nov;8(11-12):1163-1173

Schaefer MS, Piper T, Geyer H, Schneemann J, Neukirchen M, Thevis M, Kienbaum P. Xenon elimination kinetics following brief exposure. Drug Test Anal. 2016 Jun 24. doi: 10.1002/dta.2001. [Epub ahead of print]

Schenk I, Heinemann H, Wagner S, Guddat S, Machnik M, Schänzer W, Barton AK, Gehlen H. Detection of inhaled budesonide in equine plasma and urine by liquid chromatography/tandem mass spectrometry. Proc. of the 20th Int. Conf. of Rac. Anal. and Vets. 2014. Mauritius (2015): 523-532. 

Schiffer L, Brixius-Anderko S, Hannemann F, Zapp J, Neunzig J, Thevis M, Bernhardt R. Metabolism of Oral Turinabol by Human Steroid Hormone-Synthesizing Cytochrome P450 Enzymes. Drug Metab Dispos . 2016 Feb;44(2):227-37

Nehal Thanawala, Sarah Cheney, Gwen Wark, Mario Thevis, Andreas Thomas, Webster Madira, Vaitsa Tziaferi, James Greening. Factitious administration of analogue insulin to a 2-year-old child. Br J Diabetes 2016;16:82-84

Thevis M. Malaria-Prophylaxe und Dopinganalytik. In: Deutsche Sporthochschule Köln (Hrsg). Impulse. Das Wissenschaftsmagazin der Deutschen Sporthochschule Köln. 2016, 01, 6-9

Thevis M. Unsaubere Pillen. Verbotene Substanzen als Verunreinigungen oder illegale Beimengung von Nahrungsergänzungsmitteln und damit verbundene gesundheitliche Risiken. Aktuel. Ernährungsmed. 2016; 41, Supplement 1: S19–S21 

Thevis M, Sigmund G, Gougoulidis V, Beuck S, Schlörer N, Thomas A, Kwiatkowska D, Pokrywka A, Schänzer W. Screening for benfluorex and its major urinary metabolites in routine doping controls. Anal Bioanal Chem. 2011 Aug; 401(2):543-51

Thevis M, Geyer H, Tretzel L, Schänzer W. Sports drug testing using complementary matrices: Advantages and limitations. J Pharm Biomed Anal. 2016 Oct 25;130:220-230. doi: 10.1016/j.jpba.2016.03.055. Epub 2016 Mar 28.

Thevis M, Machnik M, Schenk I, Krug O, Piper T, Schänzer W, Düe M, Bondesson U, Hedeland M. Nickel in equine sports drug testing - pilot study results on urinary nickel concentrations. Rapid Commun Mass Spectrom. 2016 Apr 15;30(7):982-4

Thevis M, Schänzer W. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis – Potential implications for sports drug testing programs Rapid Commun. Mass Spectrom. 2016, 30, 635–651 

Thevis M, Kuuranne T, Walpurgis K , Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing Drug Test Anal . 2016 Jan;8(1):7-29 

Thevis M, Krug O, Piper T, Geyer H, Schänzer W. Solutions Advertised as Erythropoiesis-stimulating Products were Found to Contain Undeclared Cobalt and Nickel Species. Int J Sports Med. 2016 Jan;37(1):82-84

Thomas A, Brinkkötter PT, Schänzer W, and Thevis M. Simultaneous determination of insulin, DesB30 insulin, proinsulin, and C-peptide in human plasma samples by liquid chromatography coupled to high resolution mass spectrometry. Forensic Toxicol (2016). doi:10.1007/s11419-016-0343-8

Thomas A, Piper T, Schänzer W, Thevis M. Aspects of modern doping control analysis, Aspekte der modernen Dopinganalytik. PHARMAKON. 2016, 4, 11-15.

Tretzel L, Thomas A , Piper T, Hedeland M, Geyer H, Schänzer W, Thevis M. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing. J Pharm Biomed Anal. 2016 May 10;123:132-40. doi: 10.1016/j.jpba.2016.02.009. Epub 2016 Feb 10.

L. Tretzel, C. Görgens, H. Geyer, A. Thomas, J. Dib, S. Guddat, V. Pop, W. Schänzer, M. Thevis. Analyses of Meldonium (Mildronate) from Blood, Dried Blood Spots (DBS), and Urine Suggest Drug Incorporation into Erythrocytes. Int J Sports Med. 2016 Jun;37(6):500-2. doi: 10.1055/s-0036-1582317. Epub 2016 May 4.

Tretzel L, Thomas A, Piper T, Hedeland M, Geyer H, Schänzer W, Thevis M. Fully automated determination of nicotine and its major metabolites in whole blood by means of a DBS online-SPE LC-HR-MS/MS approach for sports drug testing. J Pharm Biomed Anal. 2016 May 10;123:132-40

Vogel M, Dib J, Tretzel L, Piper T, Thomas A, Schänzer W, Thevis M. Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry. Anal Bioanal Chem. 2016 Sep; 408(23):6431-42.

Vogel M. Moderne Nachweismethoden für EPO und EPO-Mimetika in der Dopinganalytik. In: Deutsche Sporthochschule Köln (Hrsg). Impulse. Das Wissenschaftsmagazin der Deutschen Sporthochschule Köln,2016, 01, 37-43 

Walpurgis K, Thomas A, Vogel M, Reichel C, Geyer H, Schänzer W, Thevis M. Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS. Drug Test Anal. 2016 Nov;8(11-12):1152-1161

Walpurgis K, Thomas A, Schänzer W, Thevis M . Myostatin inhibitors in sports drug testing: Detection of myostatin-neutralizing antibodies in plasma/serum by affinity purification and Western blotting. Proteomics Clin Appl. 2016 Feb;10(2):195-205

2015

Baume N, Geyer H, Vouillamoz M, Grisdale R, Earl M, Aguilera R, Cowan DA, Ericsson M, Gmeiner G,Dorota Kwiatkowska D, Kioukia-Fougia N, Molina A, Ruivo J,k Segura J, Van Eenoo P,Jan N, Robinson N, Saugy M. Evaluation of longitudinal steroid profiles from male football players in UEFA competitions between 2008 and 2013. Drug Test Anal. 2016 Jul;8(7):603-12. doi: 10.1002/dta.1851. Epub 2015 Sep 3.

Josef Dib, Nils Schlörer, Wilhelm Schänzera and Mario Thevisa, Studies on the collision-induced dissociation of adipoR agonists after electrospray ionization and their implementation in sports drug testing. J. Mass Spectrom. 2015, 50, 407–417

Dvorak J,Baume N,Botré F, Broséus J, Budgett R, Frey WO, Geyer H, Harcourt PR, Ho D, Howman D, Isola V, Lundby C, Marclay F, Peytavin A, Pipe A,Pitsiladis YP, Reichel C, Robinson N, Rodchenkov G, Saugy M,Sayegh S, Segura J, Thevis M, Vernec A, Viret M, Vouillamoz M, Zorzoli M. Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015. Br J Sports Med. 2014 May;48(10):801-6.

Ulrich Flenker, Phillip Riemann, Carmen Weigt, Katja Stöver, Frank Hülsemann, Patrick Diel, Wilhelm Schänzer: Isotopenanalyse in der Sportwissenschaft. In Impulse, Das Wissenschaftsmagazin der Deutschen Sporthochschule Köln, 02 (2015) 38 45

Forsdahl G, Erceg D, Geisendorfer T, Turkalj M, Plavec D, Thevis M, Tretzel L, Gmeiner G. Detection of testosterone esters in blood. Drug Test Anal . 2015 Dec;7(11-12):983-910

Geyer H, Thevis M, Schänzer W. Dopinganalytik und Forschung – die Zukunft der Dopingbekämpfung. In. PharmActuel 02/15. Doping im Sport. Schweizerischer Apothekerverband, Bern 2015, 27

Geyer H, Braun H. Inadvertent doping.  In: Castell LM, Stear SJ, Burke LM. Nutritional supplements in sport, exercise and health. An A-Z Guide. Routledge, London, New York, 2015, 15-19

Görgens C, Guddat S, Orlovius AK, Sigmund G, Thomas A, Thevis M, Schänzer W: "Dilute-and-inject" multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing. Anal Bioanal Chem. 2015 Jul;407(18):5365-79

Christian Görgens, Sven Guddat, Josef Dib, Hans Geyer, Wilhelm Schänzer and Mario Thevis: Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry. Drug Test Anal, 2015 Dec;7(11-12):973-9

Hansson A, Knych H, Stanley S, Thevis M, Bondesson U, Hedeland M. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes. Drug Test Anal. 2015, 7, 673–683

Frank Hülsemann, Christine Lehn, Sabine Schneider, Glen Jackson, Sarah Hill, Andreas Rossmann, Nicole Scheid, Philip J. H. Dunn, Ulrich Flenker and Wilhelm Schänzer. Global spatial distributions of nitrogen and carbon stable isotope ratios of modern human hair. Rapid Commun. Mass Spectrom. 2015, 29, 2111–2121

Andre Knoop, Oliver Krug, Marco Vincenti, Wilhelm Schänzer and Mario Thevis: In vitro metabolism studies on the selective androgen receptor modulator LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry. Eur. J. Mass Spectrom. 21, 27–36 (2015)

Krug O, Thomas A, Walpurgis K, Piper T, Sigmund G, Schänzer W, Thevis M: Mass spectrometric analysis of black market products with suspiciously doping relevant ingredients by HPLC-(HR)MS, GC-(HR)MS, ICP-MS, and 1D-gel electrophoresis-UPLC-MS n. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (23). Sportverlag Strauß, Köln  (2015) 201 205 

Piper T, Schänzer W, Thevis M. Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry. J Steroid Biochem Mol Biol. 2015 Dec 14. doi: 10.1016/j.jsbmb.2015.12.013. [Epub ahead of print] 

Reichel C, Benetka W, Lorenc B, Thevis M. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control. Drug Test Anal. 2016 Nov;8(11-12):1131-1137

Reihlen P,Blobel M, Kempkes R, Reichel C, Völker Schänzer E, Majer B, Schänzer W.Optimizing SAR-PAGE. Drug Test Anal. 2015 Dec;7(11-12):1014-6

Schenk I, Machnik M, Röttgen H, Flenker U, Guddat S and Schänzer W. Evaluation of salicylic acid concentrations in horse blood and urine with regard to the actual threshold. In: Soma LR, Uboh CE and Hill WT (eds.) Proceedings of the 19th International Conference of Racing Analysts and Veterinarians 2012, Philadelphia, USA (2015) 115 -124.

Wilhelm Schänzer and Mario Thevis: Human sports drug testing by mass spectrometry. Mass Spectrom Rev. 2017 Jan;36(1):16-46. doi: 10.1002/mas.21479. Epub 2015 Jul 24

Semenistaya E, Zvereva I, Thomas A, Thevis M, Krotov G, Rodchenkov G. Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. Drug Test Anal. 2015 Oct;7(10):919-25

Stear SJ, Braun H, Currell K. Introduction.  In: Castell LM, Stear SJ, Burke LM (eds.). Nutritional supplements in sport, exercise and health. An A-Z Guide. Routledge, London, New York, 2015, 1-39

Sigmund G, Dib J, Tretzel L, Piper T, Bosse C, Schänzer W, Thevis M. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls. Drug Test Anal. 2015 Dec;7(11-12):1057-62

Thevis M, Dib J, Thomas A, Höppner S, Lagojda A, Kuehne D, Sander M, Opfermann G, Schänzer W. Complementing the characterization of in vivo generated N-glucuronic acid conjugates of stanozolol by collision cross section computation and analysis. Drug Test Anal . 2015 Dec;7(11-12):1050-6

Thevis M, Milosovich S, Licea-Perez H, Knecht D, Cavalier T, Schänzer W. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863 , its bishydroxylated metabolite, and its implementation into routine doping controls.]Drug Test Anal. 2016 Aug;8(8):858-63. doi: 10.1002/dta.1870. Epub 2015 Sep 11

Mario Thevis, Hans Geyera, Andreas Thomasa, Laura Tretzela, Isabelle Baillouxc,Corinne Buissonc, Francoise Lasnec, Maximilian S. Schaefer, Peter Kienbaum, Irmela Mueller-Stoever, Wilhelm Schänzer: Formation of the diuretic chlorazanil from the antimalarial drug proguanil - Implications for sports drug testing. Journal of Pharmaceutical and Biomedical Analysis 115 (2015) 208–213

Thevis M, Kuuranne T, Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal. 2015 Jan;7(1):1-20

Thevis M , Schänzer W . Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. J Pharm Biomed Anal. 2014, 101:66-83. 

Mario Thevis, Andreas Lagojda, Dirk Kuehne, Andreas Thomas, Josef Dib, Annelie Hansson, Mikael Hedeland, Ulf Bondesson, Tina Wigger, Uwe Karst and Wilhelm Schänzer: Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing. Rapid Commun. Mass Spectrom. 2015, 29, 991–999

Thomas A, Görgens C, Guddat S, Thieme D, Delanna F, Schänzer W, Thevis M. Simplifying and expanding the screening for peptides < 2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. J Sep Sci. 2016 Jan;39(2):333-41

Andreas Thomas, Paul Brinkkötter, Wilhelm Schänzer , Mario Thevis: Metabolism of human insulin after subcutaneous administration: A possible means to uncover insulin misuse. Analytica Chimica Acta 2015 Oct 15;897:53-61

Thomas A, Walpurgis K, Tretzel L, Brinkkötter P, Fichant E, Delahaut P, Schänzer W, Thevis M. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS. Drug Test Anal. 2015 Dec;7(11-12):990-8

Tretzel L, Thomas A, Sköld K, Zeeberg D, Schänzer W, Thevis M: Improvement of the stability of Synacthen® in Dried Blood Spots by means of heat stabilization. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (23). Sportverlag Strauß, Köln  (2015) 126 129

Tretzel L, Thomas A, Geyer H, Pop V, Schanzer W, Thevis M. Dried blood spots (DBS) in doping controls: a complementary matrix for improved in- and out-of-competition sports drug testing strategies. Anal Methods. 2015; 7: 7596.

Tretzel L, Thomas A, Geyer H, Delahaut P, Schänzer W, Thevis M. Determination of Synacthen® in dried blood spots for doping control analysis using liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2015 Jun;407(16):4709-20

Vogel M, Thomas A, Schänzer W, Thevis M. EPOR-Based Purification and Analysis of Erythropoietin Mimetic Peptides from Human Urine by Cys-Specific Cleavage and LC/MS/MS. J Am Soc Mass Spectrom (2015) 26:1617-25

Vogel M, Blobel M, Thomas A, Walpurgis K, Schänzer W, Reichel C, Thevis M. Isolation, enrichment, and analysis of erythropoietins in anti-doping analysis by receptor-coated magnetic beads and liquid chromatography-mass spectrometry. Anal Chem. 2014 Dec 16;86 (24):12014-21

Weber C, Kamber M, Lentillon-Kaestner V, Krug O, Thevis M . Seizures of doping substances at the Swiss Border - a descriptive investigation. Forensic Sci Int. 2015 Dec;257:359-68.  

2014

Braun, H; de Marees, M; Mester, J; Thevis, M; Schaenzer, W. (2014). Vitamin D status of young elite German athletes. International Journal of Sport Nutrition and Exercise Metabolism, 2014, 24, Issue S1. doi: http://dx.doi.org/10.1123/ijsnem.24.s1.s1

Braun H, de Marees M, Mester J, Schänzer W. Erfassung des Vitamin-D-Status und Knochen-Stoffwechsel relevanter Parameter bei Nachwuchsleistungssportlerinnen und –sportlern. BISp-Jahrbuch: Forschungsförderung 2013/2014. 2015;19-25.

Cox HD, Lopes F, Woldemariam GA, Becker JO, Parkin MC, Thomas A, Butch AW, Cowan DA, Thevis M, Bowers LD, Hoofnagle AN. Interlaboratory Agreement of Insulin-Like Growth Factor 1 Concentrations Measured by Mass Spectrometry.Clin Chem. 2014 Mar;60(3):541-8

Geesmann B, Mester J, Koehler K. Energy Balance, Macronutrient Intake, and Hydration Status During a 1,230 km Ultra-Endurance Bike Marathon. Int J Sport Nutr Exerc Metab. 2014 Oct;24(5):497-506

Geyer H, Schänzer W, Thevis M. Anabolic agents: Recent strategies for their detection and protection from inadvertent doping.  Br J Sports Med. 2014 May; 48 (10):820-6

Görgens C, Guddat S, Schänzer W, Thevis M: Screening and confirmation of myo-inositol trispyrophosphate (ITPP) in human urine by hydrophilic interaction liquid chromatography high resolution / high accuracy mass spectrometry for doping control purposes. Drug Test Anal. 2014 Nov-Dec;6(11-12):1102-7

Höppner S, Delahaut P, Schänzer W, Thevis M. Mass spectrometric studies on the in vivo metabolism and excretionof SIRT1 activating drugs in rat urine, dried blood spots, and plasmasamples for doping control purposes. J. Pharm. Biomed. Anal. 2014, 88, 649-659

Krug O,Thomas A,Walpurgis K, Piper T, Sigmund G, Schänzer W, Laussmann T, Thevis M. Identification of black market products and potential doping agents in Germany 2010 2013. Eur J Clin Pharmacol (2014), 70:1303-1311

Krug O, Kutscher D, Piper T, Geyer H, Schänzer W, Thevis M. Quantifying cobalt in doping control urine samples - a pilot study. Drug Test Anal. 2014 Nov-Dec;6(11-12):1186-90

Krumbholz A, Anielski P, Gfrerer L, Graw M, Geyer H, Schänzer W, Dvorak J, Thieme D. Statistical significance of hair analysis of clenbuterol to discriminate therapeutic use from contamination. Drug Test Anal. 2014 Nov-Dec;6(11-12):1108-16

Mareck U, Gougoulidis V Flenker U, Schänzer W (Cologne): Case study: GC/C/IRMS data of an unsusual urine sample. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (22). Sportverlag Strauß, Köln (2014) 146 149

Mareck U, Fußhöller G, Haenelt N, Geyer H, Guddat S, Gougoulidis V, Klose C, Thevis M, Schänzer W (Cologne): Quality control in steroid profiling. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (22). Sportverlag Strauß, Köln (2014) 193 195

Mareck U, Geyer H, Fußhöller G, Haenelt N, Guddat S, Gougoulidis V, Klose C, Thevis M, Schänzer W (Cologne): German athletes with naturally elevated T/E – evaluation of follow up study. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (22). Sportverlag Strauß, Köln (2014) 196 198

Ojanperä I, Sajantila A, Vinogradova L, Thomas A, Schänzer W, Thevis M Post-mortem vitreous humour as potential specimen for detection of insulin analogues by LC-MS/MS. Forensic Sci Int. 2013 Dec 10;233(1-3)

Piper T, Thomas A, Schänzer W, Thevis M (Cologne): Nitrogen isotope ratios of endogenous urinary AICAR. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (22). Sportverlag Strauß, Köln (2014) 150 153

Piper T, Thomas A, Baume N, Sobolevsky T, Saugy M, Rodchenkov G, Schänzer W, Thevis M: Determination of (13) C/(12) C ratios of endogenous urinary 5-amino-imidazole-4-carboxamide 1?-D-ribofuranoside (AICAR). Rapid Commun Mass Spectrom. 2014, 28, 1194 202. doi: 10.1002/rcm.6891.

Reihlen P, Blobel M, Völker-Schänzer E, Majer B, Schänzer W (Cologne): Detection windows of rEPO using SAR- and IEF-PAGE. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (22). Sportverlag Strauß, Köln (2014) 129 132

Sigmund G, Koch A, Orlovius AK, Guddat S, Thomas A, Schänzer W, Thevis M. Doping control analysis of trimetazidine and characterization of major metabolites using mass spectrometric approaches. Drug Test Anal. 2014 Nov-Dec;6(11-12):1197-205

Stoffel W, Hammels I, Jenke B, Binczek E, Schmidt-Soltau I, Brodesser S, Odenthal M, Thevis M, Obesity resistance and deregulation of lipogenesis in ?6-fatty acid desaturase (FADS2) deficiency. EMBO Rep. 2014 Jan 1;15(1):110-20.

Thevis M, Thomas A, Geyer H, Schänzer W. Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls. Growth Horm IGF Res. 2014, 24(6):276-280.

Thevis M, Piper T, Geyer H, Schaefer MS, Schneemann J, Kienbaum P, Schänzer W. Urine analysis concerning xenon for doping control purposes. Rapid Commun Mass Spectrom. 2015 Jan 15;29(1):61-6

Thevis M, Thomas A, Schänzer W: Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions. Expert Rev Proteomics. 2014 Dec;11(6):663-73.

Thevis M, Piper T, Geyer H, Thomas A, Schaefer M, Kienbaum P, Schänzer W: Measuring xenon in human plasma and blood by gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 2014, 28, 1501–1506

Mario Thevis, Andreas Thomas,Thomas Piper,Oliver Krug, Philippe Delahaut and Wilhelm Schänzer. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometrybased identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes. Eur. J. Mass Spectrom. 20 (2014) 73–83

Thevis M, Sigmund G, Thomas A, Vogel M, Walpurgis K, Kwiatkowska D, Geyer H, Schänzer W. Isotope-dilution mass spectrometric quantification of the prodrug lisdexamfetamine in human urine in doping control analysis. Rapid Commun Mass Spectrom. 2014 Apr 15; 28(7):781-6

Thevis M, Krug O, Geyer H, Wenzel F, Bux J, Stahl L, Hollman W, Thomas A, Schänzer W. Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS – a pilot study. Drug Test. Analysis 2013, 5, 380–383

Thevis M, Kuuranne T, Geyer H, Schänzer W.Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Anal. 2014 Jan;6(1-2):164-84.

Thomas A, Schänzer W, Thevis M: Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC-IM-MS). Drug Test Anal. 2014 Nov-Dec;6(11-12)

Tretzel L, Thomas A, Geyer H, Gmeiner G, Forsdahl G, Pop V, Schänzer W, Thevis M: Use of dried blood spots in doping control analysis of anabolic steroid esters. J Pharm Biomed Anal, 2014 Mar 21 96C:21-30. doi: 10.1016/j.jpba.2014.03.013. [Epub ahead of print]

Walpurgis K, Piper T, Wenzel F, Schänzer W, Thevis M (Cologne, Düsseldorf): Investigations on storage-induced changes of the red blood cell lipidome. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (22). Sportverlag Strauß, Köln (2014) 102 109

Zhang L, Thevis M, Piper T, Jochmann MA, Wolbert JB, Kujawinski DM, Wiese S, Teutenberg T, Schmidt TC Carbon Isotope Ratio Analysis of Steroids by High-Temperature Liquid Chromatography-Isotope Ratio Mass Spectrometry. Anal Chem. 2014 Mar 4;86(5):2297-302 

2013

Franzki R, Braun H, Schänzer W, Köhler K: Essstörungen im Sport: Vergleich von Sportstudenten und Studenten weiterer Studiengänge mittels Eating Disorder Inventory-2. Aktuel Ernahrungsmed 2013; 38(04): 283-289

Grau M, Pauly S, Ali J, Walpurgis K, Thevis M, Bloch W, Suhr F: (2013) RBC-NOS-Dependent S-Nitrosylation of Cytoskeletal Proteins Improves RBC Deformability. PLoS ONE 8(2): e56759. doi:10.1371/journal.pone.0056759

Guddat S, Fußhöller G, Beuck S, Thomas A, Geyer H, Rydevik A, Bondesson U, Hedeland M, Lagojda A, Schänzer W, Thevis M: Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing. Anal Bioanal Chem. 2013 Jul 23. [Epub ahead of print]

Hoerner NR, Braun H, Schänzer W, Köhler K. The effect of energy restriction on exercise-induced release of hormone and metabolites. Proceedings of the German Nutrition Society 2013, 18, 82.

Höppner S, Delahaut P, Schänzer W, Thevis M. Mass spectrometric studies on the in vivo metabolism and excretionof SIRT1 activating drugs in rat urine, dried blood spots, and plasmasamples for doping control purposes. J. Pharm. Biomed. Anal. 2014, 88, 649-659

Höppner S, Schänzer W, Thevis M: Mass spectrometric studies on the in vitro generated metabolites of SIRT1 activating drugs for doping control purposes. J Mass Spectrom. 2013 Jul;48(7):830-43. doi: 10.1002/jms.3227.

Huelsemann F, Koehler K, Braun H, Schaenzer W, Flenker U: Human dietary ?(15) N intake: Representative data for principle food items. Am J Phys Anthropol. 2013 Aug 6. doi: 10.1002/ajpa.22328. [Epub ahead of print]

Sandra Jahn, Simon Beuck, Ines M¨oller, Mario Thevis and Uwe Karst: Using electrochemistry for metabolite simulation and synthesis in preventive doping research: application to the Rycal S107 and the PPARd-agonist GW1516. Anal. Methods, 2013, 5, 1214–1224

Koehler K, Thevis M, Schaenzer W. Meta-analysis: Effects of glycerol administration on plasma volume, haemoglobin, and haematocrit. Drug Testing and Anal. 2013, 5, 896-899

Karsten Koehler, Silvia Achtzehn, Hans Braun, Joachim Mester, and Wilhelm Schänzer: Comparison of self-reported energy availability and metabolic hormones to assess adequacy of dietary energy intake in young elite athletes. Appl. Physiol. Nutr. Metab. 38: 725–733 (2013)

Koehler K, Braun H, de Marees M, Geyer H, Thevis M, Mester J, Schaenzer W: Glycerol administration before endurance exercise: metabolism, urinary glycerol excretion and effects on doping-relevant blood parameters. Drug Test Anal. 2013 Jan 28. doi: 10.1002/dta.1446. [Epub ahead of print]

Machnik M, Schenk I, Düe M. Schänzer W. Medikamentenkontrolle im Pferdesport unter Berücksichtigung von pharmakologisch wirksamen Konzentrationen. Prakt. Tierarzt (2013) 94, 9, 808-817

Machnik M, Schenk I, Düe M. Schänzer W. Medikamentenkontrolle im Pferdesport unter Berücksichtigung von pharmakologisch wirksamen Konzentrationen. Prakt. Tierarzt (2013) 94, 9, 808-817

Marc Machnik, Ina Schenk, Wilhelm Schänzer: Medikamentenkontrolle im Rahmen der Kaufuntersuchung beim Pferd. Der Praktische Tierarzt, 94 Heft 8 (2013) 712 18

Orlovius AK, Thomas A, Schänzer W and Thevis M. AOD-9604 does not influence the WADA hGH isoform immunoassay. Drug Testing and Analysis DOI 10.1002/dta.1557

Piper T, Emery C, Thomas A, Saugy M, Thevis M. Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing. Anal Bioanal Chem. 2013 Apr 9. [Epub ahead of print]

Reichel C, Thevis M. Gel electrophoretic methods for the analysis of biosimilar pharmaceuticals using the example of recombinant erythropoietin. Bioanalysis. 2013 Mar;5(5):587-602

Eva de Rijke, Martien L. Essers, Jeroen C.W. Rijk, Mario Thevis, Toine F.H. Bovee, Leendert A. van Ginkel and Saskia S. Sterk: Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis. Food Additives & Contaminants: Part A, 2013, Publisher: Taylor & Francis, London.

Rydevik A, Bondesson U, Thevis M, Hedeland M. Mass spectrometric characterization of glucuronides formed by a new concept, combining Cunninghamella elegans with TEMPO. J Pharm Biomed Anal. 2013 Jun 28;84C:278-284. doi: 10.1016/j.jpba.2013.06.012. [Epub ahead of print]

Wilhelm Schänzer und Mario Thevis: Bodybuilding und Anabolika. Sportmedizin in Nordrhein, Mitgliederjournal, 2013 Ausgabe 2, 12-17.

Schänzer W, Guddat S, Thomas A, Opfermann G, Geyer H, Thevis M: Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. Drug Test Anal. 2013, 5, 810-818

Thevis M, Thomas A, Schänzer W: Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods. Anal Bioanal Chem. 2013 Aug 8. [Epub ahead of print]

Thevis M, Piper T, Horning S, Juchelka D, SchänzerW. Hydrogen isotope ratio mass spectrometry and high-resolution/high-accuracy mass spectrometry in metabolite identification studies: Detecting target compounds for sports drug testing. Rapid Commun. Mass Spectrom. 2013, 27, 1904–1912

Thevis Mario, Schänzer Wilhelm: Fleisch als Dopingmittel. Labor & More 4 (2013) 24 28

Thevis M, Krug O, Schänzer W: Monitoring phosphodiesterase-4 inhibitors using liquid chromatography/(tandem) mass spectrometry in sports drug testing. Rapid Commun Mass Spectrom. 2013 May 15;27(9):993-1004.

Thevis M, Geyer L, Geyer H, Guddat S, Dvorak J, Butch A, Sterk SS, Schänzer W: Adverse analytical findings with clenbuterol among U-17 soccer players attributed to food contamination issues. Drug Test Anal. 2013 Apr 4. doi: 10.1002/dta.1471. [Epub ahead of print]

Mario Thevis, Andreas Thomas, Simon Beuck, Anthony Butch, Jiri Dvorak and Wilhelm Schänzer: Does the analysis of the enantiomeric composition of clenbuterol in human urine enable the differentiation of illicit clenbuterol administration from food contamination in sports drug testing? Rapid Commun. Mass Spectrom. 2013, 27, 507–512

Mario Thevis, Thomas Piper, Simon Beuck, Hans Geyer and Wilhelm Schänzer: Expanding sports drug testing assays: Mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105. Rapid Commun. Mass Spectrom. 2013, 27, 1173–1182.

Thevis M, Kuuranne T, Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Analysis 2013; 5: 1-19

Thomas A, Walpurgis K, Delahaut P, Kohler M, Schänzer W, Thevis M.: Detection of small interfering RNA (siRNA) by mass spectrometry procedures in doping controls. Drug Test Anal. 2013, 5, 853-860

Thomas A, Vogel M, Piper T, Krug O, Beuck S, Schänzer W, Thevis M: Quantification of AICAR-ribotide concentrations in red blood cells by means of LC-MS/MS. Anal Bioanal Chem. 2013 Jul 5. [Epub ahead of print]

Walpurgis K, Kohler M, Thomas A, Wenzel F, Geyer H, Schänzer W, Thevis M: Effects of gamma irradiation and 15 days of subsequent ex vivo storage on the cytosolic red blood cell proteome analyzed by 2D-DIGE and Orbitrap MS. Proteomics Clin Appl. 2013 May 13. doi: 10.1002/prca.201300009. [Epub ahead of print]

Weigt C, Hertrampf T, Kluxen FM, Flenker U, Hülsemann F, Fritzemeier KH, Diel P. Molecular effects of ER alpha- and beta-selective agonists on regulation of energy homeostasis in obese female Wistar rats. Mol Cell Endocrinol. 2013 Sep 5;377(1-2):147-58


2012

Barroso O, Handelsman DJ, Strasburger C, Thevis M: Analytical challenges in the detection of peptide hormones for anti-doping purposes. Bioanalysis. 2012 Jul;4(13):1577-90

Beuck S, Sigmund G, Koch A, Schänzer W, Pokrywka A, Kwiatkowska D, Thevis M: Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry. Drug Test Anal. 2012 Jul 12. doi: 10.1002/dta.1388: [Epub ahead of print]

Beuck S, Schänzer W, Thevis M: Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. Drug Test Anal. 2012 Feb 24. doi: 10.1002/dta.390. [Epub ahead of print]

Braun H, Köhler K, Geyer H, Mester J, Thevis M, Schänzer W. Nahrungsergänzungsmittelkonsum, Einfluß auf die Mikronährstoffzufuhr bei Nachwuchsleistungssportlern. Deutsche Zeitschrift für Sportmedizin. 2012; 63(7-8): 237.

Braun, H., Koehler, K., Geyer, H., Mester, J., Thevis, M., Schaenzer, W. Dietary supplement use, impact on micronutrient intake of young German athletes. In: Meeusen, R., Duchateau, J., Roelands, B., Klass, M., De Geus, B., Baudry, S., Tsolakidis, E. (eds.). 17th annual congress of the European College of Sport Sciences, Book of abstracts. Bruges, Belgium (2012), 237

Bredehöft M, Baginski R, Parr MK, Thevis M, and Schänzer,W: Investigations of the microbial transformation of cortisol to prednisolone in urine samples. J Steroid Biochem Mol Biol 2012, 129, 54–60

Flenker U: Isotope ratio mass spectrometry - history and terminology in brief. Drug Test. Analysis, 2012, 4, 893-896

Flenker U, Geppert LN, Ickstadt K: Validity of stable isotope data in doping control: perspectives and proposals. Drug Test. Analysis, 2012, 4. 934-941

Friedmann T, Flenker U, Georgakopoulos C, Alsyrafi M, Williams SA, Gill RD. Evolving concepts and techniques for anti-doping. Bioanalysis 2012, 4(13), 1667-80

Geesmann, B., Kramer, F., Koehler, K., Mester, J. Energy balance and food sources during an ultra endurance cycling event. In: Meeusen, R., Duchateau, J., Roelands, B., Klass, M., De Geus, B., Baudry, S., Tsolakidis, E. (eds.). 17th annual congress of the European College of Sport Sciences, Book of abstracts. Bruges, Belgium (2012), 89-90

Gómez C, Pozo OJ, Geyer H, Marcos J, Thevis M, Schänzer W, Segura J, Ventura R. New potential markers for the detection of boldenone misuse. J Steroid Biochem Mol Biol. 2012 Jun 2. [Epub ahead of print]

Guddat S, Fußhöller G, Geyer H, Thomas A, Braun H, Haenelt N, Schwenke A, Klose C, Thevis M, Schänzer W. Clenbuterol-regional food contamination a possible source for inadvertent doping in sports. Drug Test Anal. 2012 Jan 17; [Epub ahead of print] DOI 10.1002/dta.1330

Hess, C.; Thomas, A.; Thevis, M.; Stratmann, B.; Quester, W.; Tschoepe, D.; Madea, B.; Musshoff, F., Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry. Anal Bioanal Chem 2012, 404 (6-7), 1813-22.

Höppner S, Schänzer W, Thevis M.: Fragmentation studies of SIRT1-activating drugs and their detection in human plasma for doping control purposes. Rapid Commun Mass Spectrom. 2013 Jan 15;27(1):35-50. doi: 10.1002/rcm.6421

Kilian, Y., Koehler, K., Wahl, P., Zinner, C., Sperlich, B., Mester, J. Comparison of different methods for estimating total energy expenditure for brief bouts of high intensity intervals.In: Meeusen, R., Duchateau, J., Roelands, B., Klass, M., De Geus, B., Baudry, S., Tsolakidis, E. (eds.). 17th annual congress of the European College of Sport Sciences, Book of abstracts. Bruges, Belgium (2012), 590

Kohler, M.; Sandberg, A.; Kjellqvist, S.; Thomas, A.; Karimi, R.; Nyren, S.; Eklund, A.; Thevis, M.; Skold, C. M.; Wheelock, A. M., Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease. The Journal of allergy and clinical immunology 2012, 3, 743-751

Koehler K, Braun H, Thevis M, Schänzer W: Glycerol as prohibited substance: meta-analysis on the effects of glycerol administration on haematocrit and plasma volume. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 59.

Koehler K, Pilger N, Zinner C, Braun H, Mester J, Schänzer W. Einfluss einer Energierestriktion und Training auf ausgewählte Parameter der Leistungsfähigkeit. Deutsche Zeitschrift für Sportmedizin. 2012; 63(7-8): 234.

Koehler K, Settner K, Braun H, Achtzehn S, Mester J, Schaenzer W. Association Between Energy Availability And Serum IGF1, T3, Leptin And Insulin In Young Female Athletes. Medicine and Science in Sports and Exercise 2012, 44, 5, S78

Koehler, K., Olivar, R., Wallmann, B., Sperlich, B., Mester, J. Underestimation of energy expenditure with the sensewear armband during uphill and level treadmill exercise. In: Meeusen, R., Duchateau, J., Roelands, B., Klass, M., De Geus, B., Baudry, S., Tsolakidis, E. (eds.). 17th annual congress of the European College of Sport Sciences, Book of abstracts. Bruges, Belgium (2012),  649

Koehler, K., Pilger, N., Zinner, C., Braun, H., Kleinert, J., Mester, J., Schaenzer, W. Effects of short-term energy restriction with and without training on physiological and psychological measures of performance. In: Meeusen, R., Duchateau, J., Roelands, B., Klass, M., De Geus, B., Baudry, S., Tsolakidis, E. (eds.). 17th annual congress of the European College of Sport Sciences, Book of abstracts. Bruges, Belgium (2012), 90

Koehler K, Schänzer W: Nahrungsergänzungsmittel. In: Graf, C. (Hrsg.)  Lehrbuch Sportmedizin. Deutscher Ärtzteverlag, Köln (2012) S.189-196

Krug O, Thomas A, Walpurgis K, Sigmund G, Schänzer W, Thevis M: Analysis of confiscated products with suspiciously doping relevant ingredients by GC-MS, LC-HRMS and LC-MSn. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 132 134

Krug O, Thomas A, Beuck S, Schenk I, Machnik M, Schänzer W, Bondesson U, Hedeland M, Thevis M. Characterization of In Vitro Synthesized Equine Metabolites of the Selective Androgen Receptor Modulators S24 and S4. J Equine Vet Sci 2012; in press

Lopez-Avila V, Cooley J, Urdahl R, Thevis M.Determination of stimulants using gas chromatography/high-resolution time-of-flight mass spectrometry and a soft ionization source.Rapid CommunMassSpectrom. 2012 Dec 15;26(23):2714-24. doi: 10.1002/rcm.6398.

M. Machnik, I. Schenk, H. Flenker, G. Apel, O. Katona, C. Habers and W. Schänzer (2012) TCO2 referencevalues in horsesdeterminedbytheIdexxblood gas analyzerVetStat. In: Proceedings of the 18th International Conference of Racing Analysts and Veterinarians, Queenstown 2010. R & W Publications Ltd., Newmarket (ISBN 978 0 473 22084 6), 50 - 57

Mareck U, Fußhöller G, Geyer H, Opfermann G, Thevis M, Schänzer W: GC -single and -triple quadrupole mass spectrometry in steroid profiling. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 9189-192.

Möller I, Thomas A, Geyer H, Schänzer W, Thevis M: Detection and method validation of peginesatide in human serum by means of LC-MS/MS. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 93 99.

Möller I, Thomas A, Delahaut P, Geyer H, Schänzer W, Thevis M: Mass spectrometric detection of peginesatide in human urine in doping control analysis. J Pharm Biomed Anal. 2012 Jul 31. [Epub ahead of print]

Möller I, Thomas A, Wingender A, Machnik M, Schänzer W, Thevis M. Detection of peginesatide in equine serum using liquid chromatography-tandem mass spectrometry for doping control purposes. Eur.J. Mass Spectrom. 18, 2012 (Epub ahead of print)

Möller I, Thomas A, Geyer H, Schänzer W, Thevis M. Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing. Anal Bioanal Chem. 2012 May 17. [Epub ahead of print]

Müller D, Opfermann G, Rojas S, Schlörer N, Pokrywka A, Kwiatkowska D, Diel P, Schänzer W, Parr MK: 5?-Androst-1-ene-3,17-dione: metabolism, influence on steroid profile and biological activity. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 44.

Orlovius AK, Guddat S, Parr MK, Guetschow M, Thevis M, Schänzer W: In vitro formation of fenoterol sulfates using different tissue preparations and recombinant sulfotransferases. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 11.

Parr MK, Schänzer W, Schlörer N, Voronina E, Hengevoss J, Diel P: Alternative detection strategies for anabolic steroid abuse by NMR metabonomics and endocrine feedback loop analyses. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 46 51.

Parr MK, Daniels J, Schlörer NE, Schänzer W: Structure proof of tibolone 3-hydroxy metabolite. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 28 33.

Parr MK, Zöllner A, Fußhöller G, Opfermann G, Schlörer N, Zorio M, Bureik M, Schänzer W. Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21, as well as CYP3A4 in xenobiotic androgen elimination - Insights from metandienone metabolism. Toxicol Lett. 2012 Sep 18;213(3):381-91. Epub 2012 Jul 31.

Pilger, N., Koehler, K., Zinner, C., Braun, H., Mester, J., Schaenzer, W. Acute effects of energy restriction during endurance training on physical performance. In: Meeusen, R., Duchateau, J., Roelands, B., Klass, M., De Geus, B., Baudry, S., Tsolakidis, E. (eds.). 17th annual congress of the European College of Sport Sciences, Book of abstracts. Bruges, Belgium (2012), 360

Piper T, Thomas A, Thevis M, Saugy M. Investigations on hydrogen isotope ratios of endogenous urinary steroids: reference-population-based thresholds and proof-of-concept. Drug Test Anal. 2012 Sep;4(9):717-27

Piper T, Degenhardt K, Federherr E, Thomas A, Thevis M, Saugy M. Effect of changes in the deuterium content of drinking water on the hydrogen isotope ratio of urinary steroids in the context of sports drug testing. Anal Bioanal Chem. 2012 Nov 6. [Epub ahead of print]

Piper T, Fusshöller G, Emery C, Schänzer W, Saugy M. Investigations on carbon isotope ratios and concentrations of urinary formestane. Drug Test Anal. 2012 Dec;4(12):942-50

Piper T, Emery C, Saugy M. Norandrosterone analysis by GC/C/IRMS. In: Schänzer W, Thevis M, Geyer H, Mareck U (eds.) Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 201-204.

Polyviou T.P., Easton C., Beis L., Malkova D., Takas P., Hambly C., Speakman J.R., Koehler K., Pitsiladis Y.P. Effects of Glycerol and Creatine Hyperhydration on Doping-Relevant Blood Parameters. Nutrients. 2012; 4(9):1171-1186.

Reichel C, Thevis M: Detection of EPO-Fc fusion protein in human blood: Screening and confirmation protocols for sports drug testing. Drug Test Anal. 2012 Jul 5. doi: 10.1002/dta.1381. [Epub ahead of print]

Reihlen P, Völker-Schänzer E, Majer B, Schänzer W. Easy-to-use IEF compatible immunoaffinity purification of Erythropoietin from urine retentates. Drug Test Anal. 2012 May 7. doi: 10.1002/dta.1361. [Epub ahead of print]

Reinartz A, Sigmund G, Machnik M, Thevis M, Schänzer W: Prevalence of antidepressants and biosimilars in elite sport – a follow-up study. Recent advances in doping analysis (20). Sportverlag Strauß, Köln (2012) 58

Rydevik A, Thevis M, Krug O, Bondesson U, Hedeland M.: The fungus Cunninghamella elegans can produce human and equine metabolites of selective androgen receptor modulators (SARMs). Xenobiotica. 2012 Nov 15. [Epub ahead of print]

Thomas A, Delahaut P, Krug O, Schänzer W, Thevis M. Metabolism of Growth Hormone Releasing Peptides. Anal Chem. 2012 Nov 13. [Epub ahead of print]

Schänzer W: Doping im Sport. In: Graf, C. (Hrsg.) Lehrbuch Sportmedizin. Deutscher Ärtzteverlag, Köln (2012), S.875-898

Schänzer W, Thevis M: Detection of illegal use of androgens and selective androgen receptor modulators. In: E. Nieschlag, H.M. Behre (eds.) Testosterone – Action,Deficiency,Substitution. 4th Edition, Cambridge University Press, 2012, 517-534.

Thevis M, Kuuranne T, Geyer H, Schänzer W. Annual banned-substance review: analytical approaches in human sports drug testing. Drug Test Analysis 2012; 4: 2-16

Thevis M, Thomas A, Schänzer W. Herausforderung Dopingbekämpfung.Gefährliche Substanzen, deren Missbrauch und Nachweis. Gyne 11, 24-26 (2012)

Thevis M, Volmer DA. Recent instrumental progress in mass spectrometry: advancing resolution, accuracy, and speed of drug detection. Drug Test Analysis 2012; 4: 242-245

Thevis M, Schänzer W, Geyer H, Thieme D, Große J, Rautenberg C, Flenker U, Beuck S, Thomas A, Holland R, Dvorak J: Traditional Chinese Medicine and Sports Drug Testing: Identification of Natural Steroid Administration in Doping Control Urine Samples Resulting from Musk (Pod) Extracts. Br J Sports Med. 2013 Jan;47(2):109-14.

Thomas A, Walpurgis K, Krug O, Schänzer W, Thevis M: Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry. J Chromatogr A. 2012 Jul 28. [Epub ahead of print]

Thomas A, Geyer H, Schänzer W, Crone C, Kellmann M, Moehring T, Thevis M. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer. Anal Bioanal Chem. 2012 Jan 10. [Epub ahead of print]

Thevis, M; Möller, I.; Beuck, S.; Schänzer, W.: Synthesis, Mass Spectrometric Characterization, and Analysis of the PPARd Agonist GW1516 and its Major Human Metabolites: Targets in Sports Drug Testing. In: Badr M. and Youssef J: Peroxisome Proliferator-Activated Receptors (PPARs): Methods and Protocols, Methods in Molecular Biology. Springer, New York, 2013, 952: 301-312

Thevis M, Geyer H, Sigmund G, Schänzer W. Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation. J Pharm Biomed Anal. 2012, 57, 26-32

Walpurgis, K., Kohler, M., Thomas, A., Wenzel, F., Geyer, H., Schänzer, W., Thevis, M., Storage-induced changes of the cytosolic red blood cell proteome analyzed by 2D DIGE and high-resolution/high-accuracy MS. Proteomics 2012, 12(21), 3263 3272

Walpurgis K, Slijepcevic M, Wenzel F, Thomas A, Geyer H, Franz S, Schänzer W, Thevis M.: Influence of repeated subcutaneous G-CSF injections on selected blood parameters relevant for monitoring programmes in sports drug testing. Drug Test Anal. 2012 Oct 9. doi: 10.1002/dta.1432. [Epub ahead of print]

Walpurgis K, Kohler M, Thomas A, Wenzel F, Geyer H, Schänzer W, Thevis M. Validated hemoglobin-depletion approach for red blood cell lysate proteome analysis by means of 2D PAGE and Orbitrap MS. Electrophoresis, 2012, 33, 2537 2545

2011

Beuck S, Bornatsch W, Lagojda a, Schänzer W, Thevis M. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research. Drug Testing and Analysis 2011, 3, 11-12: 756–770.

Beuck S, Schänzer W, Thevis M. Investigation of the in vitro metabolism of the emerging drug candidate S107 for doping-preventive purposes. J Mass Spectrom. 2011 Feb;46(2):112-30

Beuck S, Möller I, Thomas A, Klose A, Schlörer N, Schänzer W, Thevis M. Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing. Anal Bioanal Chem. 2011 Apr 1. [Epub ahead of print]

Braun H, Köhler K, Geyer H, Schänzer W. Nahrungsergänzungsmittel: Doping- und Gesundheitsgefahren. E&M - Ernährung und Medizin 2011, 26, 174-178

Braun, H., Koehler, K., Mester, J., Thevis, M., Schaenzer, W. Micronutrient intake of young elite German athletes. In: Cable, N.T. , George, K. (eds.). 16th annual congress of the European College of Sport Sciences, Book of abstracts. Liverpool, UK (2011) 295 296

De Knijf G, Flenker U, Vanappelghem C, Manci CO, Kalkman VJ, Demolder H (2011): The status of two boreo-alpine species, Somatochlora alpestris and S. arctica, in Romania and their vulnerability to the impact of climate change (Odonata: Corduliidae), International Journal of Odonatology, DOI:10.1080/13887890.2011.578565

Geesmann, B., Wonneberger, M., Weber, S., Koehler, K. The effect of vitamin C supplementation on the aerobic performance. In: Cable, N.T. , George, K. (eds.). 16th annual congress of the European College of Sport Sciences, Book of abstracts. Liverpool, UK (2011) 111 112

Geert De Knijf, Ulrich Flenker, Cédric Vanappelghem, Cosmin O. Manci, Vincent J. Kalkman, Heidi Demolder. The status of two boreo-alpine species, Somatochlora alpestris and S. arctica, in Romania and their vulnerability to the impact of climate change (Odonata: Corduliidae). International Journal of Odonatology, 14 (2) (2011) 111 126

Geyer H, Braun H, Burke LM, Stear SJ, Castell LM: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance--Part 22. Br J Sports Med 2011;45:752-754. doi:10.1136/bjsports-2011

Görgens C, Guddat S, Tomas A, Geyer H, Schänzer W: Identification and quantitative determination of long-term alcohol markers ethylglucuronide and ethylsulfate in human urine by LC-MS/MS in doping control analysis. . In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 309 312

Guddat S, Solymos E, Orlovius A, Thomas A, Sigmund G, Geyer H, Thevis M, Schänzer W. High-throughput screening for various classes of doping agents using a new 'dilute-and-shoot' liquid chromatography-tandem mass spectrometry multi-target approach. Drug Testing and Analysis 2011, 3, 11-12: 836-850.

Koehler K, De Marees M, Braun H, Schaenzer W. Evaluation of two portable sensors for energy expenditure assessment during high-intensity running, European Journal of Sport Science 2011 (epub ahead of print) DOI:10.1080/17461391.2011.58643

Koehler K, Braun H, Marees M, Geyer H, Thevis M, Mester J, Schaenzer W: Urinary excretion of exogenous glycerol administration at rest. Drug Testing and Analysis 2011, 3, 11-12: 877-882.

Koehler K, Huelsemann F, de Marees M, Braunstein B, Braun H, Schaenzer W. Case Study: Simulated and real-life energy expenditure during a three-week expedition. Int J Sport Nutr Exerc Metab. 2011 Dec;21(6):520-6

Koehler K, Braun H, Schänzer W: Einsatz von Nahrungsergänzungsmitteln im Sport. Leistungssport, 2011, 5, 47-48

Koehler K, Braun H, de Marees M, Geyer H, Thevis M, Mester J, Schaenzer W. Urinary excretion of exogenous glycerol administered before endurance exercise. Medicine and Science in Sports and Exercise 2011, 45, 5, S591-2

Koehler K, Braun H, Achtzehn S, Hildebrand U, Predel HG, Mester J, Schänzer W. Iron status in elite young athletes: gender-dependent influences of diet and exercise. Eur J Appl Physiol. 2011 May 19. [Epub ahead of print]

Kohler, M., Schänzer, W. and Thevis, M. RNA interference for performance enhancement and detection in doping control Drug Testing and Analysis, 3 (2011) 661–667. doi: 10.1002/dta.330

Mareck U, Guddat S, Schwenke A, Beuck S, Geyer H, Flenker U, Elers J, Backer V, Thevis M, Schänzer W. Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry. Drug Testing and Analysis 2011, 3, 11-12: 820-827.

Ines Möller, Annette Wintermeyer, Katja Bender, Martin Jübner, Andreas Thomas, Oliver Krug, Wilhelm Schänzer, Mario Thevis: Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Test Analysis, 2 (2011) 609–620

Möller I, Thomas A, Geyer H, Schänzer W, Thevis M. Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. Rapid Commun Mass Spectrom. 2011, 15, 2115-23.

Orlovious AK, Guddat S, Parr MK, Koch A, Gütschow M, Thevis M, Schänzer W: Identification and Monitoring of octopamine sulfoconjugate in urine by LC/(ESI)-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 34 42

Orlovius AK, Parr MK, Guddat S, Gütschow M, Thevis M, Schänzer W: Sulfoconjugated metabolites for doping control analysis. Book of Abstracts des "Joint Meeting of the Austrian and German Pharmaceutical Societies: Shaping the future – Trends and perspectives in pharmaceutical sciences", 20.–23.09.2011, Innsbruck, Austria. 2011, 235

Parr MK, Opfermann G, Schlörer N, Geyer H, Rataj F, Zierau O, Diel p, Schänzer W: Sense or nonsense of prohormone designing. Reduced metandienone as supplement.. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 15 23

Parr MK, Zöllner A, Fußhöller G, Opfermann G, Hobler A, Bernhardt R, Bureik M, Schänzer W: New players in the nightwatch research. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 60 62

Parr MK, Blatt C, Zierau O, Geyer H, Diel P, Schänzer W: Insights on effects of “dietary supplement” ingredient methyl-1-testosterone. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 264 265

Parr MK. Neuroenhancement – Doping fürs Gehirn – Ein Thema für Sportstudierende? – aktuelle Studienergebnisse. In: Bodemer I, Jesse B (eds.). KleineS Handbuch der Lehre an der DSHS Köln. Deutsche Sporthochschule Köln (2011) 36 37

Parr MK, Blatt C, Zierau O, Hess C, Gütschow M, Fusshöller G, Opfermann G, Schänzer W, Diel P. Endocrine Characterization of the Designer Steroid Methyl-1-Testosterone: Investigations on Tissue-Specific Anabolic-Androgenic Potency, Side Effects, and Metabolism. Endocrinology, 152 (2011) 4718-4728

Parr MK, Westphal F, Sönnichsen F, Opfermann G, Müller D, Schänzer W: Seizure of unapproved drug named “1-Androsterone” Book of Abstracts des "Joint Meeting of the Austrian and German Pharmaceutical Societies: Shaping the future – Trends and perspectives in pharmaceutical sciences", 20.–23.09.2011, Innsbruck, Austria. 2011, 231

Parr MK, Pokrywka A, Kwiatkowska D, Schänzer W: Ingestion of desigener supplements produced positive doping cases unexpected by the athletes. Biol Sport 28 (2011) 153 157

Parr MK, Opfermann G, Schänzer W. Mass spectra of physiological active substances - including drugs, steroid hormones and endocrine disruptors 2011. CD Rom.Wiley-VCH Verlag GmbH & Co. KGaA. ISBN 978 3 527 33080 5

Parr MK, Opfermann G, Geyer H, Westphal F, Sönnichsen FD, Zapp J, Kwiatkowska D, Schänzer W. Seized designer supplement named "1-Androsterone": Identification as 3?-hydroxy-5?-androst-1-en-17-one and its urinary elimination. Steroids 76 (2011) 540 547

Parr MK, Fußhöller G, Schlörer N, Opfermann G, Geyer H, Rodchenkov G, Schänzer W. Detection of delta6-methyltestosterone in a "dietary supplement" and GC-MS/MS investigations on its urinary metabolism.Tox Letters 201 (2011) 101 104

Parr MK, Flenker U, Schänzer W. The assay of endogenous and exogenous anabolic an-drogenic steroids. In: Ghigo E, Lanfranco F, Strasburger CJ (eds). Hormone Use and Abuse by Athletes, Springer Science & Business Media LLC New York (2011) 121 130 ISBN 978 1 4419 7013 8

Piper T, Schlug C, Mareck U, Schänzer W: Investigations on changes in 13C/12C ratios of endogenous urinary steroids after pregnenolone administration. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 112

Piper T, Fußhöller G, Emery C, Schänzer W, Saugy M: Investigations on carbon isotope ratios and concentrations of urinary formestane. . In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 100

Piper T, Fußhöller G, Schänzer W: Investigations on the deconjugation processes of conjugated urinary steroids during degradation with 18O labelled water. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 296 299

Piper T, Schlug C, Mareck U, Schänzer W. Investigations on changes in (13) C/(12) C ratios of endogenous urinary steroids after pregnenolone administration. Drug Test Anal. 2011 Apr 28. doi: 10.1002/dta.281. [Epub ahead of print]

Reihlen P, Völker-Schänzer E, Majer B, Schänzer W: Easy to use IEF compatible immunoaffinity purification of urine retentates. . In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 152 153

Solymos E, Guddat S, Geyer H, Thomas A, Thevis M, Schänzer W. Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: Intra-individual variability of urinary concentrations. Drug Testing and Analysis 2011, 3, 11-12: 892-895.

E. Solymos , S. Guddat , H. Geyer , U. Flenker , A. Thomas , J. Segura , R. Ventura , P. Platen , M. Schulte-Mattler , M. Thevis ,W. Schänzer: Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing. Anal Bioanal Chem, online 2010, DOI 10.1007/s00216-010-4589-4

Schänzer W. Neuroenhancement – Doping fürs Gehirn – Ein Thema für Sportstudierende? – aktuelle Studienergebnisse. In: Bodemer I, Jesse B (eds.). KleineS Handbuch der Lehre an der DSHS Köln. Deutsche Sporthochschule Köln (2011) 33 36

Schänzer W. Aktuelle Tendenzen in der Dopinganalytik. In Spitzer G und Franke E (Hrsg.) Sport, Doping und Enhancement – Transdisziplinäre Perspektiven. Band 1, Sportverlag Strauß, 2010, 107-114

Sperlich B, Koehler K, Holmberg HC, Zinner C, Mester J. Table tennis: cardiorespiratory and metabolic analysis of match and exercise in elite junior national players. Int J Sports Physiol Perform., 2011, 6, 234-242

Sperlich, B., De Marées, M., Koehler, K., Linville, J., Holmberg, H. C., Mester, J.: Effects of 5 weeks' high-intensity interval training vs. volume training in 14-year-old soccer players. J Strength Cond Res 25(5): 1271 1278, 2011

Mario Thevis, Gregor Fußhöller, Wilhelm Schänzer: Zeranol: doping offence or mycotoxin? A case-related study. Drug Testing and Analysis 2011, 3, 11-12: 777-783.

Thevis M, Koch A, Sigmund G, Thomas A and Schänzer W: Analysis of octopamine in human doping control samples. Biomedical Chromatography online DOI 10.1002/bmc.1705 (2011)


Thevis M, Thomas A, Schänzer W. Doping control analysis of selected peptide hormones using LC-MS(/MS). Forensic Sci Int. 2011 Jul 11. [Epub ahead of print]

Thevis M, Thomas A, Schänzer W. Doping control analysis of selected peptide hormones using LC-MS(/MS). Forensic Sci Int. 2011 Jul 11. [Epub ahead of print]

Thevis M, Thomas A, Schänzer W. Doping control analysis of selected peptide hormones using LC-MS(/MS). Forensic Sci Int. 2011 Jul 11. [Epub ahead of print]

Thevis M, Thomas A, Möller I, Geyer H, Dalton JT, Schänzer W. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. Rapid Commun Mass Spectrom. 2011, 15, 2187-95

Thevis M, Geyer H, Thomas A, Schänzer W. Trafficking of drug candidates relevant for sports drug testing: Detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet. Drug Test Anal. 2011; 3: 331-336

Thevis M, Kuuranne T, Geyer H, Schänzer W. Annual banned-substance review: Analytical approaches in human sports drug testing. Drug Test Anal. 2011 Jan; 3(1):1-14.

Thevis M, Thomas A, Schänzer W. Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem. 2011 Mar 20. [Epub ahead of print]

A. Thomas, H. Geyer, S. Guddat, W. Schänzer. M. Thevis Dried blood spots (DBS) for doping control analysis. Drug Testing and Analysis 2011, 3, 11-12: 806-813.

A. Thomas, W. Schänzer, P. Delahaut. M. Thevis Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls. Methods. 2011, DOI: 10.1016/j.ymeth.2011.08.009

A. Thomas, W. Schänzer. M. Thevis Analysis of prohibited peptides in doping controls by means of liquid-chromatography mass spectrometry. Ther Drug Monit (ICTDMCT 2011 Conference Abstract). 2011, 33, 471.

A. Thomas, E. Solymos, W. Schänzer, N. Baume, M. Saugy, F. Dellanna. M. Thevis Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes. Analytica Chimica Acta. 2011, DOI: 10.1016/j.aca.2011.09.027

Thomas A, Kohler M, Schänzer W, Delahaut P, Thevis M. Determination of IGF-1 and IGF-2, their degradation products and synthetic analogues in urine by LC-MS/MS. Analyst 2011,136, 1003 1012

Thomas A, Höppner S, Geyer H, Schänzer W, Petrou M, Kwiatkowska D, Pokrywka A, Thevis M. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry. Anal Bioanal Chem. 2011 Feb 6. [Epub ahead of print]

Tinworth KD, Wynn PC, Boston RC, Harris PA, Sillence MN, Thevis M, Thomas A, Noble GK. Evaluation of commercially available assays for the measurement of equine insulin. Domest Anim Endocrinol. 2011, 41, 81-90.

Völker-Schänzer E, Majer B, Kempkes R, Reihlen P, Thomas A, Thevis M, Schänzer W: An efficient sample preparation for CERA analysis in serum. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (19). Sportverlag Strauß, Köln (2011) 317 320

Voronina E, Parr MK, Schlörer NE: 1H NMR-based metabonomics for drug testing. In: Book of abstracts. Euromar 2011, 33.Discussion meeting of the MR spectroscopy division of the GDCh and 8. European Federation of ERP groups meeting. Frankfurt 21-25. August 2011 (2011) 198

Walpurgis K, Thomas A, Laussmann T, Horta L, Metzger S, Schänzer W, Thevis M. Identification of fibroblast growth factor 1 (FGF-1) in a black market product. Drug Testing and Analysis 2011, 3, 11-12: 791–797.

Wolf S, Rataj F, Zierau O, Ostermann K, Diel P, Parr MK, Vollmer G, Rödel G. A novel combined approach to detect androgenic activities with yeast based assays in Schizosaccharomyces pombe and Saccharomyces cerevisiae. Toxicol Lett. 2010,199, 410-5.

Wolf S, Diel P, Parr MK, Rataj F, Schänzer W, Vollmer G, Zierau O: Long-term detection of methyltestosterone (ab-) use by a yeast transactivation system. Arch Toxicol. 2011, 85, 285-292

2010

Achtzehn S, de Marées M, Voss SC, Sperlich B, Romberg S, Schänzer W, Mester J. Reticulocytes: Reference Range and Comparison of Different Laboratory Devices. Dstch. Z. Sportmed. 2010, 61, 208-215

Braun H, Koehler K, Geyer H: Verunreinigungen von Nahrungssupplementen- Eine Quelle verbotener Substanzen? Schweizer Zeitschrift für Ernährungsmedizin. 2010, 4, 18-21

Braun H. Besonderheiten der Ernährung in Sportarten mit Gewichtsklassen. Aktuel. Ernährungsmed. 2010, 35, 178-182

Braun H. Dietary supplements. In: Jeukendrup A (ed), Sports Nutrition: From Lab to Kitchen, Meyer & Meyer Sport UK (2010) 86 91

Geyer H: Doping-Fallstricke im Fussball. In: Deutscher Fußball-Bund (ed.) DFB-Kongress 2010, Aktuelle Wissenschaft für den Spitzenfußball. Philippka-Sportverlag, Münster 2010, 58-61

Green RP, Hollander AS, Thevis M, Thomas A, Dietzen DJ: Detection of surrepititious administration of analog insulin to an 8-week-old infant. Pediatrics 2010, 125, 1236 1240

Hülsemann F, Flenker U, Parr M, Geyer H, Schänzer W. Authenticity control and identification of origin of synthetic creatine-monohydrate by isotope ratio mass spectrometry. Food Chemistry 125, 2011, 767-772

Koch A, Sigmund G, Guddat S, Thevis M, Schänzer W: Octopamine and biogenic amines. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 163 166

Köhler K, Braun H, De Marées M, Fusch, G, Fusch C, Mester J, Schaenzer W (2010). Parallel assessment of nutrition and activity in athletes: Validation against doubly labelled water, 24-h urea excretion, and indirect calorimetry. Journal of Sports Sciences, 28, 13, 1435 – 49

Köhler K: Energetische Voraussetzungen in Rückschlagspielen. In: LandesSportBund Nordrhein-Westfalen (Hg.): Sport ist Spitze - Landessportprogramm Talentsuche und Talentförderung. Meyer & Meyer, Aachen (2009) 93–96

Köhler K, de Marees M, Braun H, Schaenzer W. Comparison of two portable devices for assessing energy expenditure during high-intensity running. Medicine & Science in Sports & Exercise 2010, 5, S304-5

Kohler M, Gotzmann A, Görgens C, Flenker U, Thevis M, Schänzer W: Comparison of hGH serum concentrations of Caucasian and African top athletes: an ethnicity study. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 196 199

Kohler M, Thomas A, Geyer H, Petrou M, Schänzer W, Thevis M. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the cologne doping control laboratory 2009. Drug Test Anal. 2010 Nov;2(11-12):533-7

Kohler M, Thomas A, Walpurgis K, Terlouw K, Schänzer W, Thevis M. Detection of His-tagged Long-R³-IGF-I in a black market product. Growth Horm IGF Res. 2010, 5, 386-90

Kohler M, Thomas A, Walpurgis K, Schänzer W, Thevis M. Mass spectrometric detection of siRNA in plasma samples for doping control purposes. Anal Bioanal Chem (2010) 398:1305-1312
Abstract Figure explaning a possible doping effect of siRNA

Kohler M, Thomas A, Walpurgis K, Terlouw K, Schänzer W, Thevis M. Detection of His-tagged Long-R(3)-IGF-I in a black market product. Growth Horm IGF Res, 2010 Jul 30, online doi:10.1016/j.ghir.2010.07.001

Machnik M, Schenk I, Schänzer W: Dopinganalytik von Phytopkarmaka im Pferdesport, in: B. Meier (Ed.), Ars Medici, Phytotherapie 1 (2010), 38 – 40.

Mareck U, Geyer H, Fußhöller G, Schwenke A, Haenelt N, Piper T, Thevis M, Schänzer W. Reporting and managing elevated testosterone/epitestosterone ratios-Novel aspects after five years' experience. Drug Test Anal. 2010 Nov;2(11-12):637-642

Maxie Kohler, Katja Walpurgis, Andreas Thomas, Markus de Maree, Joachim Mester, Wilhelm Schänzer and Mario Thevis: Effects of endurance exercise on the urinary proteome analyzed by 2-D PAGE and Orbitrap MS. Proteomics Clin Appl, 4 (2010) 568–576.

Möller I, Wintermeyer A, Thomas A, Krug O, Bender K, Schänzer W, Thevis M: In-vitro metabolism of the synthetic cannabinoid JWH-018 and implementation of its major metabolites in human doping controls. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 157 158

Niehoff A, Kersting UG, Helling S, Dargel J, Maurer J, Thevis M, Brüggemann GP. Different mechanical loading protocols influence serum cartilage oligomeric matrix protein levels in young healthy humans. Eur J Appl Physiol. 2010, 3, :651-7

Orlovius AK, Parr MK, Guddat S, Gütschow M, Thevis M, Schänzer W: Detection of urinary phase-I and phase-II metabolites of ephedrine and oxilofrine by LC-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 152 155

Palm FM, Schenk I, Neuhauser S, Schubert D, Machnik M, Schänzer W, Aurich C:Concentrations of altrenogest in plasma of mares and foals and in allantoic and amniotic fluid at parturition. Theriogenology, 74, 2010, 229 - 235.

Parr MK, Fußhöller G, Gütschow M, Hess C, Schänzer W: GC-MS(/MS) investigations on long-term metabolites of 17-methyl steroids. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 64 73

Parr MK, Westphal F, Sönnichsen FD, Geyer H, Schänzer W: 1-DHEA identification in seized dietary supplement. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 241 244

Parr MK, Diel P, Zierau O, Schänzer: Investigations regarding the WADA classification of the supplement ingredient androsta-1,4,6-triene-3,17-dione. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 34 41

Parr MK, Opfermann G, Westphal F, Sönnichsen F, Schänzer W: Designer steroid 3ß-hydroxy-5a-androst-1 ene-17-one: Identification in seized dietary supplement and its urinary metabolism. Proceedings of the Drug Analysis Symposium 2010, Antwerp, Belgium, Belgian Society of Pharmaceutical Sciences (2010) 75

Parr MK, Diel P, Zierau O, Schänzer W: Characterization of the anabolic and androgenic properties of the unapproved aromatase inhibitor androsta-1,4,6-triene-3,17-dione. Endocrine Reviews, Supplement 1, 2010, 31, 1750

Parr MK, Opfermann G, Schänzer W. Mass Spectra of Androgens, Estrogens, and other Steroids 2010. CD Rom.Wiley-VCH Verlag GmbH & Co. KGaA. ISBN 978 3 527 32727 0

Parr MK, Schänzer W. Detection of the misuse of steroids in doping control. Journal of Steroid Biochemistry & Molecular Biology 121 (2010) 528–537.

Maria K. Parr, Ulrich Flenker, Wilhelm Schänzer. Sports-Related Issues and Biochemistry of Natural and Synthetic Anabolic Substances. Endocrinol. Metab.Clin. N. Am., 2010, 39, 45-57

Piper T, Geyer H, Schänzer W. Degradation of urine samples and its influence on the (13) C/(12) C ratios of excreted steroids. Drug Test Anal. 2010 Nov;2(11-12):620-9

Piper T, Opfermann G, Thevis M, Schänzer W. Determination of (13)C/(12)C ratios of endogenous urinary steroids excreted as sulpho conjugates. Rapid Commun Mass Spectrom. 2010 Nov 15;24(21):3171-81.

Piper T, Geyer H, Gougoulidis V, Flenker U, Schänzer W. Determination of 13C/12C ratios of urinary excreted boldenone and its main metabolite 5beta-androst-1-en-17beta-ol-3-one. Drug Test. Analysis 2010, 2, 217–224.

Schröder H, Gebhardt W, Thevis M. Anabolic, doping, and lifestyle drugs, and selected metabolites in wastewater-detection, quantification, and behaviour monitored by high-resolution MS and MS( n ) before and after sewage treatment. Anal Bioanal Chem. 2010, 398, 1207 1229

Thevis M, Gerace E, Thomas A, Beuck S, Geyer H, Schlörer N, Kearbey JD, Dalton JT, Schänzer W. Characterization of in vitro generated metabolites of the selective androgen receptor modulators S-22 and S-23 and in vivo comparison to post-administration canine urine specimens. Drug Test Anal. 2010 Nov;2(11-12):589-98

Thevis M, Schänzer W; Targeting new performance enhancing drugs in doping controls: Selective androgen receptor modulators (SARMs). Spectroscopy Europe, 2010, 22, 6-11

Thevis M: Mass spectrometry in sports drug testing: characerization of prohibited substances and doping control analytical assays. John Wiley & Sons Inc., Hoboken, New Jersey, 2010 (Buch, 360 Seiten) Info

Thevis M, Thomas A, Fußhöller G, Beuck S, Geyer H, Schänzer W: Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes. Rapid Commun. Mass Spectrom. 2010; 24: 2245 2254

Mario Thevis, Andreas Thomas, Maxie Kohler, Simon Beuck, Ines Möller, Mathias Schäfer, Grigory Rodchenkov, Sheng Yin, Joseph A. Loo, Hans Geyer, and Wilhelm Schänzer: Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis. Eur. J. Mass Spectrom. 16(3), 301–312 (2010)

Thevis M, Hemmersbach P, Geyer H, Schänzer W: Dopinganalytik im Behindertensport. F.I.T., Wissenschaftsmagazin der Deutschen Sporthochschule Köln, 01 (2010) 37 43.

Thevis M, Geyer H, Schänzer W: Doping im Sport: Methoden, Analytik, Entwicklungstendenzen. In: Höfling W, Horst J: Doping-warum nicht ? Mohr Siebeck, Tübingen, 2010, 13-21

Thevis M, Möller I, Thomas A, Beuck S, Rodchenkov G, Bornatsch W, Geyer H, Schänzer W: Characterization of two major urinary metabolites of the PPARdelta-agonist GW1516 and implementation of the drug in routine doping controls. Anal Bioanal Chem. 2010 Apr;396(7):2479-91. Epub 2009 Nov 28

Thevis M, Sigmund G, Geyer H, Schänzer W: Stimulants and Doping in Sports. Endocrinol. Metab Clin N Am, 2010, 39, 89–105

Thevis M, Thomas A, Schänzer W: Insulin. In: Thieme D, Hemmersbach P (eds.) Doping in sports. Handbook of Experimental Pharmacology 195, Springer, Heidelberg, Dordrecht, London, New York, 2010, 209-226

Thevis M, Bredhöft M, Kohler M, Schänzer W: Mass spectrometry-based analysis of IGF-1 and hGH. In: Thieme D, Hemmersbach P (eds.) Doping in sports. Handbook of Experimental Pharmacology 195, Springer, Heidelberg, Dordrecht, London, New York, 2010, 201-207

Thevis M, Schänzer W: Synthetic anabolic agents: Steroids and nonsteroidal selective androgen receptor modulators. In: Thieme D, Hemmersbach P (eds.) Doping in sports. Handbook of Experimental Pharmacology 195, Springer, Heidelberg, Dordrecht, London, New York, 2010, 99-126

Thomas A, Kohler M, Delahaut, P, Schänzer W, Thevis, M: Preliminary results for the development of a peptide screening method by means of LC-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 109 117

Thomas A, Beuck S, Eickhoff JC, Guddat S, Krug O, Kamber M, Schänzer W, Thevis M: Quantification of urinary AICAR concentrations as a matter of doping controls. Anal Bioanal Chem 2010:2899-2908

Thomas A, Kohler M, Mester HJ, Geyer H, W. S, Thevis M. Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. Drug Test. Analysis 2010;2:144-148

Thomas A, Guddat S, Kohler M, Krug O, Schänzer W, Petrou M, Thevis M: Comprehensive plasma-screening for known and unknown substances in doping controls. Rapid Commun Mass Spectrom 2010;24:1124-1132

Voss S, Lüdke A, Romberg S, Schänzer E, Flenker U, deMarees M, Achtzehn S, Mester J, Schänzer W Effects of High Intensity Exercise on Isoelectric Profiles and SDS-PAGE Mobility of Erythropoietin Int J Sports Med 31 (2010) 367 – 371

Ytterberg AJ, Dunsmore J, Lomeli SH, Thevis M, Xie Y, Ogorzalek Loo RR, Loo JA: The role of mass spectrometry for peptide, protein, and proteome characterization. In: Cole RB (Ed.) Electrospray and MALDI Mass Spectrometry: Fundamentals, Instrumentation, Practicalities, and Biological Applications, 2nd Edition”. Wiley VCH. 2010, 685-721

Walpurgis K, Kohler M, Thomas A, de Maree M, Mester J, Schänzer W, Thevis M: Effects of endurance exercise on the urinary proteome analyzed by 2D-PAGE and Orbitrap mass spectrometry. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (18). Sportverlag Strauß, Köln (2010) 187 190

Andy Zöllner, Maria Kristina Parr, Calin-Aurel Dragan, Stefan Dräs, Nils Schlörer, Frank T. Peters, Hans H. Maurer, Wilhelm Schänzer, Matthias Bureik. CYP21-catalyzed production of the long-term urinary metandienone metabolite 17ß-hydroxymethyl-17a-methyl-18-norandrosta-1,4,13-trien-3-one: a contribution to the fight against doping. Biol.Chem. 2010, 391, 119-127

2009

Beuck S, Schlörer N, Kamber M, Schänzer W, Thevis M: Hypoxia-inducible factor (HIF) pathway as target for doping purposes and mass spectrometric characterisation of orally available model HIF-stabilizers. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 155 164

Simon Beuck, Tobias Schwabe, Stefan Grimme, Nils Schlörer,Matthias Kamber, Wilhelm Schänzer, and Mario Thevis. Unusual Mass Spectrometric Dissociation Pathway of Protonated Isoquinoline-3-Carboxamides Due to Multiple Reversible Water Adduct Formation in the Gas Phase. J Am Soc Mass Spectrom 2009, 20, 2034–2048

Beuck S, Schwabe T, Grimme S, Schlörer N, Kamber M, Schänzer W, Thevis M: Unusual mass spectrometric dissociation pathway of protonated isoquinoline-3-carboxamides due to multiple reversible water adduct formation in the gas phase. J Am Soc Mass Spectrom 2009, 20, 2034 2048

Hans Braun, Karsten Koehler, Hans Geyer, Jens Kleinert, Joachim Mester, Wilhelm Schänzer: Dietary Supplement Use Among Elite Young German Athletes. IJSNEM, 19 (2009) 97 109

Braun H, Koehler K, Achtzehn S, Predel G, Thevis M, Mester J. Magnesium – dietary intake, supplement use and serum concentration in elite young German athletes. In: Loland S, Bø K, Fasting K, Hallén J, Ommundsen Y, Roberts G, Tsolakidis E (eds.). 14th annual congress of the European College of Sport Sciences, Book of abstracts. Oslo, Norway (2009) 130

Braun H, Koehler K, Geyer H, Thevis M, Schaenzer W. Dietary supplement use of elite German athletes and knowledge about the contamination problem. In: Loland S, Bø K, Fasting K, Hallén J, Ommundsen Y, Roberts G, Tsolakidis E (eds.). 14th annual congress of the European College of Sport Sciences, Book of abstracts. Oslo, Norway (2009) 378

Braun H: Dietary supplements – risk and benfits. In: Jeukendrup A, Wolfarth B (eds). Proceedings of the Sport nutrition conference, Munich 2009. Nestle Nutrition and Power Bar, Munich (2009) 15 19

Brooker L, Parr MK, Cawley A, Flenker U, Howe C, Kazlauskas R, Schänzer W, George A: Development of criteria for the detection of adrenosterone administration by gas chromatography-mass spectrometry and gas chromatography-combustion-isotope ratio mass spectrometry for doping control. Drug Test. Analysis 2009, 1, 587-595

Flenker U: Recent developments in stable isotope research: Joint European Stable Isotope User Meeting 2008. Bioanalysis 2009, 1, 13-16

Flenker U: Stable isotope analysis of bioelements: an introduction. Bioanalysis 2009, 6, 1119 1129

Ulrich Flenker and Wilhelm Schanzer: Comment on ‘‘Validation of specificity in doping control: problems and prospects’’. Accred Qual Assur DOI 10.1007/s00769-009-0585-9

Flenker U, Linster B, Gougoulidis V, Hülsemann F, Schänzer W: Possible absence of lipid 13C depletion in sterols and steroids from eukaryotes. In: AWI – Alfred Wegener Institute for Polar and Marine Research, Research Unit Potsdam (ed.): Terra Nostra - Schriften der GeoUnion Alfred-Wegener-Stiftung 09/03, Brandenburgische Universitätsdruckerei und Verlagsgesellschaft, Potsdam, 2009, 35

Fußhöller G, Schänzer W: Improved steroid profiling using GC tandem mass spectrometry - Preliminary results –. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 233 236

Geyer H, Mareck U, Haenelt N, Schänzer W: Atypical steroid profiles in connection with ethanol findings in urine. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 261 264

Gotzmann A, Grosse j, Schänzer W: Detection of total ß-hCG in doping control – A case study. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 269 272

Gougoulidis V, Piper T, Flenker U, Schänzer W: Comparison of normal-phase and reverse-phase HPLC clean up for 13C/12C analysis of endogenous urinary steroids. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 189 192

Guay C, Goudreault D, Schänzer W, Flenker U, Ayotte C. Excretion of norsteroids phase II metabolites of different origin in human.  Steroids. 2009 Mar;74(3):350-8. 

Guddat S, Thevis M, Kapron J, Thomas A, Schänzer W: Application of FAIMS to anabolic androgenic steroids in sport drug testing. Drug Test. Analysis 2009, 1, 545-553

Huelsemann F. Analysis of human protein and energy metabolism: application of a new method in sports. In: Loland S, Bø K, Fasting K, Hallén J, Ommundsen Y, Roberts G, Tsolakidis E (eds.). 14th annual congress of the European College of Sport Sciences, Book of abstracts. Oslo, Norway (2009) 143

Hülsemann F, Flenker U, Machnik M, Schenk I, Cinner C, Mester J, Schänzer W: Identifizierung von Bicarbonat-Applikation bei Mensch und Pferd per IRMS. In: AWI – Alfred Wegener Institute for Polar and Marine Research, Research Unit Potsdam (ed.): Terra Nostra - Schriften der GeoUnion Alfred-Wegener-Stiftung 09/03, Brandenburgische Universitätsdruckerei und Verlagsgesellschaft, Potsdam, 2009, 46-47

Hülsemann F, De Marees M, Flenker U, Von Kuk C, Schmidt A, Schänzer W, Mester J, Bloch W: Auf den Spuren der Botenläufer der Inka. Ein Laufexperiment in den südamerikanischen Anden. F.I.T. Das Wissenschaftsmagazin, 1 (2009) 4-11

Hülsemann F, Flenker U, Koehler K, Schaenzer W. Effect of a controlled dietary change on carbon and nitrogen stable isotope ratios of human hair. Rapid Commun. Mass. Spec. 2009; 23: 2448 2454

Koehler K, Braun H, Achtzehn S, Predel HG, Mester J, Schaenzer W. Iron status in young elite athletes: influence of diet, exercise and gender. In: Loland S, Bø K, Fasting K, Hallén J, Ommundsen Y, Roberts G, Tsolakidis E (eds.). 14th annual congress of the European College of Sport Sciences, Book of abstracts. Oslo, Norway (2009) 259

Koehler K, Huelsemann F, deMarees M, Braun H, Mester J, Schaenzer W. Nutrition strategies for a 3-week solo dessert crossing: a case study. In: Loland S, Bø K, Fasting K, Hallén J, Ommundsen Y, Roberts G, Tsolakidis E (eds.). 14th annual congress of the European College of Sport Sciences, Book of abstracts. Oslo, Norway (2009) 576

Koehler K, Parr MK, Geyer H, Mester J, Schänzer W: Serum testosterone and urinary excretion of steroid hormone metabolites after administration of a high-dose zinc supplement. European Journal of Clinical Nutrition 2009; 63: 65-70

Kohler M, Franz S, Regeniter A, Ikonen A, Walpurgis K, Thomas A, Schänzer W, Thevis M: Comparison of the urinary protein patterns of athletes by 2D-gel electrophoresis and mass spectrometry – a pilot study. Drug Test. Analysis 2009, 1, 382-386

Kohler M, Franz S, Regeniter A, Ikonen A, Walpurgis K, Thomas A, Schänzer W, Thevis M: Comparison of the urinary protein patterns of athletes by 2D-gel electrophoresis and mass spectrometry – a pilot study. Drug Test. Analysis 2009, 1, 382-386

Kohler M, Thomas A, Püschel L, Schänzer W, Thevis M: Identification of human pituitary growth hormone variants by mass spectrometry. J Proteome Res, 8 (2009) 1071-1076

Kohler M, Thomas A, Geyer H, Horta L, Schänzer W, Thevis M: Detection of the protease Bacillolysin in doping-control urine samples. Drug Test. Analysis 1 (2009) 143–145

Kohler M, Püschel K, Thomas A, Schänzer W, Thevis M: Detection of recombinant growth hormone in plasma by a 2D-PAGE method: an update. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 127 136

Kohler M, Thomas A, Walpurgis K, Horta L, Schänzer W, Thevis M: Detection of proteases and their proteolysis and autolysis products in urine by LC-MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 107 116

Lüdke A, Flenker U, Lüdke S, Schänzer W: Influence of storage on the mobility values of human erythropoietin. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 273 276

Lüdke A, Lüdke S, Völker-Schänzer E, Schänzer W: Detection of Mircera in blood plasma using isoelectric focusing combined with magnetic beads purification. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 301 304

Machnik M, Kaiser S, Koppe S, Kietzmann M, Toutain PL, Schenk I, Düe M, Guddat S, Schänzer W: Pharmacokinetic data of methylxanthines in horses after iv and oral administration of caffeine, theobromine and theophylline. In: Houghton E, Ipek Keskin F, Wade JF, Yazicioglu N (eds.) Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya 2008, R & W Publications, Newmarket (2009) 132 133

Machnik M, Sigmund G, Koch A, Thevis M, Schänzer W: Prevalence of antidepressants and biosimilars in elite sports. Drug Test. Analysis 2009, 1, 286-291

Machnik M, Gerlach M, Kietzmann M, Niedorf F, Thevis M, Schenk I, Guddat S, Düe M, Schänzer W: Detection and pharmacokinetics of tetrahydrogestrinone in horses. J.vet.Pharmacol.Therap. 2009; 32: 197-202

Mareck U, Haenelt N, Geyer H, Guddat S, Kamber M, Brenneisen R, Thevis M, Schänzer W: Temporal indication of cannabis use by means of THC glucuronide determination. Drug Test. Analysis 2009, 1, 505-510

Orlovius AK, Guddat S, Parr MK, Kohler M, Gütschow M, Thevis M, Schänzer W: Terbutaline sulfoconjugate: characterization and urinary excretion monitored by LC/ESI-MS/MS. Drug Test Analysis 2009, 1, 568-575

Orlovius AK, Guddat S, Parr MK, Kohler M, Gütschow M, Thevis M, Schänzer W: Terbutaline sulfoconjugate: Characterisation and urinary excretion monitored by LC/ESI-MS/MS. In: Deutsche Pharmazeutische Gesellschaft. Jahrestagung der DPhG 2009. Abstractband. Deutsche Pharmazeutische Gesellschaft, Frankfurt, 2009, 235

Parr MK, Geyer H, Gütschow M, Schänzer W: Recent steroid findings in “designer supplements”. In: Deutsche Pharmazeutische Gesellschaft. Jahrestagung der DPhG 2009. Abstractband. Deutsche Pharmazeutische Gesellschaft, Frankfurt, 2009, 129

Parr MK, Gütschow D, Daniels J, Opfermann G, Thevis M, Schänzer W: Identification of steroid isoxazole isomers marketed as designer supplement. Steroids 2009: 74: 322-328

Parr MK , Laudenbach-Leschowsky U, Höfer N, Schänzer W, Diel P: Anabolic and androgenic activity of 19-norandrostenedione after oral and subcutaneous administration - Analysis of side effects and metabolism. Toxicology Letters, 188 (2009) 137–141

Parr MK, Opfermann G, Schänzer W: Analytical methods for the detection of clenbuterol. Bioanalysis, 1 (2009) 437 450

Parr MK, Haenelt N, Fußhöller G, Flenker U, Geyer H, Rodchenkov G, Opfermann G, Schänzer W: Recent steroid findings in “Designer Supplements”. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 71 80

Piper T, Flenker U, Schänzer W: Determination of 13C/12C ratios of endogenous urinary steroids excreted as sulphates: method validation and reference population. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 237 240

Piper T, Riemann P, Opfermann G, Mareck U, Geyer H, Vajiala G, Flenker U, Schänzer W: Determination of 13C/12C ratios of urinary epitestosterone and its main metabolites 5a- and 5ß-androstane-3a,17a-diol. Drug Test Analysis 2009, 1, 576-586

Piper T, Flenker U, Schänzer W: Determination of 13C/12C ratios of endogenous urinary steroids excreted as sulphates: Methods validation and reference population. In: AWI – Alfred Wegener Institute for Polar and Marine Research, Research Unit Potsdam (ed.): Terra Nostra - Schriften der GeoUnion Alfred-Wegener-Stiftung 09/03, Brandenburgische Universitätsdruckerei und Verlagsgesellschaft, Potsdam, 2009, 65

Piper T, Flenker U, Mareck U, Schänzer W: 13C/12C Ratios of endogenous urinary steroids investigated for doping control purposes. Drug Test. Analysis 2009, 1, 65-72

Piper T, Thevis M, Flenker U, Schänzer W. Determination of the deuterium/hydrogen ratio of endogenous urinary steroids for doping control purposes. Rapid Commun Mass Spectrom, 23 (2009) 1917 192

Pozo OJ, Lootens L, Van Eenoo P, Deventer K, Meuleman P, Leroux-Roels G, Parr MK, Schänzer W, Delbeke FT: Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism. Drug Test. Analysis 2009, 1, 554-567

Schenk I, Machnik M, Guddat S, Schubert D, Schänzer W: Stability of a representative selection of drugs in horse blood. In: Houghton E, Ipek Keskin F, Wade JF, Yazicioglu N (eds.) Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya 2008, R & W Publications, Newmarket (2009) 225 235

Sigmund G, Thevis M, Koch A, Guddat S, Schänzer W: Determination of methoxyphenamine in doping control analyses. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 225 228

Thevis M, Hemmersbach P, Geyer H, Schänzer W: Doping im Behindertensport. Dopingkontrollaktivitäten bei den Paralympischen Spielen 1984 2008 und in Deutschland 1992 2008. Med. Klin. 2009, 12, 918-924

Thevis M, Geyer H, Kamber M, Schänzer W: Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. Drug Test. Analysis 2009, 1, 387–392

Thevis M, Schänzer W, Thomas A, Beuck S, Möller I: Nachweis von GW1516. Chromchat, 2009, 14-17

Thevis M, Guddat G, Schänzer W: Doping control analysis of trenbolone and related compounds using liquid chromatography–tandem mass spectrometry. Steroids 2009; 74: 315-321

Thevis M, Beuck S, Thomas A, Kohler M, Schlörer N, Vajiala I, Schänzer W: Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis. Drug Test.Analysis 2009; 1: 32-42

Thevis M, Beuck S, Thomas A, Kortner B, Kohler M, Rodchenkov G, Schänzer W: Doping control analysis of emerging drugs in human plasma - identification of GW501516, S-107, JTV-519, and S-40503. Rapid Commun Mass Spectrom, 23(8) (2009)1139 46

Mario Thevis , Andreas Thomas, Maxie Kohler, Simon Beuck and Wilhelm Schänzer: Emerging drugs: mechanism of action, mass spectrometry and doping control analysis. J Mass Spectrom, 44 ( 2009) 442–460

Thevis M, Kuuranne T, Geyer H, Schänzer W: Annual banned-substance review: the Prohibited List 2008 - analytical approaches in human sports drug testing. Drug Test.Analysis 2009; 1: 4-13

Thevis M, Schänzer W: Dopingmittel der Zukunft und deren Nachweis. Selektive Androgenrezeptor Modulatoren (SARMs) und HIF-Stabilisatoren. F.I.T. Das Wissenschaftsmagazin, 1 ( 2009) 14-17

Thevis M, Sigmund G, Thomas A, Gougoulidis V, Rodchenkov G, Schänzer W: Doping control analysis of metamfepramone and two major metabolites using liquid chromatography-tandem mass spectrometry. Eur J Mass Spectrom, 15 (2009) 507 515

Thevis M, Schänzer W: Dopingbekämpfung aus der Sicht der Kontrollinstanz - Prävention durch vorausschauende Analytik. Deutsche Zeitschrift für Sportmedizin, 3 (2009) 66 69

Thevis M, Schänzer W: Detektion ausgewählter makromolekularer Substanzen und Manipulationsversuche in der Dopinganalytik. Deutsche Zeitschrift für Sportmedizin. 3 (2009) 70 72

Thevis M, Beuck S, Thomas A, Fußhöller G, Sigmund G, Schlörer N, Rodchenkov G, Schäfer M, Schänzer W. Electron ionization mass spectrometry of the ryanodine receptor-based Ca2+-channel stabilizer S-107 and its implementation into routine doping control. Rapid Commun. Mass Spectrom. 23 (2009) 2363–2370

Thevis M, Schänzer W: Challenges in identification and quantification of proteins in doping control. In: Mitochondria to Proteins: New challenges for anti-doping science. Proceedings of the 7th annual USADA Symposium on anti-doping-science, Colorado Springs, USA October 17-20, 2008. USADA 2009, 204-239

Thevis M, Schänzer W: Performance-enhancing drugs. In: Maughan RJ (ed) The olympic textbook of science in sport. Wiley-Blackwell, 2009, 285-303

Thomas A, Kohler M, Walpurgis K, Schänzer W, Thevis M: Proteolysis and autolysis of proteases and the detection of degradation products in doping control. Drug Testing and Analysis 1 (2009) 81 86

Thomas A, Kohler M, Schänzer W, Kamber M, Delahaut P, Thevis M: Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom, 2009, 23, 2669 2674

Thomas A, Schänzer W, Thevis M:Determination of insulin to C-peptide ratios as marker for a surreptitious insulin application. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 277 280

Van Renterghem P, Van Eenoo P, Geyer H, Schänzer W, Delbeke FT: Alternative steroid profiling: Reference ranges for urinary endogenous steroids in a caucasian population of athletes. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (17). Sportverlag Strauß, Köln (2009) 81 90

2008

Bredehöft M, Schänzer W, Thevis M: Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry. Rapid Commun. Mass Spectrom., 22 (2008) 477 485

Braun H, Geyer H, Koehler K: Meat products as potential doping traps? International Journal of Sports Nutrition and Exercise Metabolism 18 (2008) 539 542

Cawley AT, Flenker U: The application of carbon isotope ratio mass spectrometry to doping control. J.Mass.Spectrom., 43 (2008) 854 864

Diel P, Friedel A, Geyer H, Kamber M, Laudenbach U, Schänzer W, Schleipen B, Thevis M, Vollmer G: The prohormone 19-Norandrostendione displays selective androgen receptor modulator (SARM) like properties after subcutaneous administration (Abstract) Acta Physiologica 192, suppl. 663 (2008) 57

Dorn SB, Bolt HM, Thevis M, Diel P, Degen G: Induction of micronuclei in V79 cells by the anabolic doping steroids tetrahydrogestrinone and trenbolone. Arch Toxicol, 82 (2008) 257 263

Flenker U, Güntner U, Schänzer W: d13C-Values of endogenous urinary steroids. Steroids, 73 (2008) 408 416

Flenker U, Schänzer W: Analytik von Steroiden – Isotopensignatur verrät Doping. Analytica pro, Nachrichten aus der Chemie, (2008) 22 23

Flenker U, Lüdke S, Güntner U, Schänzer W: Which factors control 13C/12C-ratios of urinary steroids? In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 163 170

Fußhöller G, Schänzer W, Krumwiede D: Improved screening of anabolic steroids in human urine using a new GC-triple quadrupole mass spectrometer - Preliminary results - In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 285 288

Geyer H, Parr MK, Koehler K, Mareck U, Schänzer W, Thevis M: Nutritional supplements cross-contaminated and faked with doping substances. J.Mass.Spectrom., 43 (2008) 892 902

Gougoulidis V, Sigmund G, Flenker U, Schänzer W: Determination of gamma-butyrolactone (GBL) -A pool for the detection of the administration of gamma-hydroxybutyric acid (GHB)- In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 325 328

Guddat S, Thevis M, Thomas A, Schänzer W: Rapid screening of polysaccharide based plasma volume expanders dextran and hydroxyethyl starch in human urine by liquid chromatography - tandem mass spectrometry. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 71 72

Guddat S, Thevis M, Schänzer W: Identification and quantification of the osmodiuretic mannitol in urine for sports drug testing using gas chromatography-mass spectrometry. Eur. J. Mass Spectrom., 14 (2008) 127 133

Guddat S, Thevis M, Thomas A, Schänzer W: Rapid screening of polysaccharide-based plasma volume expanders dextran and hydroxyethyl starch in human urine by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr., DOI: 10.1002/bmc.98

Hintikka L, Kuuranne T, Aitio O, Thevis M, Schänzer W, Kostiainen R.:Enzyme-assisted synthesis and structure characterization of glucuronide conjugates of eleven anabolic steroid metabolites. Steroids, 73 (2008) 257 65, Epub 2007 Oct 26.

Hintikka L, Kuuranne T, Leinonen A, Thevis M, Schänzer W, Halket J, Cowan D, Grosse J, Hemmersbach P, Nielen MW, Kostiainen R: Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison. J.Mass.Spectrom., 43 (2008) 965 973

Frank Hülsemann, Markus de Marées, Ulrich Flenker, Carsten von Kuk, Anette Schmidt, Ellen Meinicke, Wilhelm Schänzer und Joachim Mester: Auf den Spuren der Botenläufer der Inka Ein Laufexperiment in den südamerikanischen Anden. F.I.T. Wissenschaftsmagazin, 1 (2008) 4-11

Köhler K, Braun H, Geyer H: Ernährung und Aktivität jugendlicher Kaderathleten. In: Ferrauti A, Platen P, Müller J (eds.) Sport ist Spitze (22) Nachwuchsleistungssport in Nordrheinwestfalen auf dem Prüfstand. Meyer & Meyer Verlag, Aachen (2008) 168 172

Kohler M, Thevis M, Schänzer W, Püschel K: Gesundheitsschäden und Todesfälle durch Doping. Rechtsmedizin, 3 (2008) 177 182

Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Thevis M, Völker-Schänzer E, Schänzer W: Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. Int J Sports Med, 29 (2008) 1-6

Kohler M, Püschel K, Sakharov D, Tonevitskiy A, Schänzer W, Thevis M: Detection of recombinant growth hormone in human plasma by a 2-D PAGE method. Electrophoresis, 29 (2008) 4495-4502

Kohler M, Püschel K, Sakharov D, Tonevitskiy A, Schänzer W, Thevis M: Detection method for recombinant human growth hormone based on 2D-PAGE. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 233 243

Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Lüdke A, Thevis M, Völker-Schänzer E, Schänzer W: Relative mobility values for the discrimination of endogenous and recombinant EPO on SDS gels. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 257 266
Kuuranne T, Leinonen A, Schänzer W, Kamber M, Kostiainen M, Thevis M: Aryl-propionamide-derived selective androgen receptor modulators: Liquid chromatographic-tandem mass spectrometric characterization of the in vitro synthesized metabolites for doping control purposes. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 69 70

Kuuranne T, Pystynen KH, Kostiainen R, Leinonen A, Thevis M, Schänzer W: Metabolism of "new" anabolic steroids: Development of in vitro methodology in metabolite production and analytical techniques. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 89-9

Kuuranne T, Leinonen A, Schänzer W, Kamber M, Kostiainen R, Thevis M: Aryl-propionamide-derived selective androgen receptor modulators: LC-MS/MS characterization of the in vitro synthesized metabolites for doping control purposes. DMD, 36 (2008) 571 581

Kuuranne T, Thomas A, Leinonen A, Delahaut P, Bosseloir A, Schänzer W, Thevis M: Insulins in equine urine: qualitative analysis by immunoaffinity purification and liquid chromatography/ tandem mass spectrometry for doping control purposes in horce-racing. Rapid Commun. Mass Spectrom., 22 (2008) 355 362

Lüdke SM, Flenker U, Schänzer W, Schomburg D: Stable carbon isotope discrimination by human 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Lipid Res, 49(12) (2008) 2620 6

Machnik M, Schenk I, Schänzer W: Analytik im Rahmen einer Kaufuntersuchung. Pferde Spiegel, 1 (2008) 9-12

Mareck U, Geyer H, Opfermann G, Thevis M, Schänzer W: Factors influencing the steroid profile in doping control analysis. J.Mass.Spectrom., 43 (2008) 877 891

Mareck U, Geyer H, Flenker U, Piper T, Thevis M, Schänzer W: Population based reference ranges and additional screening marker for the improvement of the detection of dehydroepiandrosterone misuse. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 149 150

Niehoff A, Kersing UG, Helling S, Dargel J, Maurer J, Thevis M, Brüggemann GP: Effect of static and dynamic mechanical loading on serum concentration of cartilage oligomeric matrix protein (COMP) (Abstract) Acta Physiologica 192, suppl. 663 (2008) 131

Parr MK, Geyer H, Gütschow M, Haenelt N, Opfermann G, Thevis M, Schänzer W: New steroids on the "supplement" market. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 73 82

Parr MK, Geyer H, Köhler K, Schänzer W: Cross-contaminations of vitamine- and mineral-tablets with metandienone and stanozolol. Lebensmittelchemie, 62 (2008) 76

Parr MK, Koehler K, Geyer H, Guddat S, Schänzer W. Clenbuterol marketed as dietary supplement. Biomedical Chromatography, 22 (2008) 298 300

Parr MK, Kazlauskas R, Schlörer N, Opfermann G, Piper T, Schulze G, Schänzer W: 6a-methylandrostenedione: gas chromatographic mass spectrometric detection in doping control. Rapid Commun. Mass Spectrom., 22 (2008) 321 329

Piper T, Mareck U, Geyer H, Flenker U, Thevis M, Platen P, Schänzer W: Determination of 13C/12C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposes. Rapid Commun. Mass Spectrom., 2008, 22, 2161 2175

Piper T, Flenker U, Schänzer W: Determination of 13C/12C ratios of endogenous urinary steroids: Method validation, reference population and implication for doping control purposes. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 151

Piper T, Flenker U, Schänzer W: Determination of D/H ratios of endogenous urinary steroids: Method validation and first results. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 181 190

Schänzer, W: Unerlaubte Mittel im Sport - Was Sie über Doping wissen sollten. Gynäkologie & Geburtshilfe, 4 (2008) 31 34

Schänzer W, Thevis M, Geyer H: Preventive doping research (Abstract). Acta Physiologica 192, suppl. 663 (2008) 37

Schänzer W, Thevis M, Geyer H: Dopingkontrollen, Dopingfallen und neue Dopingsubstanzen. Praxis der Naturwissenschaften - Biologie in der Schule, 3 (2008) 24 30

Schänzer W, Geyer H, Haenelt N, Mareck U, Platen P, Schrader Y, Schmechel A, Thevis M: Evaluation of urinary steroid profiles. In: Bowers L, Zardo CC, O´Connell C (ed.). Intra-individual reference ranges. Proceedings of the 5th annual USADA Symposium on Anti Doping Science 29.-30.09.06 Lausanne, USADA (2008) 9-14

Sigmund G, Thevis M, Koch A, Guddat, S, Schänzer W: Methods for the detection of tuaminoheptane. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 301 304

Thevis M, Kohler M, Schlörer M, Fußhöller G, Schänzer W: Screening for quinolinone-derived selective androgen receptor modulators using GC-MS and LC-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 59 68

Thevis M, Schänzer W: Verschleierung von Peptidhormon-Missbrauch mit Proteasen und deren Nachweis in der Dopinganalytik. In: Verbotene Methode – Erhöhung des Sauerstofftransfers. Doping-Kleinkonferenz 2007. Schriftenreihe des Bundesinstituts für Sportwissenschaft. 3 (2008) 125 133

Thevis M, Schänzer W: Leistungssteigernde Substanzen im LC-MS/MS. Nachrichten aus der Chemie, 56 (2008) 910 913

Thevis M., Guddat S, Flenker U, Schänzer W: Quantitative analysis of urinary glycerol levels for dopinbg control purposes using gas chromatography-mass spectrometry. Eur. J. Mass Spectrom., 14 (2008) 117 125

Thevis M, Sigmund G, Koch A, Guddat S, Maurer HH, Schänzer W: Doping control analysis of methoxyphenamine using liquid chromatography-tandem mass spectrometry. Eur. J. Mass Spectrom., 14 (2008) 145 152

Thevis M, Lohmann W, Schrader Y, Kohler M, Bornatsch W, Karst U, Schänzer W: Use of electrochemically synthesised metabolite of a selective androgen receptor modulator for mass spectrometry-based sports drug testing. Eur. J. Mass Spectrom., 14 (2008) 163 170

Thevis M, Kohler M, Schlörer N, Fußhöller G, Schänzer W: Screening for two selective androgen receptor modulators using gas chromatography-mass spectrometry in doping control analysis. Eur. J. Mass Spectrom., 14 (2008) 153 161

Thevis M, Sauer M, Geyer H, Sigmund G, Mareck U, Schänzer W: Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry. Journal of Sport Sciences, 26 (2008) 1059-1065

Mario Thevis und Wilhelm Schänzer: Dopingmittel der Zukunft und deren Nachweis Selektive Androgenrezeptor Modulatoren (SARMs) und HIF-Stabilisatoren. F.I.T. Wissenschaftsmagazin, 1 (2008) 14 17

Mario Thevis, Maxie Kohler, Andreas Thomas, Nils Schlörer and Wilhelm Schänzer: Doping control analysis of tricyclic tetrahydroquinoline derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom, 22 (2008) 2471–2478

Thevis M, Kohler M, Schlörer N, Kamber M, Kühn A, Linscheid MW, Schänzer W.: Mass spectrometry of hydantoin-derived selective androgen receptor modulators. J Mass Spectrom, 43 (2008) 639 50

Thevis M, Schänzer W: Mass spectrometry of selective androgen receptor modulators. J.Mass.Spectrom. 43 (2008) 865 876

Thevis M, Geyer H, Schänzer W: Dopingkontrollaktivitäten in Deutschland 1989 2006. Med Klin 103 (2008) 282 298

Thevis M, Kohler M, Thomas A, Maurer J, Schlörer N, Kamber M, Schänzer W. Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS Anal. Bioanal. Chem. 2008; 391: 251-261

Thevis M, Schrader Y, Thomas A, Sigmund G, Geyer H, Schänzer W. Analysis of confiscated black market drugs using chromatographic and mass spectrometric approaches. J. Anal. Toxicol. 32 (2008) 232 240

Thevis M, Kohler M, Schlörer N, Schänzer W: Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation. J. Am. Soc. Mass Spectrom. 19 (2008) 151 158

Thevis M, Kohler M, Schänzer W: New drugs and methods of doping and manipulation. Drug Discovery Today, 13 (2008) 59 66

Thevis M, Schänzer W: Massenspektrometrie-basierte Analytik neuer Dopingsubstanzen. Analytik News, 2008 (Online-Magazin www.analytik-news.de)

Thevis M, Schänzer W: Illicit Organogenesis: Methods and substances of doping and manipulation. Organogenesis, 4 (2008) 230-237.

Thieme D, Sachs H, Thevis M: Formation of the N-methylpyridinium derivative to improve the detection of buprenorphine by liquid chromatography-mass specrometry. J.Mass.Spectrom. 43 (2008) 974 979

Thomas A, Sigmund G, Guddat S, Schänzer W, Thevis M: Determination of selected stimulants in urine for sports drug analysis by solid phase extraction via cation exchange and means of liquid chromatography-tandem mass spectrometry. Eur. J. Mass Spectrom. 14 (2008) 135 143

Thomas, A, Geyer H, Kamber M, Schänzer W, Thevis M: Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. J.Mass.Spectrom. 43 (2008) 908 915

Thomas A, Geyer H, Kamber M, Schänzer W, Thevis M:Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 211 212

Van Renterghem P, Van Eenoo P,Van Thuyne W, Geyer H, Schänzer W, Delbeke FT: Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites. J. Chromatogr B Analyt Technol Biomed Life Sci, 2008 Dec 15;876(2):225-35

Voss SC, Flenker U, Majer B, Schänzer W: Stability tests for haematologic parameters in an anti- oping context. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (16). Sportverlag Strauß, Köln (2008) 345

Voss SC, Flenker U, Majer B, Schänzer W: Stability tests for hematological parameters in antidoping analyses. Laboratory Hematology 14 (2008) 24 29

2007

Benchaar, S.A., Xie, Y., Phillips, M., Ogorzalek Loo, R.R., Galkin, V.E., Orlova, A., Thevis, M., Muhlrad, A., Almo, S.C., Loo, J.A., Egelman, E.H., Reisler, E.: Mapping the interaction of cofilin with subdomain 2 on actin. Biochemistry, 46 (2007) 225 233

Binczek E, Jenke B, Holz B, Günter RH, Thevis M, Stoffel W: Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation. Biol Chem, 388 (2007) 405 418

Dworak M, Diel P, Voss S, Hollmann W, Strüder HK: Intense exercise adenosine concentrations in rat brain: Implications for a homeostatic sleep drive. Neuroscience 150 (2007) 789 795

Diel P, Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, Vollmer G, Zierau O: Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. Toxicol Lett, 169 (2007) 64 71

Flenker U, Gougoulidis V, Sigmund G, Schänzer W: 13C/12C- und 15N/14N-Verhältnisse während Verstoffwechselung von Ephedra-Alkaloiden. Jahrestagung der Arbeitsgemeinschaft Stabile Isotope 08.-10.10.2007 Universität Bayreuth. Book of Abstracts (2007)

Flenker U, Güntner U, Schänzer W: Delta13C-Values of endogenous urinary steroids, Steroids, 73(4) (2008) 408 16. Epub 2007 Dec 4.

Flenker U, Hebestreit M, Piper T, Hülsemann F, Schänzer W: Improved performance and maintenance in gas chromatography/ isotope ratio mass spectrometry by precolumn solvent removal. Anal Chem, 79 (11) (2007) 4162 8

Flenker U, Hülsemann F, Gougoulidis V, Sigmund G, Schänzer W: Elucidation of original and metabolic sources of Ephedrines by stable isotope analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 209 216

Fußhöller G, Mareck U, Schmechel A, Schänzer W:Long-term detection of metandienone abuse by means of the new metabolite 17ß-hydroxymethyl-17?-methyl-18-norandrost-1,4,13-trien-3-one. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 393 396

Geyer H, Köhler K, Mareck U, Parr MK, Schänzer W, Thevis M: Nutritional supplements cross-contaminated and faked with prohormones, "classic" anabolic steroids and "designer steroids". In: Effectivness of the Antidoping fight. 2006 IAAF world anti doping symposium. IAAF, Monaco (2007) 95 99

Geyer H, Flenker U, Haenelt N, Mareck U, Piper T, Schmechel A, Schrader Y, Platen P, Schänzer W: Steroid profiling and GC/C/IRMS for the detection of the misuse of testosterone gel. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 133 142

Gotzmann A, Voß SC, Schänzer W: Abbot IMxÒ total ß-hCG-kit versus Roche ElecsysÒ hCG STAT-kit: Validation and performance comparison. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 351 354

Gotzmann A, Thevis M, Schänzer W. Approaches to the analysis of glucocorticosteroids for inhalative treatment in human doping control and some considerations for equine doping control. In: Houghton E, Kijima-SudaI, Wade JF (eds.) Proceedings of the 16th international conference of racing analysts and veterinarians. R & W Communications, Newmarket (2007) 519 524

Guddat S, Schänzer W, Wachsmuth P, Thevis M: Doping control screening procedure for Trenbolone analogues in human urine by LC-(APCI)-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 397 400

Hinrichs T, Franke J, Voss S, Schänzer W, Platen P: Totale Hämoglobinmasse und Eisenstoffwechsel bei Leistungssportlerinnen. 40. Deutscher Sportärztekongress. Deutsche Zeitschrift für Sportmedizin 7/8 (2007) 200

Hülsemann F, Flenker U, Schänzer W, Mester J: Stabile Isotope der Bioelemente als neuartige Belastungsparameter. 40. Deutscher Sportärztekongress. Deutsche Zeitschrift für Sportmedizin 7-8 (2007) 201

Hülsemann F, Flenker, U: Körperliche Belastung induziert Veränderungen der delta 15N-Werte von Haar und urinärem Harnstoff beim Menschen. Jahrestagung der Arbeitsgemeinschaft Stabile Isotope 08.-10.10.2007 Universität Bayreuth. Book of Abstracts (2007)

Hülsemann F, Flenker U: Herkunfts und Qualitätskontrolle von synthetischem Kreatin-Monohydrat. Jahrestagung der Arbeitsgemeinschaft Stabile Isotope08.-10.10.2007 Universität Bayreuth. Book of Abstracts (2007)

Hülsemann F, Flenker U, Machnik M, Schänzer W: Isolation of bicarbonate from equine urine for isotope ratio mass spectrometry. Isotopes in Environmental and Health Studies, 43 (2007) 267 273

Koehler K, Geyer H, Guddat S, Orlovius A, Parr MK, Thevis M, Mester J, Schänzer W: Sibutramine found in Chinese herbal slimming tea and capsules. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 367 370

Kohler M, Parr MK, Opfermann G, Thevis M, Schlörer N, Marner FJ, Schänzer W: Metabolism of 4-hydroxyandrostendione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites. Steroids, 72 (2007) 278 286

Kohler M, Püschel K, Schänzer W, Thevis M: Mass spectrometric identification of human pituitary growth hormone variants after two-dimensional polyacrylamide gel electrophoresis. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 21 30

Lüdke S, Sauer M, Paul M, Schänzer W: The Cologne import information system: A tool to highlight long term trends in the Black Market for drugs and doping substances. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 441 444

Machnik M, Tobias S, Hammer I, Kietzmann M, Düe M, Weinberger T, Schenk I, Schänzer W: Controlling therapeutic substances - a European harmonised approach: Pharmacokinetic study on the &#945;-agonists romifidine and detomidine in horses. In: Houghton E, Kijima-Suda I, Wade JF (eds.) Proceedings of the 16th international conference of racing analysts and veterinarians. R & W Communications, Newmarket (2007) 421 429

Machnik M, Walpurgis K, Gerlach M, Hegger I, Kietzmann M, Düe M, Weinberger T, Schänzer W: Controlling therapeutic substances - a European harmonised approach: Determination of the detection time for dembrexine following multiple oral administration of horses. In: Houghton E, Kijima-Suda I, Wade JF (eds.) Proceedings of the 16th international
conference of racing analysts and veterinarians. R & W Communications,Newmarket (2007) 434 437

Machnik M, Löhlein W, Schrader Y, Köhler K, Freymark J, Schänzer W: Behandlung von Sportpferden mit Corticosteroiden: Nachweiszeiten von Flumethason und Betamethason beim Pferd nach i.v. Applikation von Actuol und i.a. Applikation von Celestovet. Pferdeheilkunde 23 (2007) 476 480

Machnik M, Hegger I, Kietzmann M, Thevis M, Guddat S, Schänzer W: Pharmacokinetics of altrenogest in horses. J vet Pharmacol Therap, 30 (2007) 86 90

Mareck U, Geyer H, Flenker U, Piper T, Thevis M, Schänzer W: Detection of dehydroepiandrosterone misuse by means of gas chromatography-combustion-isotope ratio mass spectrometry. Eur. J. Mass Spectrom. 13 (2007) 419 426

Mareck U: Nahrungsergänzungsmittel mit Hormonen belastet. Medical Tribune, 1 (2007) 9

Mareck U, Haenelt N, Parr MK, Geyer H, Guddat S, Thevis M, Schänzer W: Direct quantification of Salbutamol in human urine by means of LC-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 87 96

Maughan RJ, Depiesse F, Geyer H : The use of dietary supplements by athletes. Journal of Sports Sciences, 25:1 (2007)103 113

Maurer J, Kohler M, Schänzer W, Thevis M: Identification of proteolytic enzymes in human urine. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 283 292

Parr MK, Zapp J, Becker M, Opfermann G, Bartz U, Schänzer W: Steroidal isomers with uniform mass spectra of their per-TMS derivatives: Synthesis of hydroxyandrostan-3-ones, androst-1-, and -4-ene-3,17-diols. Steroids, 72 (2007) 545 551

Parr MK, Geyer H, Hoffmann B, Köhler K, Mareck U, Schänzer W: High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market. Biomed Chromatogr, 21 (2007) 164 168

Parr MK, Orlovius A, Guddat S, Gütschow M, Thevis M, Schänzer W: Sulfoconjugates of heavy volatile nitrogen containing doping substances utilizing LC-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 97 102.

Parr MK, Opfermann G, Piper P, Schänzer W: Characterisation of steroid metabolites recently detected in doping control analyses. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 143 152

Petkovic V, Thevis M, Lochmatter D, Besson A, Eble A, Flück CE, Mullis EP: GH mutant (R77C) in a pedigree presenting with the delay of growth and pubertal development: structural analysis of the mutant and evaluation of the biological activity. Eur J Endocrinol 157 Suppl 1 (2007) 67 74

Petkovic V, Besson A, Thevis M, Lochmatter D, Eble A, Flück CE, Mullis EP. Evaluation of the biological activity of a GH mutant (R77C) and its impact on GH responsiveness and stature. J Clin Endocrin Metab, 92 (207) 2893-2901

Piper T, Hebestreit M, Flenker U, Geyer H, Schänzer W: A new method to determine d13CVPDB-values of trace amounts of Boldenone and its main metabolite. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 169 178

Piper T, Flenker U, Schänzer W: Untersuchungen zum D/H-Verhältnis endogener urinärer Steroide. Jahrestagung der Arbeitsgemeinschaft Stabile Isotope 08.-10.10.2007 Universität Bayreuth. Book of Abstracts (2007)

Schänzer W, Thevis M: Doping im Sport. Med Klin, 102 (2007) 631 646

Schmidt A, Voss S, Hinrichs T, Franke J, Platen, Bloch W. Schänzer W, Schinköthe T: Durch Höhentraining hervorgerufene immunologische Veränderungen bei Leistungssportlern. 40. Deutscher Sportärztekongress. Deutsche Zeitschrift für Sportmedizin 7/8 (2007) 266

Thevis M, Schänzer W: Massenspektrometrie-basierte Analytik neuer Dopingsubstanzen. Analytik News, 2008 (Online- Magazin www.analytik-news.de)

Thevis M, Kohler M, Maurer J, Schlörer N, Kamber M, Schänzer W: Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis. Rapid Commun. Mass Spectrom. 21 (2007) 3477-3486

Thevis M, Schänzer W: Muskelmasse dank SARM. Nachweis selektiver Androgenrezeptor Modulatoren in der Dopinganalytik. Labor & More, 4 (2007) 52 53

Thevis M, Geyer H, Schänzer W: Selektive Androgenrezeptor Modulatoren (SARMs) und Erythropoietin-Mimetika. Neue Therapeutika und deren Potenzial zum Missbrauch im Sport. Deutsche Zeitschrift für Klinische Forschung, 9/10 (2007) 65 69

Thevis M, Sigmund G, Koch A, Schänzer W: Determination of tuaminoheptane in doping control urine samples. Eur.J.Mass.Spectrom., 13 (2007) 213 221

Thevis M, Schänzer W: Doping mit neuen Medikamenten. Medical Sports Network, (2007) 54 55

Thevis M, Maurer J, Schänzer W: Manipulation von Dopingproben. F.I.T. Wissenschaftsmagazin, 1 (2007) 4-8

Thevis M, Schänzer W. Mass spectrometric identification of peptide hormones in doping-control analysis. Analyst, 132 (2007) 287 291

Thevis M, Maurer J, Kohler M, Geyer H, Schänzer W. Proteases in Doping Control Analysis. Int J Sports Med, 29(7) (2007) 545 549

Thevis M, Schänzer W: Emerging Drugs - Potential for misuse in sport and doping control detection strategies. Mini-Reviews in Medicinal Chemistry, 7 (2007) 533 539

Thevis M, Geyer H, Mareck U, Flenker U, Schänzer W: Doping-control analysis of the 5alpha-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite. Ther Drug Monit, 29(2) (2007) 236 47

Thevis M: Dopinganalytik von Peptidhormonen. Medical Sports Network 1 (2007) 30 32

Thevis M, Schänzer W: current role of LC-MS(/MS) in doping control. Anal Bioanal Chem, 388(7) (2007) 1351-1358

Thevis M, Geyer H, Mareck U, Sigmund G, Henke J, Henke L, Schänzer W: Detection of manipulation in doping control urine sample collection: a multidisciplinary approach to determine identical urine samples. Anal Bioanal Chem, 399(7) (2007) 1539-1543

Thevis, M., Loo, J.A., Ogorzalek Loo, R.R., Schänzer, W.: Recommended criteria for the mass spectrometric identification of target peptides and proteins (< 8 kDa) in sports drug testing. Rapid Commun. Mass Spectrom, 21 (2007) 297 304

Thevis, M., Schänzer, W.: Mass spectrometry in sports drug testing: Structure characterization and analytical assays. Mass Spectrom Rev, 26 (2007) 79 107

Thevis M, Loo JA, Ogorzalek Loo RR, Schänzer W: Recommended criteria for the mass spectrometric identification of target peptides and proteins. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 67 68

Thevis M, Kohler M, Schänzer W: Mass spectrometry of new growth promoting drugs: Hydantoin-derived selective androgen receptor modulators and growth hormone secretagogues. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 263 273

Thomas A, Thevis M, Delahaut P, Bosseloir A, Schänzer W: Identification and determination of degradation products of human insulin and its long acting synthetic analogues in urine by means of ESI-LC-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (15). Sportverlag Strauß, Köln (2007) 293 302

Thomas A, Thevis M, Delahaut P, Bosseloir A, Schanzer W: Mass spectrometric identification of degradation products of insulin and its long-acting analogues in human urine for doping control purposes. Anal Chem, 79(6) (2007) 2518 24

Voss SC, Thevis M, Schinkothe T, Schänzer W: Detection of homologues blood transfusion. Int J Sports Med, 28 (2007) 633 637

2006

Ayotte C, Romiguiere C, Fakirian A, Flenker U, Hebestreit M, Piper T, Schänzer W: The usefulness of GC/C/IRMS in determining the origin of low levels 19-NA-application in routine analysis. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 277 287

Bredehöft, M., Thevis, M, Delahaut P, Kamber M, Schänzer W.: Detection of synacthen in human plasma with LC-ESI-MS/MSusing after immunoaffinity purification. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 363 365

Deligiannis, A., Björnstad, H., Carre, F., Heidbüchel, H., Kouidi, E.,Panhuyzen-Goedkoop, M., Pigozzi, F., Schänzer, W., Vanhees, L.: ESC Study group of sports cardiology position paper adverse cardiovascular effects
of doping in athletes. European Journal of Cardiovascular Prevention and Rehabilitation, 13 (2006) 687 694

Flenker U, Hebestreit M, Piper T, Schänzer W: A new, effective and robust method to couple gas chromatography and isotope ratio mass Spectrometry. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 299 306

Friedel, A., Geyer, H., Kamber, M., Laudenbach-Leschowsky, U., Schänzer. W., Thevis, M., Vollmer, G., Zierau. O., Diel, P.: Tetrahydrogestrinone is a potent but unselective binding steroid and affects glucocorticoid signalling in the liver. Toxicol Lett, 164 (2006) 16 23

Friedel A, Geyer H, Kamber M, Laudenbach-Leschowsky U, Schänzer W, Thevis M, Vollmer G, Zierau O, Diel P.: 17ß-Hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. Toxicol Lett, 165 (2006) 149 155

Fußhöller G, Koch A, Mareck U, Thomas A, Thevis M, Schänzer W: New sample preparation procedure for the confirmation of stanozolol and its metabolites by GC/MSMS and LC/ESI-MSMS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 229 238

Geyer H,Mareck U, Köhler K, Parr MK, Schänzer W: Cross-contaminations of vitamine- and mineral-tablets with metandienone and stanozolol. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 11 16

Gotzmann A, Thevis M, Bredehöft M, Schänzer W: Ciclesonide (Alvesco ® ) - a new glucocorticosteroid for inhalative treatment. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 27 33

Guddat S, Sigmund G, Thomas A, Opfermann G, Thevis M, Schänzer W: Detection of meclofenoxate and its degradation products dimethylaminoethanol and p-chloro-phenoxyacetic acid. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 399 402

Hasler, J., Herklotz, R., Luppa, P.B., Diver, J.M., Thevis, M., Metzger, J., Savoca, R., Jermini, F., Huber, A.: Impact of recent biochemical findings on the determination of free and bioavailable testosterone: evaluation and proposal for clinical use. J. Lab. Med., 30 (2006) 491 505

Hebestreit, M., Flenker, U., Fußhöller, G., Geyer, H., Güntner, U., Mareck, U., Piper, T., Thevis, M., Ayotte, C., Schänzer, W.: Determination of the origin of urinary norandrosterone traces by gas chromatography combustion isotope ratio mass spectrometry. Analyst, 131 (2006) 1021-1026

Hebestreit, M., Flenker, U., Buisson, C., Andre, F., Le Bizec, B., Fry, H., Lang, M., Preiss-Weigert, A., Heinrich, K., Hird, S., and Schänzer M.: Application of Stable Carbon Isotope Analysis to the Detection of Testosterone Administration to Cattle. J Agric Food Chem, 54 (2006) 2850-2858

Kietzmann M, Düe M, Ammer H, Machnik M: Dopingrelevanz des Arzneimitteleinsatzes beim Pferd. Nulllösung oder Grenzwert ? Pharmakokinetische Überlegungen. Der praktische Tierarzt 9 (2006) 698 702

Kietzmann M, Düe M, Weinberger T, Machnik M: Überlegungen zur Abschätzung von Karenzzeiten bei Sportpferden. Pferde Spiegel 3 (2006) 107-109.

Koehler K, Parr MK, Geyer H, Bode C, Schaenzer W: Serum testosterone and urinary steroid profiles after administration of a zinc supplement. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 403 406

Kohler M, Parr MK, Opfermann G, Schaenzer W:Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 169 179

Mareck U, Fußhöller G, Geyer H, Haenelt N, Kamber M, Brenneisen R, Schänzer W: Temporal indication of marijuana use. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 101 110

Mareck, U., Geyer, H., Guddat, S., Haenelt, N., Koch, A., Kohler, M., Opfermann, G., Thevis, M., Schänzer, W.: Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry. Radid. Commun. Mass Spectrom. 20 (2006) 1954-1962

Mareck, U.: Illegale Dopingmittel in Nahrungsergänzungsmitteln. Lebensmittelchemie, 60 (2006) 133

Opfermann G, Kohler M, Fußhöller G, Parr MK, Sigmund G., Schänzer W: Comparison of uncertainties: the standard deviations of the method of two calibration curves with different preparatory steps. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 489 492

Parr MK, Opfermann G, Schänzer W: Detection of new 17-alkylated anabolic steroids on WADA 2006 list. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 249 258

Parr MK, Geyer H, Hoffmann B, Köhler K, Mareck U, Schänzer W: High amounts of 17-methylated anabolic-androgenic steroids in effervescent tablets on the dietary supplement market. Biomed. Chromatogr. (2006) in press

Parr MK, Geyer H, Köhler K, Schänzer W: Cross-contaminations of vitamine- and mineral-tablets with metandienone and stanozolol. In: Joint meeting of the Czech, German and Hungarian pharmaceutical societies. Marburg: Verlag Görich & Weiershäuser (2006) 77

Piper T, Gougoulidis V, Flenker U, Schänzer W: Presentation of the IRMS - results of suspicious samples with elevated T/E ratios in 2005. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 289 298

Schänzer W, Sauer M: Doping im Sport. In: H. Haag, Strauß, B. (eds.)Themenfelder der Sportwissenschaft. Hofmann-Verlag, Schorndorf (2006) 37 51

Schänzer W, Geyer H, Fußhöller G, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M: Mass Spectrometric Identification and Characterization of a New Long-Term Metabolite of Metandienone. Rapid Commun. Mass Spectrom. 10 (2006) 2252-2258

Schänzer W, Thevis M: Doping-Analytik. Praxis der Naturwissenschaften-Chemie in der Schule, 2 (2006) 3-8

Schänzer W: Doping im Sport. Arzneiverordnung in der Praxis, 33 (2006) 4-6

Schänzer W, Geyer H, Fußhöller H, Halatcheva N, Kohler M, Parr MK, Guddat S, Thomas A, Thevis M: Mass spectrometric identification and characterization of a new long-term metabolite of Metandienone. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 217 218

Schrader Y, Thevis M, Schänzer W: Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography / mass spectrometry. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 199 201

Schrader Y, Thevis, M., Schänzer, W.: Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry. Drug Metab Dispos. 34 (2006) 1328-1335

Sigmund G, Thevis M, Schiffer AK, Schänzer W: Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 403 406

Thevis M, Fußhöller G, Geyer H, Rodchenkov G, Sigmund G, Koch A, Thomas A, Schänzer W: Detection of stanozolol and ist major metabolites in human urine by liquid chromatography-tandem mass spectrometry. Chromatographia 64 (2006) 441 446

Thevis, M., Bredehöft, M., Geyer, H., Kamber, M., Delahaut, P., Schänzer, W.: Determination of synacthen in human plasma using immunoaffinity purification and liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom., 20 (2006) 3551-3556

Thevis, M., Wilkens, F., Geyer, H., Schänzer, W.: Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes. Rapid Commun. Mass Spectrom. 20 (2006) 3393-3402

Thevis, M., Sigmund, G., Schiffer, A.K., Schänzer, W.: Determination of N-desmethyl- and N-bisdesmethyl metabolites of Sibutramine in doping control analysis using liquid chromatography-tandem mass spectrometry. Eur. J. Mass Spectrom. 12, (2006) 129 136

Thevis, M., Thomas, A., Delahaut, P., Bosseloir, A., Schänzer, W.: Doping Control Analysis of Intact Rapid-Acting Insulin Analogues in Human Urine by LiquidChromatography-Tandem Mass Spectrometry. Anal Chem, 78 (2006) 1897-1903

Thevis, M., Schänzer, W.: Analytik modifizierter Steroidhormone mittels Flüssigkeitschromatographie/ Tandem-Massenspektrometrie. J Lab Med, 30 (2006) 26 32

Thevis, M., Kamber, M., Schänzer, W.: Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes. Rapid Commun Mass Spectrom, 20 (2006) 870 876

Thevis M, Krug O, Schanzer W.Mass spectrometric characterization of efaproxiral (RSR13) and its implementation into doping controls using liquid chromatography-atmospheric pressure ionization-tandem mass spectrometry. J Mass Spectrom, 41 (2006) 332 8

Thevis M, Horning S, Makarov A, Schänzer W: Mass spectrometric characterization of efaproxiral (RSR13) and stanozolol using electrospray ionization with high resolution/high accuracy mass spectrometry. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 239 247

Thevis M, Kamber M, Schänzer W: Identification of metabolically stable selective androgen receptor modulators (SARMs) in human urine. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 87 89

Thomas A, Thevis M, Delahaut P, Bosseloir A, Schänzer W: Qualitative determination of rapid acting synthetic insulin analogues in urine by means ofLC-MS/MS. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 367 376

Thomas, A., Geyer, H., Mester, H.J., Schänzer, W., Zimmermann, E., Thevis, M.: Quantitative determination of adrenaline and nordadrenaline in urine using liquid chromatography-tandem mass spectrometry. Chromatographia 64 (2006) 587 591

Voss SC, Majer B, Schänzer W, Thevis M: Validation of a flow cytometric method to detect homologues blood transfusion. In: Schänzer W, Geyer H, Gotzmann A, Mareck U (eds.) Recent advances in doping analysis (14). Sport und Buch Strauß, Köln (2006) 343 344

2005

Buisson, C., Hebestreit, M., Press Weigert, A., Heinrich, K., Fry, H., Flenker, U., Banneke, S., Prevost, S., Andre, F., Schaenzer, W., Houghton, E., Le Bizec, B.: Application of stable isotope analysis to the detection of 17ß-estradiol administration to cattle. J. Chrommatogr. A, 1093 (2005) 69 80

Bredehöft, M., Thevis, M., Schänzer, W.: Excretion Study: Betamethasone-17,21-dipropionate Ointment and possible Metabolites in Man Analysed with LC-ESI-MS/MS. In: W. Schänzer, H. Geyer, A. Gotzmann, U.Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 415 418

Flenker, U., von Kuk, C., Hülsemann, F., Gougoulidis, V., Güntner, U., Schänzer, W.: Influence of Changes in Diet on the Dynamics of 13C/12C-ratios in Selected Urinary Steroids. Part II: Motivation, Model Assumptions and First Results. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 227 233

Fusshöller, G., Mareck, U., Schänzer, W.: Improved Detection of 3'Hydroxystanozolol Using 3'Hydroxystanozolol-D3 as Internal Standard. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 387 390

Geyer, H. Gorius, I. Dreyer, N. Mareck, U., Thevis, M., Schänzer, W.: Investigation about the effects and the detection of finasteride. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 479 482

Gotzmann, A., Thevis, M., Bredehöft, M., Schänzer, W.: Glucocorticosteroids in Routine Doping Analysis: Metabolism and Detection of Fluticasone-17-propionate. . In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 29 37

Guddat, S., Thevis, M., Mareck, U., Geyer, H., Schänzer, W.: Identification of Cyclodextrin by Liquid Chromatography -Tandem Mass Spectrometry. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 419 422

Guddat, S., Thevis, M., Schanzer, W.: Identification and quantification of the plasma volume expander dextran in human urine by liquid chromatography-tandem mass spectrometry of enzymatically derived Isomaltose. Biomed Chromatogr, 19 (2005) 743 750

Hebestreit, M., Flenker, U., Fußhöller, G., Güntner, U., Geyer, H., Mareck, U., Schänzer, W.: Mission (Im)possible? Gas
Chromatography/Combustion/Isotope Ratio Mass Spectrometry of Trace Amounts of Urinary Norandrosterone. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 209 218

Kuuranne, T., Ellfolk, M., Kuoppasalmi, K., Leinonen, A., Schänzer, W., Thevis, M., Hintikka, L., Kostiainen, R., Georgakopoulos, C.: Steroid glucuronides - synthesis and development of liquid chromatographic/mass spectrometric analysis in the detection of doping in sport. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 169 178

Machnik, M., Levens, H., Kietzmann, M., Thevis, M., Schenk, I., Düe, M., Weinberger, T., Schänzer, W.: Controlling therapeutic substances-a european harmonised approach: 1. A pharmacokinetic study of 4-methylaminoanttipyrine in horses after intravenous administration of dipyrone. Proceedings of the 15th international conference of racing analysts and veterinarians, Dubai, 21st -26th March 2004 (2005)

Machnik, M., Massmann, S., Kietzmann, M., Schenk, I., Düe, M., Weinberger, T., Schänzer, W.: Controlling therapeutic substances-a european harmonised approach: 2. A pharmacokinetic study of dembrexine in horses. Proceedings of the 15th international conference of racing analysts and veterinarians, Dubai, 21st -26th March 2004 (2005)

Machnik, M., Sigmund, G., Schänzer, W.: Antidepressants - Therapeutic Use or Doping Abuse? . In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 85 93

Mareck, U., Geyer, H., Guddat, S., Koch, A., Haenelt, N., Opfermann, G. Thevis, M., Schänzer, W.: Screening for Anastrozole in Doping Analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 127 136

Mareck, U., Sigmund, G., Opfermann, G., Geyer, H., Thevis, M., Schänzer, W.: Identification of the aromatase inhibitor letrozole in urine by gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom, 19 (2005) 3689-3693

Mareck, U., Geyer, H., Parr, M.K., Schänzer, W.: Hoch dosierte Anabolika in Nahrungsergänzungsmitteln. Lebensmittelchemie, 59 (2005) 14

Opfermann, G., Geyer, H., Guddat, S., Koch, A., Kohler, M., Mareck, U., Thevis, M., Schänzer, W.: Detection of Exemestane and its Metabolites Using GC-MS and LC-MS-MS: A Comparative Study for Screening Purposes. In:
W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 115 126

Parr, M.K., Fusshöller, G., Opfermann, G., Kohler, M., Hebestreit, M., Schänzer, W.: Synthesis of Reference Compounds for the Identification of Metabolites of 4&#64979;Hydroxytestosterone. . In: W. Schänzer, H. Geyer,
A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 65 74

Parr, M.K., Becker, M., Bartz, U., Opfermann, G., Schänzer, W.: Synthesis of isomers of 5-androstan-17-ol-3-one, androst-1- and -4-ene-3,17-diol and their characterisation with GC/MS. In: DPhG-Jahrestagung 2005, Mainz. Deutsche Pharmazeutische Gesellschaft (2005) 120

Sauer, M., Sörensen, O., Schänzer, W.: Diskret, flexibel und schnelle Reports: ein LIMS für das Handling von Dopingproben. GIT Labor Fachzeitschrift, 8 (2005) 644 647

Thevis, M., Schänzer, W.: Identification and characterization of peptides and proteins in doping control analysis. Current Proteomics, 3 (2005) 191 208

Thevis, M., Schänzer, W.: Designer-Steroide und Dopinganalytik - Modifizierte Steroidhormone erfordern neue Nachweismethoden. GIT Labor-Fachzeitschrift, 11 (2005) 945 947

Thevis, M., Geyer, H., Bahr, D., Schänzer, W.: Identification of fentanyl, alfentanil, sufentanil, remifentanil and their major metabolites in human urine by liquid chromatography/tandem mass spectrometry for doping control purposes. Eur. J. Mass Spectrom, 11 (2005) 419 427

Thevis, M., Makarov, A. A., Horning, S., Schänzer, W.: Mass spectrometry of stanozolol and its analogues using electrospray ionization and collision-induced dissociation with quadrupole-linear ion trap and linear ion trap-orbitrap hybrid mass analyszers. Rapid Commun. Mass. Spectrom. 19 (2005) 3369-3378

Thevis, M., Schebalkin, T., Thomas, A., Schänzer, W.: Quantification of Clenbuterol in Human Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry. Chromatographia 62 (2005) 435 439

Thevis, M., Schänzer, W.: Mass spectrometric analysis of androstan-17ß-ol-3-one and androstadiene-17ß-ol-3-one isomers. J Am Soc Mass Spectrom 16 (2005) 1660-1669

Thevis, M., Schänzer, W.: Analysis of low molecular weight substances in doping control. In: Kraemer, W.J., Rogol, A.D. (eds.) The Endocrine system in sports and exercise. Blackwell Publishing, Oxford (2005) 47 68

Thevis, M., Geyer, H., Mareck, U., Schänzer, W.: Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry. J. Mass Spectrom. 2005; 40: 955–962

Thevis, M., Schänzer, W.: Mass spectrometry in doping control analysis. Current Organic Chemistry, 9 (2005), 825-848

Thevis, M., Thomas, A., Delahaut, P., Bosseloir, A., Schänzer, W.: Qualitative determination of synthetic analogues of insulin in human plasma by immunoaffinity purification and liquid chromatography-tandem mass spectrometry for doping control purposes. Anal Chem 77(11) (2005) 3579-3585

Thevis, M., Bommerich, U., Opfermann, G., Schänzer, W.: Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 40 (2005) 494 502

Thevis, M., Geyer, H., Schänzer, W.: Identification of oral antidiabetics and their metabolites in human urine by liquid chromatography/tandem mass spectrometry - a matter for doping control analysis. Rapid Commun Mass Spectrom 19 (2005) 928 936

Thevis, M., Schänzer, W.: Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: Ephedrines, ß-receptor blockingagents, diuretics, sympathomimetics and cross-linked hemoglobins. J.Chromatogr.Sci. 43 (2005) 22 31

Thevis, M., Geyer, H., Mareck, U., Schänzer, W.: Screening for Synthetic Steroids in Human Urine by LC-ESI-MS/MS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport
und Buch Strauß, Köln (2005) 147 155

Thevis, M., Thomas, A., Delahaut, P., Bosseloir, A., Schänzer, W.: Qualitative Determination of Synthetic Insulin Analogues in Human Plasma by Means of LC-MS/MS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 245 254

Thevis, M., Ogorzalek-Loo, R.R., Loo, J.A., Bredehöft, M., Schänzer, W. Probing for Characteristics of Growth Hormone by LC-ESI-MS/MS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 355 366

Thevis, M., Geyer, H., Mareck, U., Schänzer, W.: Detection of Oral Antidiabetic Agents in Human Urine by LC-ESI-MS/MS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 243 244

Von Kuk, C., Flenker, U., Güntner, U., Hülsemann, F., Schänzer, W.: Influence of Changes in Diet on the Dynamics of 13C/12C-ratio in Selected Urinary Steroids. Part I: Study Design, 13C/12C-ratio of Applied Foodstuffs and Effect on Anthropometrical Data. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sport und Buch Strauß, Köln (2005) 219 225

Voss, S., Gotzmann, A., Geyer, H., Mareck, U., Schänzer, W.: Evaluation of LH Concentration in Male and Female Urines. Effects of a Single LH Application on the Steroid Profile. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (13). Sportund Buch Strauß, Köln (2005) 423 426

2004

Bräutigam, B., Sauer, M.: Dopingdimensionen und Medikamentenmissbrauch. Handlungsfelder für die Prävention. Landschaftsverband Westfalen-Lippe, Münster (2004).

Flenker, U., Güntner, U. Schänzer, W.:13C/12C-Measurment of 17-Ketosteroids to detect abuse of androgenic steroids in sport. In: Bowers, L., Hildebrand, L., Symanski, E.J. (eds.) Application of gas chromatography-combustion-isotope ratio mass spectrometry to doping control. Proceedings of the 2nd annual USADA Symposium on anti-doping-science, Los Angeles, USA August 21-24, 2003. USADA (2004) 29 34

Geyer, H., Schänzer, W.: Nahrungsergänzungsmittel als Dopingfalle. In: Cachay, K., Halle, A., Teubert, H. (Red.): Sport ist spitze. 18. Internationaler Workshop Sportgesspräch 16.17.02.2003 Oberhausen. Meyer u. Meyer Verlag, Aachen (2004) 21 35

Geyer, H., Parr, M.K., Mareck, U., Reinhart, U., Schrader, Y., Schänzer, W.: Analysis of non-hormonal nutritional supplements for anabolic-androgenic steroids - Results of an international study. Int J Sports Med, 25, (2004) 124 129 download als PDF-file

Geyer, H., Gülker, A., Mareck, U., Parr, M.K., Schänzer, W.: Some good news from the field of nutritional supplements. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 91 97

Geyer, H., Flenker, U., Mareck, U., Sommer, F., Schänzer, W.: Perliminary results regarding the detection of the misuse of testosterone gel. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 121 127

Gotzmann, A., Thevis, M., Mareck, U., Bredehöft, M., Guddat, S., Schänzer, W.: LC-MS/MS analysis of glucocorticosteroids: First experiences with therapeutic use exemption in routine doping analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 55 63

Gotzmann, A., Bredehöft, M., Thevis, M., Schänzer, W.: Detection of prednisolone, prednisone and 20ß-dihydroprednisolone in equine urine by means of LC/MS/MS. In: Hill. D.W., Hill, W.T.(eds.) Proceedings of the 14th international conference of racing analysts and veterinarians, Orlando 2002. R & W publications, Newmarket (2004) 176-179.

Guddat, S., Thevis, M., Schänzer, W.: Detection and quantification of thev plasma volume expander dextran in human urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 197 201

Güntner, U., Flenker, U., Ayotte, C., Ueki, M., Schänzer, W.: D/H-Isotope analysis of endogenous steroids - first results. . In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 251 259

Gougoulidis, V., Flenker, U., Platen, P., Schänzer, W.: Changes of 13C/12C in free fatty acids during a four month-long health orientated fitness training with an obese patient - a case study -. In: Proceedings of the joint European stable isotope users group meeting. Vienna, August 30-September 3, 2004. JESIUM (2004) 9

Güntner, U., Flenker, U., Geyer, H., Ueki, M., Ayotte, C., Schänzer, W.: Measurement of D/H and 13C/12C in endogenous steroids can reveal transdermal application of testosterone. In: Proceedings of the joint European stable isotope users group meeting. Vienna, August 30-September 3, 2004. JESIUM (2004) 10

Hebestreit, M., Flenker, U., Schänzer, W.: Hardware-considerations of purification of steroids by normal-phase HPLC for GC-C-IRMS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 323 327

Hülsemann, F., Flenker, U., Schänzer, W.: Detection of the origin of creatine monohydrate in nutritional supplements and differentiation from endogenous creatine in human urine by EA-IRMS. Proceedings of the joint European stable isotope users group meeting. Vienna, August 30-September 3, 2004. JESIUM (2004) 11

Machnik, M., Düe, M., Parr, M., von Kuk, C., Schänzer, W.: Case study: Doping substances in equestrian food supplements. Chromatographia Supplement 59, (2004) 131 135

Machnik, M., Thevis, M., von Kuk, C., Guddat, S., Schänzer, W.: Gestrinone analysis in equine urine by LC-MS/MS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 149 157

Mahler N, Geyer H, Parr MK, Kamber, M.: Untersuchung von Nahrungsergänzungsmitteln des Schweizer Marktes. Schweizerischen Zeitschrift für Sportmedizin und Sporttraumatologie, 3 (2004) 133.

Mareck, U., Kress, A., Schwarz, H. Geyer, H., Schänzer, W.: Untersuchung und Beurteilung eines neuen Drogenscreening Test-Sticks zur Prävention von Cannabismissbrauch im Sport. Dtsch Z Sportmed 2 (2004) 48 51 download als PDF-file

Mareck, U., Thevis, M., Guddat, S., Gotzmann, A., Bredehöft, M., Geyer, H., Schänzer, W.: Comprehensive sample preparation for anabolic steroids, glucocorticosteroids, beta-receptor blocking agents, selected anabolic androgenic steroids and buprenorphine in human urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 65 68

Mareck, U., Sigmund, G., Opfermann, G., Geyer, H., Schänzer, W.: Screening on letrozoleand ist metabolite in doping analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 203 209

Parr, M.K., Geyer, H., Opfermann, G., Schänzer, W.: Prescription drugs and new anabolic steroids in nutritional supplements. . In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 71 80

Parr, M.K., Opfermann, G., Schänzer, W.: Analytical properties of 4-hydroxysteroids and some esters. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 129 138

Parr, M.K., Geyer, H., Reinhart, U., Schänzer, W.: Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements. Food Additives and Contaminants. 21 (2004) 632-640.

Schänzer, W. Thevis, M.: Doping und Dopinganalytik. Chem. Unserer Zeit, 38 (2004) 230-241.

Schänzer, W.: Abuse of androgens and detection of illegal use. In: E. Nieschlag, H.M. Behre (eds.) Testosterone - Action - Deficiency - Substitution. Third Edition. Cambridge University Press, Cambridge, (2004), 715-735.

Schänzer, W. Thevis, M.: Analytik von Steroidhormonen und Designer-Steroiden. GIT Labor-Fachzeitschrift. 5 (2004) 440 443

Schrader, Y., Schänzer, W.: Plasma levels of 19-norsteroids after administration of oral and sublingual norandrostendione. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 109 119

Strompen, O., Opfermann, G., Enbergs, H., Schänzer, W.: Determination of endogenous steroid profiles in equine urine by gas chromatography/mass spectrometry. Proceedings of the 14th international conference of racing analysts and veterinarians, Orlando 2002. R & W publications, Newmarket (2004) 429 433

Thevis, M., Opfermann, G., Schänzer, W.: N-methyl-N-trimethylsilyltrifluoroacetamide-promoted synthesis and mass spectrometric characterisation of deuterated ephedrines. Eur.J.Mass Spectrom. 10 (2004) 673 681

Thevis, M., Schänzer, W.: Neue Nachweismethoden in der Dopinganalytik - Künstliche Sauerstofftherapeutika aus quervernetztem Rinderhämoglobin -. F.I.T., Wissenschaftsmagazin der Deutschen Sporthochschule Köln, 2 (2004) 10 12 download als PDF-file

Thevis; M., Schänzer, W.: Detection of plasma volume expanders. In: Bowers, L., Symanski, E. (eds.) Oxygen transport enhancing agents and methods. USADA Colorado Springs (2004) 152 155

Thevis, M., Opfermann, G., Krug, O., Schänzer,. W.: Electrospray ionization mass spectrometric characterization and quantitation of xanthine derivatives using isotopically labelled analogues: an application for equine doping control analysis. Rapid Commun. Mass Spectrom. 2004; 18: 1553 1560 download als PDF-file

Thevis, M., Schänzer, W.: Determination of the doping agent tetrahydrogestrinone by LC-APCI-MS/MS. Biosystems solutions 10 (2004) 10 11

Thevis, M., Opfermann, G., Schänzer, W.: Mass spectrometric characterization of synthetic steroid derivatives. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 141 148

Thevis, M., Opfermann, G., Krug, O., Schänzer, W.: Synthesis of stable deuterated ephedrines and theobromine promoted N-methyl-N-trimethylsilyltrifuoroacetamide. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 195 196

Von Kuk, C., Schänzer, W.: Characteristics and abundance of various conjugated metabolites commending the analysis of the sulphate fraction. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 221 229

Wüst, B., Thevis, M.: High resolution quantitative analysis of ß2-agonists in human urine by LC/MS using the agilent LC(MSD TOF. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (12). Sport und Buch Strauß, Köln (2004) 169 175

2003

Bialas, B., Schänzer, W.: Validation of EPO Prescan Parameters - Hct, Hb, %Reti - The Influence of Physical long-term Exercise, Long Distance Flying and the Diurnal and Annual Variation of these Parameters. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 365 372

Flenker, U., Schänzer, W: Expression of differences in isotopic composition. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 179 182

Geyer, H., Bredehöft, M., Mareck, M., Parr, M.K., Reinhart, U.,
Schänzer, W: Oxandrolone and High Doses of Metandienone Found in Nutritional Supplements. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 77 84

Geyer, H., Parr, M.K., Mareck, U., Reinhart, U., Schrader, Y., Schänzer, W.: Doping Substances in Nutritional Supplements - Results of an International IOC Study -. VIIth IOC Olympic World Congress on Sport Sciences. Physical, Nutritional and Psychological care of the Athlete in the 21st century. Athens, Greece, 7-11October 2003, Book of Abstracts 14

Geyer, H., Bredehöft, M., Mareck, U., Parr, M.K., Schänzer, W.: High Doses of the anabolic steroid metandienone found in dietary supplements. European Journal of Sport Science 3, 1 (2003) download als PDF-file

Gotzmann, A., Bredehöft, M., Thevis, M., Schänzer, W.: Detection of Prednisolone, Prednisone and 20?Dihydroprednisolone in Human and Equine Urine by Means of LC-MS/MS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 33 41

Guddat, S., Thevis, M., Schänzer, W.: The Diuretic Mannitol - A Problem in Doping Analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 323 328

Kuk, von C., Flenker, U., Schänzer, W.: Urinary Steroid Sulphates: Sample Preparation, Reference Values and Investigations in Biosynthesis and Metabolism. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 169 178

Kuuranne, T., Kurkela, M., Thevis, M., Schänzer, W.; Finel, M., Kostiainen, R.: Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 31 (2003) 1117-1124

Machnik, M., Düe, M., Parr, K., Schänzer, W.: Anabole Steroide in pflanzlichen Arzneimitteln für Pferde. Pferdeheilkunde 19 (2003) 2 März/April 155-158.

Machnik, M. Düe, M., Parr, M.K., Schänzer, M.: Anabolic Steroids in Plant Medicines for Horses. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 85 90

Mareck, U., Sigmund, G., Opfermann, G., Geyer, H., Schänzer, W.: Identification of Non-steroidal Aromatase Inhibitors in Doping Analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 91 100

Mareck, U., Kress, A., Schwarz, U.W., Geyer, H., Schänzer, W.:
Feasibility Study on Commercially Available THC Drug Screen Test Devices. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 109 118

Mareck, U., Geyer, H., Parr, M.K., Reinhart, U., Schänzer, W.: Untersuchung von nicht-hormonellen Nahrungsergänzungsmitteln (NEM) auf nicht deklarierte anabol-androgene Steroide - eine internationale Studie -. Lebensmittelchemie, 57 (2003) 64 65

Parr, M.K., Geyer, H., Sigmund, G., Koehler, K., Schänzer, W.: Screening of Nutritional Supplements for Stimulants and other Drugs. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 67 75

Parr, M.K., Geyer, H., Rommelfanger, J., Schänzer, W.: Anabole Steroide in Nahrungsergänzungsmitteln in Deutschland. Lebensmittelchemie 57 (2003) 158 159

Parr, M.K., Geyer, H., Gülker, A., Mareck, U., Schänzer, W.: Nahrungsergänzungsmittel-Alternativen mit geringem Dopingrisiko. Leistungssport, 6 (2003) 31 32

Parr, M.K., Geyer, H., Reinhart, U., Mareck, U., Schänzer, W.: Verunreinigungen von Nahrungsergänzungsmitteln mit anabolen Steroiden. Lebensmittelchemie, 57 (2003) 36

Kinzie, S.D., Thevis, M., Ngo, K., Whitelegge, J., Loo, J.A., Abu-Omar, M.M.: Posttranslational Hydroxylation of Human Phenylalanine Hydroxylase Is a Novel Example of Enzyme Self-Repair within the Second Coordination Sphere of Catalytic Iron. J Am Chem Soc. 125, 16 (2003) 4710 1.

Thevis, M., Schänzer, W.: Dopinganalytik mittels GC-MS und LC-MS/MS. CLB Chemie in Labor und Biotechnik, 54, 5 (2003) 180 183

Thevis, M., Schänzer, W.: Effect of the Location of Hydrogen Abstraction on the Fragmentation of Diuretics in Negative Electrospray Ionization Mass Spectrometry. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 43

Thevis, M., Opfermann, G., Schänzer, W.: LC-ESI-MS/MS Screening and Confirmation Methods for ß2-Agonistes in Human or Equine Urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 129

Thevis, M., Ogorzalek-Loo, R.R., Loo, J.A., Schänzer, W.: Doping Control analysis of Bovine Hemoglobin-Baed Oxygen Therapeutics in Human Plasma by LC-ESI-MS/MS In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 217 226

Thevis, M. Ogorzalek-Loo, R.R., Loo, J.A., Bryer-Ash, M., Schänzer, W.: Mass Spectrometric Identification of Synthetic Insulins. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 227 237

Thevis, M., Sigmund, G., Schänzer, W.: Confirmation of Ephedrines - Comparison between GC-MS and LC-MS/MS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (11). Sport und Buch Strauß, Köln (2003) 303 307

Thevis, M., Opfermann, G., Schänzer, W.: Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for ß2-agonists in human or equine urine. J. Mass. Spectrom. 38 (2003) 1197 1206. download als PDF-file

Thevis, M,. Loo, R.R., Loo, J. A.: Mass spectrometric characterization of transferrins and their fragments derived by reduction of disulfide bonds. J Am Soc Mass Spectrom. 14, 6 (2003) 635 47.

Thevis, M., Schänzer, W.: Dopinganalytik mittels GC-MS und LC-MS/MS. CLB Chemie in Labor und Biotechnik, 54.Jahrgang, Heft 05/2003.

Thevis, M., Ogorzalek Loo, R.R., Loo. J.A.: In-gel derivatisation of proteins for cysteine-specific cleavages and their analysis by mass specrometry. J. Proteome Research, 2003; 2(2), 163-172. download als PDF-file

Thevis, M., Ogorzalek Loo, R. R., Loo, J. A., Schanzer, W.: Doping Control Analysis of Bovine Hemoglobin-Based Oxygen Therapeutics in Human Plasma by LC-Electrospray Ionization-MS/MS. Anal Chem, 2003; 75(14); 3287 3293. Abstract download als PDF-file

Thevis M, Schanzer W, Schmickler H.: Effect of the location of hydrogen abstraction on the fragmentation of diuretics in negative electrospray ionization mass spectrometry.
J Am Soc Mass Spectrom. 2003 Jun;14(6):658-70. Abstract

Thevis, M., Opfermann, G., Schänzer, W.: Urinary concentrations of morphine and codeine after consumption of poppy seeds. Journal of Analytical Toxicology, 27,1 (2003) 53 56. Abstract

2002

Geyer, H., Bredehöft, M., Mareck, U., Parr, M., Schänzer, W.: Hohe Dosen des Anabolikums Metandienon in Nahrungsergänzungsmitteln gefunden. Dtsch.Apoth.Ztg. 142, 29 (2002) 50

Geyer, H., Schänzer, W.: Dopingrisiken durch Nahrungsergänzungsmittel. Leistungssport, 32 (2002), 54-55

Geyer, H.: Special aspects of doping analysis. In: Proceedings of the congress "Innovazioni scientifiche per l´analisi di tracce nell´investigazione forense" 15. -16. April 2002 Università di Torino (2002) 29 31

Geyer, H.: Doping substances in nutritional supplements. Results of the international IOC study. In: Council of Europe (ed.). Proceedings of the 2nd Seminar and Workshop of doping control officers. Sofia 26.-27.10.2002 (T-DO 2002 38 Final). Council of Europe , Strasbourg (2002) 30 31.

Geyer, H., Parr, M.K., Reinhart, U., Schrader, Y., Mareck, U., Schänzer, W.:
Analysis of Non-Hormonal Nutritional Supplements for Anabolic Androgenic Steroids - an International Study -. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 83 85 PDF-file

Geyer, H., Parr, M., Mareck, U., Reinhart, U, Schrader, Y., Schänzer, W.: Doping substances in nutritional supplements. In: Schänzer, W., Delbeke, F., Deligiannis, A, Gmeiner, G., Maughan, R., Mester, J. (eds.) Health and doping risks of nutritional supplements and social drugs. Sport und Buch Strauß, Köln (2002).

Gotzmann, A., Voss, S., Machnik, M., Schänzer, W.: Detection of Hemopure® and Hemoglobin in Human Plasma by HPLC/UV and Different Types of Columns - an Approach to Screen for this Substance in Doping Analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 181 190 PDF-file

Kress, A., Mareck-Engelke, U., Geyer, H., Schänzer, W: Alternative Bulk Materials to XAD-2 (Serdolit® AD-II, Serva). In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 205 210 PDF-file

Kuk, von C., Schänzer, W.:Estrogens as Additional Parameters of Steroidprofile in Doping Analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 211 216 PDF-file

Mareck-Engelke, U., Sigmund, G., Opfermann, G., Geyer, H., Schänzer, W.: Identification of the aromatase inhibitor aminogluthedimide in urine by gas-chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 16 (2002) 2209-2214 download als PDF-file

Mareck-Engelke, U., Schulze, G., Geyer, H., Schänzer, W.: The appearance of urinary 19-norandrosterone during pregnancy. European Journal of Sport Science 2, 2 (2002) download als PDF-file

Mareck-Engelke, U., Sigmund, G., Opfermann, G., Geyer, H., Schänzer, W.:
Identification of the Aromatase Inhibitor Aminoglutethimide in Doping Analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 35 50 PDF-file

Parr, M.K., Geyer, H., Reinhart, U., Schänzer, W.:Approaches towards an Improved Analysis of Nutritional Supplements for Anabolic Androgenic Steroids. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 87 96 PDF-file

Parr, M.K., Schänzer, W.: Sind Asthma-Medikamente Dopingmittel. Lungenheilkunde, 4, 1 (2002) 8-11

Schänzer, W.: Untersuchung von nicht-hormonellen Nahrungsergänzungsmitteln (NEM) auf nicht-deklarierte anabol-androgene Steroide. Olympiastützpunkt Köln/Bonn/Leverkusen OSP News 1 (2002) 19

Schänzer, W.: The Cologne Workshop. Olympic Review XXVII-45 (2002) 25

Schänzer, W.: Der Sachverständige: Grenzwerte und Methoden. In: Eimer, R.B (ed.) 2. Internationaler Sport-Recht Kongress.Avario Publication Ltd. Scotland/Deutschland (2002) 179 191

Thevis, M., Schmickler, H., Schänzer, W.: Mass spectrometric behavior of thiazide-based diuretics after electrospray ionization and collision-induced dissociation. Anal. Chem., 74 (2002) 3802 8 download als PDF-file

Thevis, M., Opfermann, G., Schänzer, W.: Mass spectrometric characterization of glucuronic acid conjugates of anabolic androgenic steroids and their metabolites. In: Proceedings of the 49th ASMS conference on mass spectrometry and allied topics, Chicago, Illnois, May 27-31, 2001 (2002)

Thevis, M., Opfermann, G., Schänzer, W.: Mass spectrometric behaviour of diuretics after electrospray ionisation and collision-induced dissociation. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 97 104 PDF-file

Thevis, M., Guddat, S., Schänzer, W.: Determination of HES, Dextran and Mannitol in Human Urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 191 204 PDF-file

Vogt, A.M., Geyer, H., Jahn, L., Schänzer, W., Kübler, W.: Kardiomyopathie assoziiert mit unkontrollierter Selbstmedikation anaboler Steroide. Z. Kardiol. 91 (2002) 357 362 download als PDF-file

Wingender, A., Sigmund, G., Schänzer, W.: Local Anaesthetics in Sport. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck (eds.) Recent advances in doping analysis (10). Sport und Buch Strauß, Köln (2002) 235 240

2001

Bialas, , B., Schwenke, D., Schänzer, W., Müller, K.: Diurnal variation of indirect parameters for the detection of recombinant human erythropoietin abuse in athletes. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 311-316.

Flenker, U., Schänzer, W.: Kinetic isotope effects during metabolism of D4-steroids. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 179-186.

Flenker, U., Schänzer, W.: 13C/12C-ratios in caffeine from different sources and in urinary excreted caffeine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 187 190

Flenker, U., Schänzer, W.: Caffeine in Doping Control: Determination of 13C in urinary excreted caffeine. European Journal of Sport Science, 1, 2 (2001) download als PDF-file

Geyer, H., Mareck-Engelke, U. Wagner, A., Schänzer, W.: Analysis of nutritional supplements for prohormones <http://www.dshs-koeln.de/biochemie/rubriken/00_home/00_nah01.html> und <http://www.dshs-koeln.de/biochemie/rubriken/00_home/00_nah01.pdf> online seit April 2001

Geyer, H., Mareck-Engelke, U. Wagner, A., Schänzer, W.: Analysis of " non -hormonal" nutritional supplements for prohormones. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 63 72

Geyer, H., Henze, M., Machnik, M., Mareck-Engelke, U., Schrader, Y., Sigmund, G., Schänzer, W.: Health risks and doping risks of nutritional supplements. In: Peters, C., Schulz, T., Michna, H. (eds.). Biomedical side effects of doping. Sport und Buch Strauß, Köln (2001) 141 153

Geyer, H.: Nutritional supplements and doping. In: Deligiannis, A. (ed.) Proceedings of the 1. International Greek symposium on sports medicine in the 21th century May 10-12, 2001. University Studio Press, Thessaloniki (2001) 49 50

Geyer, H., Henze, M., Schrader, Y.: Dopingrisiken von Nahrungsergänzungsmitteln. Gütegemeinschaft Gesundheitssportzentrum. Newsletter 2 (2001) 5-8

Geyer, H., Schänzer, W.: Nahrungsergänzungsmittel und Doping. In: D. Lagerstrom, G. Uhlenbruck (eds.): 5. Ausdauerforum. Kurzbeiträge. (2001) 24 26.

Henze, M.K., Spahn-Langguth, H., Schänzer, W.: Reactions of salbutamol and reproterol with urine matrix components-preliminary results. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 29 34

Henze, M.K., Opfermann, G., Spahn-Langguth, H., Schänzer, W.: Screening of ß-2 agonists and confirmation of fenoterol, reproterol and terbutaline with gas chromatography - mass spectrometry as tetrahydroisoquinoline derivatives. J. Chromatogr. B 751 (2001) 93 105

Henze, M.K., Geyer, H., Mareck-Engelke, U., Schänzer, W.: Verunreinigungen von Nahrungsergänzungsmitteln mit anabolen Steroiden. Lebensmittelchemie, 55, (2001) 68

Henze, M.K., Geyer, H., Mareck-Engelke, U., Schänzer, W.: Verunreinigungen von Nahrungsergänzungsmitteln mit anabolen Steroiden. In: GDCh-Jahrestagung Chemie 2001, 23.-29. September 2001, Universität Würzburg, Kurzreferate Sammelband (2001) 27

Machnik, M, Schrader, Y., Schänzer, W.: Plasma levels of 19-norsteroids after oral and buccal administration of norandrostendione. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 125 132

Machnik, M., Schänzer, W.: Nachweis von Dopingsubstanzen im Humanhaar. F.I.T., Wissenschaftsmagazin der Deutschen Sporthochschule Köln, 1 (2001) 12 15.

Mareck-Engelke, U., Geyer, H., Schänzer, W.: Cannabismissbrauch im Hochleistungssport. Dtsch. Z. Sportmed. 52, 10 (2001) 280-284. download als PDF-file

Mareck-Engelke, U., Sigmund, G., Opfermann, G., Geyer, H., Schänzer, W.: Screening for Tamoxifen, Clomiphene and Cyclofenil in doping analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 53 62

Schänzer, W.: Doping im Sport. In: R. Rost (Hrsg.): Lehrbuch der Sportmedizin. Deutscher Ärzte Verlag, Köln (2001) 133 154

Schänzer, W.: Online-Dopinglexikon; Online-Aufklärungsmaterial für Kinder u. Jugendliche; Online-Lehrbuch zum Doping (Dopinganalytik; Nebenwirkungen von Dopingsubstanzen, Dopingdefinitionen) -alle Beiträge ständig aktualisiert- <http://www.dopinginfo.de> online seit März 2001

Schänzer, W.: Kann HNO-ärztliche Therapie als Doping gelten ? (30.08.01) < www.hno-aerzte.de/servier/15.01.pdf > (gefunden 10.09.01)

Schänzer, W.: Dopinganalytik. GIT Labor-Fachzeitschrift 10 (2001) 1096-1098

Sigmund, G., Opfermann, G., Seinsch, I., Schänzer, W.: Detection of bupropion and metabolites. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 259 264

Thevis, M., Opfermann, G., Schänzer, W.: High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 35 42

Thevis, M., Opfermann, G., Schänzer, W.: Synthesis and GC/MS-characterisation of glucuronide conjugates of anabolic steroids. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 107 114

Thevis, M., Opfermann, G., Schänzer, W.: Screening and confirmation methods for the detection of plasma volume expanders in human urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (9). Sport und Buch Strauß, Köln (2001) 13 18

Thevis, M., Opfermann, G., Schmickler, H., Schänzer, W.: Mass spectrometry of steroid glucuronide conjugates. I. Electron impact fragmentations of 5a-/5ß-androstan-3a-ol-17-one glucuronides, 5a-estran-3a-ol-17-one glucuronide and deuterium-labelled analogues. J. Mass Spectrom. 36 (2001) 159-168.

Thevis, M., Opfermann, G., Schänzer, W: High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry. Biomed. Chromatogr. 15 (2001) 393 402

Thevis, M., Opfermann, G., Schmickler, H., Schänzer, W..: Mass spectrometry of steroid glucuronide conjugates. II - Electron impact fragmentations of 3-keto-en- and 3-keto-5a-steroid-17-O-glucuronides and 5a-steroid-3a,17ß-diol 3- and 17-glucuronides. J. Mass Spectrom. 36 (2001) 998 1012.

Thevis, M., Opfermann, G., Schänzer, W.: Nachweis des Plasmavolumenexpanders Hydroxyethlstärke in Humanurin. Dtsch. Z. Sportmed. 52, 11 (2001) 316-320. download als PDF-file

2000

Flenker, U., Gougoulidis, V., Schänzer, W.: Confirmation of doping with synthetic endogenous anabolic steroids: Validation of the method and concepts of of inference. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (8). Sport und Buch Strauß, Köln, (2000) 69 78

Geyer, H., Henze, M.K., Mareck-Engelke, U., Sigmund, G., Schänzer, W.: Analysis of nutritional supplements for dope substances. In: Biotechnology 2000. The world congress on biotechnology 3.-8.9.00 Berlin. Book of abstracts Vol. 3 (2000) 236 238

Geyer, H., Mareck-Engelke, U., Reinhart, U., Thevis, M., Schänzer, W.:
Positive Dopingfälle mit Norandrosteron durch verunreinigte Nahrungsergänzungsmittel. Dtsch. Z. Sportmed. 51, 11 (2000) 378 382 download als PDF-file

Geyer, H., Mareck-Engelke, U., Reinhart, U., Thevis, M., Schänzer, W.: The analysis of nutritional supplements for anabolic-androgenic steroids. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (8). Sport und Buch Strauß,Köln (2000) 23 32

Gotzmann, A., Komanns, B., Adib, A., Bredehöft, M., Schänzer, W.: Creatine- A doping substance ? In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (8). Sport und Buch Strauß, Köln (2000) 33 40

Henze, M.K., Opfermann, G., Schänzer, W.: Mass spectrometric identification of beta-2-agonists. In: L.A. Van Ginkel, A. Ruiter (eds). Residues of veterinary drugs in food. Volume 1, CIP-Gegevens Koninklijke Bibliotheek, Den Haag (2000) 546 553

Henze, M.K.: Athletes and fenoterol. Letters to the editor. Thorax, 55 (2000), 44

Henze, M.K., Opfermann, G., Spahn-Langhuth, H., Schänzer, W.: Screening of beta-2-agonists and confirmation of fenoterol, reproterol, orciprenaline and terbutaline after cyclisation with formaldehyde. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (8). Sport und Buch Strauß, Köln (2000) 59 68

Mareck-Engelke, U., Schultze, G., Geyer, H., Schänzer, W.: 19-norandrosterone in pregnant women. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (8). Sport und Buch Strauß, Köln (2000) 145 154

Schänzer, W.: Die medizinische Revolution. Über die Effizienz von Dopingkontrollen und Nebenwirkungen verbotener Substanzen. In: M. Gamper, J. Mühlethaler, F. Reidhaar (eds.): Doping. Spitzensport als gesellschaftliches Problem. NZZ Verlag, Zürich (2000) 191 218

Schänzer, W.: Dopinganalytik und Grenzwertproblematik. In: V. Röhricht, K. Vieweg (eds). Doping-Forum - Aktuelle rechtliche und medizinische Aspekte-Boorberg-Verlag, Suttgart, München, Hannover, Berlin, (2000) 17 26

Schänzer, W.: Dopingkontrollen und aktueller Stand der Nachweismethoden. Deutsche Zeitschrift für Sportmedizin,51, 7 +8 (2000) 260 266 download als PDF-file

Schänzer, W., Breidbach, A., Geyer, H., v.Kuk, K., Nolteernsting, E., Thevis, M.: Metabolism of nortestosterone, norandrostendione and norandrostendiol: Identification of 3a-hydroxy-4-en-17-one glucuronide and 3a,16a-dihydroxy-5a-estran-17-one glucuronide and sulphate. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (8). Sport und Buch Strauß, Köln (2000) 155-174.

Thevis, M., Opfermann, G., Schänzer, W..: Detection of the plasma volume expander hydroxyethyl starch in human urine. J. Chromatogr. B 744 (2000) 345-350.

Thevis, M., Opfermann, G., Schänzer, W: Mass spectrometry of partially methylated alditol acetates derived from hydroxyethyl starch. J. Mass Spectrom. 35, (2000) 77 84

Thevis, M., Schänzer, W.: Morphin-Dopingproblematik und Ernährung. F.I.T., Wissenschaftsmagazin der Deutschen Sporthochschule Köln, Oktober (2000) 14 17.

Thevis, M., Opfermann, G., Schänzer, W.: Rapid screening method to detect hydroxyethyl starch (HES) in human urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (8). Sport und Buch Strauß, Köln (2000) 41 46

Thevis, M., Nolteernsting, E., Opfermann, G., Schänzer, W.: Synthesis and GC/MS-characterisation of glucuronide conjugates of anabolic steroids.
In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (8). Sport und Buch Strauß, Köln (2000) 89 98

1999


Bellahn, I., Nolteernsting, E., Opfermann, G., Schänzer, W.: Preliminary Results of Excretion Studies with Salbutamol. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 489 496

Bialas, B., Breidbach, A., Schänzer, W.: Individual reference ranges for serum erythropoietin (sEpo)-Part II: Influence of long distance flying. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (7). Sport und Buch Strauß, Köln, (1999) 301 310

Breidbach, A., Schänzer, W.: Individual Reference Ranges for serum Erythropoietin (sEPO) - A Possible Approach to Detect Misuse. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 301-310.

Flenker, U., Horning, S., Nolteernsting, E., Geyer, H., Schänzer, W.: Measurement of 12C/13C-Ratios to Confirm Misuse of Endogenous Steroids. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 243 256

Flenker, U., Nolteernsting, E., Geyer, H., Schänzer, W.: A Screening method for synthetic testosterone and ist precursors based on GC/C/IRMS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (7). Sport und Buch Strauß, Köln, (1999) 241 248

Geyer, H., Mareck-Engelke, U., Schänzer, W.: The Black Market of Anabolic Agents. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 421 430

Geyer, H., Nolteernsting, E., Schänzer, W.: Finasteride - a substance for manipulation in dope control ? In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (7). Sport und Buch Strauß, Köln, (1999) 71 80

Henze, M.K., Opfermann, G., Schänzer, W.: Liquid-liquid extraction-pH profiles of selected beta-2-sympathomimetic agonists. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (7). Sport und Buch Strauß, Köln, (1999) 335 340

Horning, S., Hoehn, M., Muenster, H., Geyer, H., Schaenzer, W.: GC/HRMS-ION TRAP Screening and Confirmation of Anabolic Steroids. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 277 286

Machnik, M, Geyer, H.,Horning, S., Breidbach, A., Delahaut, P., Schänzer, W.: Longterm Detection of Clenbuterol in Human Scalp Hair by Means of Gaschromatography / High Resolution Mass Sectrometry (GC/HRMS). In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 31 36

Machnik, M, Geyer, H.,Horning, S., Breidbach, A., Delahaut, P., Schänzer, W.: Longterm Detection of Clenbuterol in Human Scalp Hair by Means of Gaschromatography / High Resolution Mass Sectrometry (GC/HRMS). J. Chromatogr. B 723 (1999) 147 155

Mareck-Engelke, U., Geyer, H., Schänzer, W.: 19-Norandrosterone - Criteria for the Decision Making Process. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 119 130

Mareck-Engelke, U., Geyer, H., Schänzer, W.: Tetrahydrocannabinol (THC) in dope control. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (7). Sport und Buch Strauß, Köln, (1999) 51 60

Rendic, S., Nolteernsting, E., Schänzer, W.: Metabolism of Anabolic Steroids by Recombinant Human Cytochrome P450 Enzymes. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 81 96

Rendic, S., Nolteernsting, E., Schänzer, W.: Metabolism of Anabolic Steroids by Recombinant Human Cytochrome P450 Enzymes. Gas chromtographic-mass specrometric determination of metabolites. J. Chromatogr. B 735 (1999) 73 83

Schänzer, W., Geyer, H., Horning, S.: 17,17-Dimethyl-18-nor-5*-androst-1,13-dien-3*-ol (18-Normetenol) in Longterm Detection and Confirmation of Positive Metandienone Cases. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 37 52

Schänzer, W.: Dem Doping keine Chance. In: J.Kozel (ed.) 25 Jahre Trainerausbildung. Die Trainerakademie Köln. Sport und Buch Strauss, Köln (1999) 59 94

Seinsch, I., Schänzer, W.:Zur Nachweisbarkeit und Nachweisdauer dopingrelevanter Verbindungen im Pferdesport. In: Lindner, A.(Hrsg.) Lahmheit und Leistung. Beiträge aus Orthopädie, Ganganalytik und Doping. Dr. Arno Lindner (1999) 51 58

Seinsch, I., von Kuk, C., Machnik, M., Siebig, G., Horning, S., Sigmund, G., Breidbach, A., Schänzer, W.: Detection of nortestosterone application in horses. A screening method for nortestosterone in horse serum wit a possible confirmation in urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (7). Sport und Buch Strauß, Köln, (1999) 353 358

Sigmund, G., Seinsch, I., Schänzer, W.: Detection of Phentermine and Phentermine Derivatives as Metabolites of Oxethazine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (6). Sport und Buch Strauß, Köln (1999) 483 488

Thevis, M., Opfermann, G., Schänzer, W.: GC/MS-Detection of hydroxyethyl starch (HES) in human urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (7). Sport und Buch Strauß, Köln, (1999) 31 40

Breidbach, A., Schänzer, W.: Erythropoietin with Nichols Institute Diagnostics Chemiluminescence Immunoassay for Erythropoietin after Gelfiltration. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß,
Köln (1998) 209-214.

Geyer, H., Berschick, P., Mareck-Engelke, U., Schänzer, W.: DNA Typing for the confirmation of manipulation in dope control. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 301

Berschick, P., Geyer, H., Schänzer, W.: Individualization of urine samples in doping control by steroid profiling and PCR based DNA analysis. In:
B. Olaisen, B. Brinckmann, P.J. Lincoln (eds.): Progress in Forensic Genetics 7, Elsevier Science (1998) 171-173.

Geyer, H., Schänzer, W., Mareck-Engelke, U., Nolteernsting, E., Opfermann, G.: Screening procedure for anabolic steroids-The control of the hydrolysis with deuterated androsterone glucuronide and studies with direct hydrolysis.
In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß,
Köln (1998) 99 102

Geyer, H.: Neues aus dem Dopingsektor. In: T. Furian, F. Ritthaler, D. Wagner, J. Walter (eds.) Leistungssteigerung durch Ernährung, Pharmaka und Substitution im Sport. Institut für Sport- und Präventivmedizin Stuttgart (1998) 24 38
.
Geyer, H.: Screening for synthetic anabolic steroids and interpretation of steroidprofiles. Proceedings of the Sprint Seminar in Anti-Doping Policies. Council of Europe, Committee for the development of sports. Sofia, 8-10 October (1998) 44.

Geyer, H.: Symposium Doping im Sport. Deutsche Sporthochschule Köln, Kurier 1 (1998) 3

Gotzmann, A., Mareck-Engelke, U.: Doping und Dopinganalytik, Anabolika im Frauensport. In: Kölner Forum. Frau und Hochschule. 1/98 (1998) 20 27.

Horning, S., Geyer, H., Gotzmann, U. Flenker, A., Schänzer, W.: Detection of exogenous steroids by 13C/12C analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 135 148

Horning, S., Muenster, H., Ziberna, A.K., Schänzer, W.: Anabolic steroid analysis in drug testing using a hybrid ion-trap spectrometer. Poceedings of the 46th ASMS Conference on Mass Spectomtry and allied topics, 31.5-4.6.98. (1998) Poster

Horning, S., Schänzer, W., Sample, B.: HRMS-Analyses performed at the 1996 Summer Olympic Games. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 329 337

Machnik, M., Delahaut, P., Horning, S., Schänzer, W.: Preparation of Immuno Affinity columns. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 121-127.

Mareck-Engelke, U., Geyer, H., Schänzer, W.: The Interpretation of female steroide profiles. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 51 70.

Nolteernsting, E., Schänzer, W.: Performance test of the new mass selective detector HP 5973 in dope analysis of anabolic androgenic steroids. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 149-156.

Schänzer, W., Geyer, H., Horning, S.: Longterm determination of metandienone and mestanolone. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 13 26.

Schänzer, W., Gotzmann, A.: The Cologne protocol to follow up positive caffeine cases. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 259-268.

Schänzer, W.,Geyer, H., Sigmund, G.: Excretion studies with dextropropoxyphene. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 305-310.

Schänzer, W.: Abuse of androgens and detection of illegal use. In: E. Nieschlag, H.M. Behre (eds.) Testosterone. Springer-Verlag, Berlin, Heidelberg, New York (1998) 545-565.

Schänzer, W.: Doping - Informationen zu Neuentwicklungen und Problemfeldern.Leistungssport 4 (1998) 14 17.

Schänzer, W.: Doping - Informationen zu Neuentwicklungen und Problemfeldern .Leistungssport 5 (1998) 42 45.

Schänzer, W.: Neuere Entwicklungen in der Dopinganalytik. In: K. Vieweg (ed.) Doping-Realität und Recht. Duncker und Humblot, Berlin (1998) 51 66.

Schänzer W.: Detection of Exogenous Anabolic Androgenic Steroids. In Karch SB (ed): Drug Abuse Handbook. CRC Press, Boston - London - New York, 1998, 671-689.

Sigmund, G., Horning, S., Seinsch, I., Schänzer, W.: Confirmation of clenbuterol-Reextraction with Hydrochloric acid. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (5). Sport und Buch Strauß, Köln (1998) 129 133

Strüder, H.K., Ferrauti, A., Gotzmann, A., Weber, K., Hollmann, W.: Effect of carbohydrates and caffeine on plasma amino acids, neuroendocrine responses and performance in tennis. Nutritional Neuroscience, 1 (1998) 419 426

Strüder, H.K., W. Hollmann, P. Platen, A. Gotzmann, K. Weber: Influence of the monoaminergic system modifications on neuroendocrine variables and physical and mental fatigue. Int. J. Sports Med. 19: (1998) 43

Strüder, H.K., W. Hollmann, P. Platen, M. Donike, A. Gotzmann, K. Weber: Einfluß des serotonergen und dopaminergen Systems auf endokrine Parameter und die körperliche und kognitive Leistungsfähigkeit. Dtsch. Z. Sportmed. 49 (Sonderheft 1) (1998) 149 153

Strüder, H.K., W. Hollmann, P. Platen, M. Donike, A. Gotzmann, K. Weber: Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans. Horm. Metab. Res. 30: (1998) 188 194

Birkland, K.I., Donike, M., Ljungqvist, A., Fagerhof, M., Jensen, J., Hemmersbach, P., Oftebro, H., Haug, E.: Blood sampling in doping control. Int. J. Sports Med. (18) 1997 8 12.

Breidbach, A., Platen, P., Schänzer, W.: Erythropoietine-Influence of physical strain and application on blood and urine. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 319 321

Flenker, U., Nolteernsting, E., Schänzer, W., Donike, M.: Detection and classification of different male steroid profiles by means of multivariate statistics. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 203 210

Geyer, H., Mareck-Engelke, U., Schänzer, W., Donike, M.: The Cologne protocol to follow up high testosterone/ epitestosterone ratios. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 107-126.

Gotzmann, A., Geyer, H., Schänzer, W.: HPLC clean-up for urine samples with disturbing background for confirmation of 17ß-methyl-5ß-androst-1-ene-3*,17*-diol (epimetenediol). In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 239-246.

Horning, S., Geyer, H., Machnik, M., Schänzer, W., Hilkert, A., Oeßelmann, J.: Detection of exogenous testosterone by 13C/12C analysis. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 275-284.

Horning, S., Schänzer, W.: Basics of High Resolution Mass Spectrometry. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 253-260.

Horning, S., Schänzer, W.: Steroid screening using GC/HRMS. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 261-270.

Machnik, M., Delahaut, P., Horning, S., Schänzer, W.: Purification and concentration of anabolic steroids by immuno affinity chromatography (IAC). In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 223 238
.
Mareck-Engelke, U., Flenker, U., Schänzer, W.: Stability of steroid profiles (6) Influence of oral contraceptives on steroide profiles. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 139-158.

Nolteernsting, E., Matondo, I., Murwisi, E., Schänzer, W.: Brief report of the doping analyses during the 6th All Africa Games in Harare 1995. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 403-413.

Opfermann, G., Schänzer, W.: Trimethylsilylation- Aspects for derivatisation. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 247-252.

Schänzer, W., Horning, S., Opfermann, G., Donike, M.: Gas Chromatography/ Mass Spectrometry identification of long term excreted metabolites of the anabolic steroid 4-chloro-1,2-dehydro-17*-methyltestosterone in humans. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 33.

Schänzer, W., Seinsch, I.: Die Problematik der Medikamentenanwendung bei Sportpferden aus der Sicht des untersuchenden Labors. Prakt. Tierarzt, coll. vet. XXVII (1997) 51 55

Schänzer, W.: Aktuelle Probleme und Tendenzen im Doping. Leistungssport 2 (1997) 4 11.

Schänzer, W.: Anabolikaabusus im Sport und gesundheitliche Schädigungen. in: B. Alliolo, M. Grußendorf, O.A. Müller, T.Olbricht, H.M. Schulte (eds.) IV. Intensivkurs für Klinische Endokrinologie. Stuttgart 15.-18. Oktober (1997) 167-172.

Schänzer, W.: Der aktuelle Stand der Dopinganalytik. in: D. Kurz, J. Mester (eds). Doping im Sport-Zwischen biochemischer Analytik und sozialem Kontext-. Sport und Buch Strauß (1997) 7-26

Schänzer, W.: Doping und Dopinganalytik. Chemie in unserer Zeit. 31, Nr.5 (1997) 218 228

Schänzer, W.: Große Fortschritte im Kampf gegen Doping. NOK-Report 4 (1997), 16 - 18

Schänzer, W.: Metabolism of anabolic andogenic steroids. 5*- and 5ß-reduction of 3-keto-4-ene steroids. In: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (4). Sport und Buch Strauß, Köln , (1997) 185-201.

Strüder, H.K., Hollmann, W., Platen, P., Donike, M., Gotzmann, A., Weber, K.: Influence of paroxetin, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in man.

Strüder, H.K.,. Hollmann, P. Platen, A. Gotzmann, K. Weber: Einfluß des serotonergen und dopaminergen Systems auf endokrine Parameter und die körperliche und kognitive Leistungsfähigkeit. In: Dickhuth, H.-H., W. Küsswetter: 35. Deutscher Sportärztekongreß W(25.-27. 9.1997), Novartis Pharma Verlag, Wehr 1997, 195

Bowers, L.D., Horning, S.: High resolution mass spectrometry. Improved detection limits from a classical technique. Smith-Klein-Beecham, Press release 16.07.1996, Atlanta (1996)

Catlin, D.H., Cowan, D.A., De LA Torre, R., Fraisse, D.,Oftebro, H.,Hatton, C.K., Starevic, B.,Becchi, M., De La Torre, X., Norli, H., Geyer, H., Walker, C.J.: Urinary testosterone (T) to epitestosterone (E) ratios by GC-MS. I. Initial compairison of uncorrected T/E in six international laboratories. J Mass Spectrometry.31 (1996) 397 402

Donike, M., Rauth,S.:Dopingkontrollen. Bundesinstitut für Sportwissenschaft, Sport und Buch Strauß, Köln (1996)

Donike, M.: Gutachten zur Frage des Nachweises von Dopingmitteln im Blut. In: Bundesinstitut für Sportwissenschaften (Hrsg) Blut und/oder Urin zur Dopingkontrolle. Schriftenreihe des Bundesinstituts für Sportwissenschaft Band 86, Verlag Karl Hofmann, Schorndorf (1996) 127 151

Geyer, H., Schänzer, W., Mareck-Engelke, U., Donike, M.: Factors influencing the steroid profile. in: M.Donike, H.Geyer, A.Gotzmann, U.Mareck-Engelke (Eds.) Recent advances in doping analysis (3) Sport und Buch Strauß, Köln (1996) 95 114.

Geyer, H., Schänzer, W., Schindler, U., Donike, M.: Changes of the urinary steroid profile after sublingual application of dihydrotestosterone. in: M.Donike, H.Geyer, A.Gotzmann, U.Mareck-Engelke (Eds.) Recent advances in doping analysis (3) Sport und Buch Strauß, Köln (1996) 215-230.

Geyer, H.: Doping im Schwimmsport. Festrede zur 50-Jahrfeier des Schwimmbezirks Düsseldorf, Schwimmbezirk Düsseldorf Report 5 (1996)16 17.

Hollmann, W., H.K. Strüder, H. Herzog, H.-G. Fischer, P. Platen, K. De Meirleir, M. Donike: Gehirn - hämodynamische, metabolische und psychische Aspekte bei körperlicher Arbeit. Dt. Ärztebl. 93 (1996) 2033-2038

Horning, S., Schänzer, W., Donike, M.: Steroid profiling in human blood. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (3). Sport und Buch Strauß, Köln (1996) 325-336.

Horning, S: Finnigan MAT 95S High Resolution Mass Spectrometer assists in sports testing. Finnigan Analytical News, 96 (1996) 1-2.

Kambouris, M., Platen, P., Donike, M.: Detection of human growth hormone in urine of athletes. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (3). Sport und Buch Strauß, Köln (1996) 313 324

Mareck-Engelke U., Geyer H., Schindler U., Flenker U., Iffland R. and Donike M.: Influence of Ethanol on Steroid Profile Parameters in: M.Donike, H.Geyer, A.Gotzmann, U.Mareck-Engelke (Eds.) Recent advances in doping analysis (3) Sport und Buch Strauß, Köln (1996) 143-156.

Mareck-Engelke, U., Flenker, U., Donike, M.: Stability of steroid profiles (5): The annual rhythm of urinary ratios and excretion rates of endogenous steroids in female and its menstrual dependency. in: M.Donike, H.Geyer, A.Gotzmann, U.Mareck-Engelke (Eds.) Recent advances in doping analysis (3) Sport und Buch Strauß, Köln (1996) 177-190.

Nolteernsting, E., Opfermann, G., Donike, M.: 1-(N,N-Diisopropylamino)-n-alkanes: A new reference system for systematical identification of nitrogen containing substances by gas-chromatography and nitrogen specific or mass spectrometrical detection. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (3). Sport und Buch Strauß, Köln (1996) 369 388

Nolteernsting, E., Schänzer, W., Donike, M.: Experiences with d3-testosterone/d3-epitestosterone as internal standards for screening and confirmation of T/E ratios. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (3). Sport und Buch Strauß, Köln (1996) 191-200.

Schänzer W., Horning S.,Opfermann G. and Donike, M.: GC/MS identification of longterm excreted metabolites of the anabolic steroid 4-chloro-1,2-dehydro-17*-methyltestosterone in human. J. Steroid Biochem. Molec. Biol., 57 (1996) 363-376.

Schänzer, W., Delahaut, P., Geyer, H., Machnik, M., Horning, S.: Longterm detection and identification of metandienone and stanozolol abuse in athletes by gas chromatography / high resoloution mass spectrometry (GC/HRMS). Journal of Chromatography B, 687 (1996) 93 108.

Schänzer, W., Horning, S., Donike, M.: Synthesis and metabolism of [16,16,16-2H3]-5*-dihydrotestosterone. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (3). Sport und Buch Strauß, Köln (1996) 201-213.

Schänzer, W.: Metabolism of anabolic androgenic steroids. Review. Clinical Chemistry, 42 (1996) 1001-1020

Seinsch, I., Sigmund, G., Horning, S., Donike, M.: Detection of salbutamol in horse urine. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (3). Sport und Buch Strauß, Köln (1996) 349-355.

Shin, H.-S., Donike, M.,: Stereospecific Derivatization of Amphetamines, Phenal Alkylamines, and Hydroxyamines and Quantification of the Enantiomers by Capillary GC/MS. Anal Chem, 68 (1996) 3015 20

STRÜDER, H.K., W. Hollmann, M. Donike, P. Platen, K. Weber: Effect of O2 availability on neuroendocrine variables at rest and during exercise: O2 breathing increases plasma prolactin. Eur. J. Appl. Physiol. 74, (1996) 443 449

Breidbach, A., Sigmund, G.: Combination of screening procedures-Mesocarb Detection as an example. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 301-304.

Donike, M., Mareck-Engelke, U. and Rauth, S.: Statistical Evaluation of Longitudinal Studies, Part 2: The Usefullness of Subject Based Reference Ranges. in: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 157 165

Donike, M., Ueki, M., Kuroda, Y., Geyer, H., Nolteernsing, E., Rauth, S., Schänzer, W., Schindler, U., Völker, E., Fujisaki, M.: Detection of dihydro-testosterone (DHT) doping - Alterations in the steroid profile and reference ranges for DHT and its 5*-metabolites. J. Sports.Med.Phys.Fitness, 35 (1995) 235 50.

Geyer, H., Mareck-Engelke, U., Nolteernsting, E., Opfermann, G., Donike, M.: The matrix problem in calibration of the GC/MS for endogenous steroids.-The search for an artificial urine in: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 199-210.

Gotzmann, A.,Schänzer, W.,Geyer, H., Donike, M.: Detection of trenbolone by HPLC. in: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 269-274.

Horning, S., Schänzer, W., Donike, M.: GC/HRMS determination of the serum (plasma) testosterone/17*-hydroxyprogesterone ratio and its significance. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 51 58.

Horning, S., Schänzer, W., Donike, M.: Steroid Profiling in Human and Horse Blood: Some Results. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 39 50.

Mareck-Engelke, U., Geyer, H., Donike, M: Stability of steroidprofiles (3): Ratios and excretion rates of endogenous steroids in male urines collected over 24 hours. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 121 134

Mareck-Engelke, U., Geyer, H., Donike, M: Stability of steroidprofiles (4): Ratios and excretion rates of endogenous steroids in female urines collected four times over 24 hours. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 135-156.

Nolteernsting, E., Geyer, H., Mareck-Engelke, U., Schänzer, W., Donike, M.: Standardisation of the T/E-determination by deuterated internal standards. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 113-120.

Schänzer W. and Donike M.: Synthesis of deuterated steroids for GC/MS quantification of endogenous steroids. In Donike M (Ed.), Proceedings of the 12th Cologne Workshop in Dope Analysis, 1994, Sport und Buch Strauß, Köln, (1995) 93 112.

Schänzer W.: The illegal use of anabolic agents in sports. In Proceedings of the Scientific conference on growth promotion in meat production. Brüssel 29.11. - 1.12. 1995, European Commission. Office for Offical Publications of the European Communities, Luxembourg, 1995, 347-362.

Schänzer, W., Geyer, H., Gotzmann, A., Horning, S., Mareck-Engelke, U., Nitschke, R., Nolteernsting, E., Donike, M.: Endogenous production and excretion of boldenone (17ß-hydroxyandrosta-1,4-dien-3-one), an androgenic anabolic steroid. in: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke (eds.) Recent advances in doping analysis (2). Sport und Buch Strauß, Köln (1995) 211

Schänzer, W., Horning, S., Donike, M.: Metabolism of anabolic steroids in humans: Synthesis of 6b-hydroxy metabolites of 4-chloro-1,2-dehydro-17a-methyltestosterone, fluoxymesterone and metandienone, Steroids 60 (1995) 353 366

Strüder, H.K., W. Hollmann, P. Platen, R. Wöstmann, M. Donike, K. Weber: Einfluß von Paroxetin, verzweitgtkettigen Aminosäuren und Tyrosin auf das endokrine System und die körperliche Leistungsfähigkeit. Dtsch. Z. Sportmed. 46 (Sonderheft) (1995) 458-463.

Widder, R.A., Bartz-Schmidt, K.U., Geyer, H., Brunner, R., Kirchoff, B., Donike, M., Heinmann, K.: Candida albicans endophthalmitis after anabolic steroid abuse. The Lancet. 345 (1995) 330.

Donike, M., Rauth, S., Mareck-Engelke, U., Geyer, H., Nitschke, R.: Evaluation of longitudinal studies, the determination of subject based reference ranges of the testosterone/ epitestosterone ratio. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Recent advances in doping analysis. Sport und Buch Strauß, Köln (1994) 33 40.

Donike, M.; Geyer, H.; Gotzmann, A.; Horning, St.;Mareck-Engelke, U.; Nitschke, R.; Nolteernsting, E.;Rauth,S.; Schänzer, W.; Seinsch, I.; Sigmund, G.:Blood analysis in doping control. Advantages and disadvantages.in: P.Hemmersbach, K.I.Birkland (eds.) Blood samples in doping control. Proceedings of the 2nd International Symposium on Drugs in Sports, Towards the Use of Blood Samples in Doping Control. Lillehammer (1994) 75 92.

Geyer, H., Mareck-Engelke, U., Schänzer, W., Donike, M.: Simple purification of urine samples for improved detection of anabolic and endogenous steroids. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Recent advances in doping analysis. Sport und Buch Strauß, Köln (1994) 97 104.

Gotzmann, A., Schänzer, W., Donike, M.:The Quantification of Cortisol (Hydrocortisone) in Horse Urine by HPLC and GC/MS: Screening and Confirmation. Proceedings of the Tenth International Conference of Racing Analysts and Veterinarians, Stockholm (1994) 307 309

Horning S., Schänzer W., Sigmund G. Donike M.: High resolution GC/MS: Determing steroid concentrations in equine and human plasma. Identification. In Kallings P., Bondesson U., and Houghton E. (Eds), Proceedings of the 10th International Conference of Racing Analysts and Veterianarians, R&P Publications, Newmarket, England, (1994) 127-131.

Horning, S., Donike, M.: High-Resolution GC/MS. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Recent advances in doping analysis. Sport und Buch Strauß, Köln (1994) 155-161.

Mareck-Engelke U., Geyer H. and Donike M.: Stability of steroid profiles (2): Excretion rates from morning urines. in: M. Donike, H. Geyer, A. Gotzmann, U.Mareck-Engelke, S.Rauth (Eds.) Recent advances in doping analysis, Sport und Buch Strauß, Köln (1994) 85 89.

Schänzer W, and Donike M.: Review - Synthesis of 6ß-hydroxy-3-keto-4-ene steroids, and synthesis of 6ß-hydroxy metabolites of anabolic steroids. In: M. Donike, H.Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Recent advances in doping analysis. Sport und Buch Strauß, Köln (1994) 9 23.

Schänzer W., Gotzmann A., Horning S. and Donike M.: Trimethylsilyl derivatisation of endogenous and synthetic corticosteroids for GC/MS Identification. In Kallings P., Bondesson U., and Houghton E. (Eds), Proceedings of the 10th International Conference of Racing Analysts and Veterianarians (1994) 140-146.

STRÜDER, H.K., M. DONIKE, J. DUPERLY, K. WEBER, W. HOLLMANN: Konzentrationsveränderungen der Aminosäuren im Plasma während eines Tennismatches über 4 h und ihr Einfluß auf Neurotransmitter. In: LIESEN, H., M. WEIß, M. BAUM (Hrsg.): Regulations- und Repairmechanismen. 33. Deutscher Sportärztekongress Paderborn 1993, Deutscher Ärzte-Verlag, Köln 1994, 541-544

STRÜDER, H.K., M. DONIKE, K. WEBER, W. HOLLMANN: Changes in concentrations of plasma amino acids during a 4 h tennis match and their effect on brain neurotransmitters. Int. Sports Med. 15,(1994) 366

Donike, M., Geyer, H., Rauth, S.: Entwicklung der Steroidprofile und der Wettkampfleistungen im Gewichtheben 1989 und 1990 nach Einführung von strikten Dopingkontrollen, Steroidprofile im Sport - 3. Mitteilung. Deutsche Zeitschrift für Sportmedizin (Sonderdruck), 44 (1993) 329 -341.

Donike, M., Ho-Sang, Shin: Chirality in doping analysis. In: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 159-162.

Donike, M., Rauth, S., Sample, B.:Excretion of ephedrine and endogenous steroids under conditions of controlled water intake and of water diuresis. In: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 163-176.

Donike, M., Rauth, S., Wolansky, A.: Reference ranges of urinary endogenous steroids determined by gas-chromatography/mass spectrometry. in: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 69 86.

Donike, M.: Steroid profiling in cologne: In: M. Donike, H. Geyer, H., A. Gotzmann, U. Mareck-Engelke, S. Rauth (Eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 47 62.

Geyer, H., Schänzer, W., Donike, M.: Probenecid as masking agent in dope control - Inhibition of the urinary excretion of steroid glucuronides. In: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 141-152.

Gotzmann, A., Donike, M.: Quantitative caffeine determination by direct injection of urine. In: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 281-284.

Gotzmann, A., Platen, P., Keizer,, H.A., Donike, M., Velde, C., Heps, U., Dobberstein, C.: Exercise induced changes of serum tryptophan (TRP) and the large-neutral-aminoacids (LNAA) and their relation to prolactin (PRL) release in trained women. Med. Sci. Sports Exerc. 25, supl. 5 (1993) 432.

Mareck-Engelke, U., Geyer, H., Donike, M.: Stability of steroid profiles. In: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 87 90.

Schänzer, W., Delahaut, P., Völker, E., Donike, M.: Immunoaffinity chromatography in isolation of anabolic steroids. In: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 307-320.

Schänzer, W., Donike, M.: Metabolism of anabolic steroids in man: Synthesis and use of reference substances for identification of anabolic steroid metabolites. In: Donike, M., Geyer, H., A. Gotzmann, U. Mareck-Engelke, S. Rauth (eds.) Proceedings of the 10th Cologne Workshop on Dope Analysis 7th to 12th June 1992, Sport und Buch Strauß, Köln (1993) 97 100.

Schänzer, W., Donike, M.: Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Analytica Chimica Acta, 275 (1993) 23 48.

STRÜDER, H.K., M. DONIKIE, A. FERRAUTI, K. WEBER, W. HOLLMANN: The effect of a 4 h tennis match on amino acid metabolism and ammonia formation. In: European Network of Sport Sciences in higher Education: 2. European Forum "Sport Science in Europa, Deutsche Sporthochschule Köln (1993)

STRÜDER, H.K., W. HOLLMANN, M. DONIKE, H.G. FISCHER, A. FERRAUTI, K. WEBER: Changes in plasma free tryptophan and branched-chain amino acids and relationship with prolactin in tennis. FIMS 7th European Sports Medicine Congress, Nicosia, Cyprus 1993, 35

Strüder, H.K., W. Hollmann, P. Platen, M. Donike, A. Gotzmann: Prolactin response to endurance exercise in relation to altered levels of plasma neutral amino acids and plasma free tryptophan. Med. Sci. Sports Exerc. 25 (Suppl.) (1993)

Donike M. and Schänzer W.: Detection of anabolic steroids in human sport-The state of the art. In C.R.Short (Ed), Procceedings of the 9th International Conference of Racing Analysts and Veteriarians, New Orleans, 1992, 17-35.

Donike, M.: Aktuelle Probleme des Dopings im Leistungssport. Leistungssport 1 (1992) 5-8.

Hanisch, F.-G., Witter, B., Crombach, G. A., Schänzer, W., Uhlenbruck,G.: N-Glycolylneuramic acid is a chemical marker of gangliosides from human breast carcinoma. In: R.Klapdor (ed) Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis. W. Zuckschwerdt Verlag München (1992) 367-370.

Schänzer W. and Donike M.: Metabolism of boldenone in man: Gas chromatographic-mass spectrometric identification of urinary excreted metabolites and determination of excretion rates. Biol. Mass Spectrom., 21 (1992) 3 16.

Schänzer W., Opfermann G. and Donike M.: 17-Epimerization of 17*-methyl anabolic steroids in humans: Metabolism and synthesis of 17alpha-hydroxy-17ß-methyl steroids. Steroids, 57 (1992) 537-550.

Donike, M., Schänzer, W.: Stoffwechsel von anabolen Steroiden: Die Ausnahmestellung von Stanozolol. In: R. Häcker, H. de Marées (eds.) Hormonelle Regulation und psychophysische Belastung im Leistungssport, Deutscher Ärzte-Verlag, Köln (1991) 49 54

Geyer, H.: Dopingkontrollen und ihre Probleme.in: W.Freitag (Hrsg.): Schwimmen Lernen und Optimieren.4. Tagungsband der Deutschen Schwimmtrainer-Vereinigung 1991

Schänzer, W., Geyer, H. Donike, M.: Metabolism of metandienone in man: Identification and synthesis of conjugated excreted urinary metabolites. Journal of Steroid Biochemistry and Molecular Biology, 38 (1991) 441-464.

Donike, M., Geyer, H., Kraft, M., Rauth, S.: Longterm influence of anabolic steroid misuse on the steroid profile. In: P. Belotti, G. Benzi, A. Ljungqvist (eds) Official Proceedings of the IInd I.A.F. World Symposium on Doping in Sport, International Athletic Foundation, Monte Carlo (1990), 107-116

Donike, M.: Overview on present analytical procedures in dope analysis. In: P. Belotti, G. Benzi, A. Ljungqvist (eds.) Official Proceedings of the IInd I.A.F. World Symposium on Doping in Sport, International Athletic Foundation, Monte Carlo (1990), 83-92

Kraft, M.: Approach to combine the present analytical methods for the detection of dope agents to a comprehensive screening procedure with GC/MG detection In: P. Belotti, G. Benzi, A. Ljungqvist (eds.) Official Proceedings of the IInd I.A.F. World Symposium on Doping in Sport, International Athletic Foundation, Monte Carlo (1990), 107-116.

Schänzer W., Opfermann G. and Donike M.: Metabolism of stanozolol: Identification and synthesis of urinary metabolites. J. Steroid Biochem., 36 (1990) 153 174


Webseite des Instituts für Biochemie der DSHS Köln, letztes Update 10.5.2022, www.dopinginfo.de